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3 Abstract 
 
 The vascular system is an essential organ in vertebrate animals and provides the organism 
with enough oxygen and nutrients. It is composed of an interconnected network of blood 
vessels, which form using a number of different morphogenetic mechanisms. Angiogenesis 
describes the formation of new blood vessels from preexisting vessels. A number of 
molecular pathways have been shown to be essential during angiogenesis. However, cellular 
architecture of blood vessels as well as cellular mechanisms involved during vessel 
formation and anasotmosis have remained largely unknown.  
 The intersegmental vessels (ISVs) of the developing zebrafish embryo have served as a 
paradigm to study angiogenesis in vivo. ISVs sprout bilaterally from the dorsal aorta (DA) in 
the zebrafish trunk, grow dorsally and ultimately connect with adjacent ISVs on the dorsal 
side of the trunk forming the dorsal longitudinal anastomotic vessel (DLAV). 
 We used antibody labeling of endothelial cell-cell junctions, single cell labeling and live-
imaging of junctions to investigate cellular architecture and mechanisms during ISV formation 
and anastonosis. In contrast to previous studies, we found that a large part of ISVs consist of 
multicellular tubes where the lumen is surrounded by several cells. Seamless tubes with an 
intracellular lumen are predominantly found in the DLAV. In addition, we found distinct 
cellular mechanisms to be involved in ISV anastomosis, forming seamless or multicellular 
tubes respectively. These results show that endothelial cells a rather plastic and can use 
different mechanisms to form functional blood vessels. 
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4.1 Structure and formation of biological tubes 
Biological tubes are found in many different varieties in the animal kingdom, such as the gut, 
the lung, the kidney, the vascular system or the tracheal system of insects. Even though 
these tubes fulfill different tasks, they all consist of polarized epithelial or endothelial tubes 
and many of them undergo branching morphogenesis. 
4.1.1 Epithelial and endothelial cell polarity 
 Cells building a polarized tube have different membrane compartments. The apical 
membrane is facing the inside of the tube (the lumen). The basal membrane is facing the 
outside, often forming a basal lamina consisting of a dense network of extracellular matrix 
(ECM) proteins. The lateral membrane is where epithelial cells are interconnected via several 
types of junctional complexes. For some specialized epithelium such as the endothelium, 
where cells do not have the typical cuboidal shape but are rather elongated and thin, the 
lateral membrane is nonexistent and apical and basal membrane are only separated by 
junctional proteins (Dejana et al., 2009). The different types of junctions can be located more 
to the apical or more to the basal side of the lateral membrane. For most epithelia, adherens 
junctions (AJ) are located to the basal side, whereas tight junctions (TJ) are located towards 
the apical side. One exception are epithelia of Drosophila melanogaster, where AJ are 
subapical and TJ, in Drosophila termed septate junctions, basal to the AJs (Figure 4.1 A and 
B; (Andrew and Ewald, 2010)). In endothelial cells (EC) AJs and TJs are thought to be 
intermingled and not clearly separated (Figure 4.1C; (Bazzoni and Dejana, 2004)). 
 
 
Figure 4.1 
 Epithelial cells: Scheme shows basic distribution of membranes and junctions in epithelial and 
endothelial cells. While epithelial cells have a rather cuboidal shape (A and B), endothelial cells have 
a flat and elongated shape (C). The apical membrane (red) is facing the lumen and the basal 
membrane (green) is facing the outside and often contacts a basal lamina (orange). Epithelial cells 
have a lateral membrane (blue) between the apical and the basal membrane. Due to their thin 
morphology EC lack the lateral membrane. AJ and TJ maintain integrity and control permeability of 
the epithelium. In mammalian epithelia TJ are located to the apical side and AJ to the basal side, 
whereas in epithelia of Drosophila melanogaster AJ are located towards the apical side. It is thought 
that junctions between EC are intermingled without a clear border between AJ and TJ. 
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4.1.2 Tube architectures 
  Different types of tubes and different mechanisms to form these have been described in the 
past (Lubarsky and Krasnow, 2003). The most prominent tube morphology is the multicellular 
tube where several cells are organized around the lumen resulting in an extensive network of 
junctions connecting these cells (Figure 4.2 A). Two types of unicellular tubes (only one cell 
around the lumen) have been described. In tubes with autocellular junctions, one cell 
reaches around the lumen and makes contact with itself. This is then seen as a single line of 
junctions (Figure 4.2 B). Such tubes are found in the tracheal system of Drosophila 
melanogaster (Ribeiro et al., 2004) and in a few specialized cells of the excretory tract in C. 
elegans (Stone et al., 2009). The second kind of unicellular tubes do not have junctions 
along the long axis of the tube-forming cell and are thus also called seamless or intracellular 
tubes (Figure 4.2 C). Such tubes are found in the terminal cells of the tracheal system, in the 
C. elegans digestive tract (Rasmussen et al., 2008) as well as in the vascular system (Wolff 
and Bar, 1972).   
 
 
4.1.3 Tube formation mechanisms 
  There are different mechanisms controlling the development of these tubes: An already 
polarized epithelial layer can undergo wrapping by first forming a groove along an axis where 
eventually the edges of the groove will seal and form a tube separated from the rest of the 
epithelial layer. This mechanism is found in neural tube development of various species 
(Figure 4.3 A;(Colas and Schoenwolf, 2001)). During budding a new tube grows from a 
preexisting epithelial tube. During this process, cells remain polarized and the lumen of the 
Figure 4.2 
 Different tube architectures: Three basic architectures of tubes have been described: (A) 
multicellular tubes: several epithelial cells organize around the circumference of the lumen. This 
results in a characteristic meshwork of junctions. (B) Unicellular tubes with autocellular 
junctions: the lumen is formed by a single cell sealed along the tube axis with an autocellular 
junction. (C) Seamless tubes: the lumen is within a cell without junctions along the tube resulting 
in an intracellular lumen (Baer et al., 2009). 
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growing tube is extended as the tube extends (Figure 4.3 B). This mechanism is used for 
many branching processes such as vascular, tracheal or lung branching morphogenesis 
(Adams and Alitalo, 2007; Metzger et al., 2008; Samakovlis et al., 1996a). The next two 
mechanisms do not involve a pre-polarized epithelium but aggregates or cords of cells. 
During cavitation a thick cord of cells forms a tube by eliminating cells inside the cord and 
polarizing the outer ones (Figure 4.3 C). During cord hollowing a rather thin cord of cells is 
transformed in an epithelial tube by polarizing all available cells (Figure 4.3 D). Examples are 
found in the vascular system (Jin et al., 2005; Strilic et al., 2009). Cell hollowing will create a 
lumen spanning through a single cell resulting in the above mentioned intracellular lumen 
(Figure 4.3 E). Such a lumen can be formed by the invagination and the fusion of apical 
membranes as seen in the fusion cells of the tracheal system of Drosophila melanogaster 
(Samakovlis et al., 1996a) or by the formation of large vacuoles as proposed for parts of the 
zebrafish vasculature (Kamei et al., 2006). A third possibility is the self-wrapping of a single 
cell resulting in an auto-cellular junction with subsequent cell self-fusion, thereby generating 
a seamless tube. Such a mechanism has been identified in the C.elegans digestive tract and 
requires specific fusogenic proteins (Figure 4.3 F; (Rasmussen et al., 2008)). Budding, cord 
hollowing and cell hollowing are the important mechanisms during vascular development.  
        
 
Figure 4.3 
 Cellular mechanisms involved in lumen formation: A number of mechanisms used to form 
biological tubes. (A) Wrapping: An epithelial sheet invaginates along the future tube axis until the 
edges meet and the tube separates from the sheet. (B) Budding: a new tube is formed from an 
existing tube maintaining polarity. (C) Cavitation: Cells in the middle of a cord of cells are 
eliminated. Concomitantly, the outer cells are polarized thereby forming a tube. (D) Cord hollowing: 
All cells in a cord of cells polarize and form a tube. (E) Cell hollowing: a lumen is formed in a single 
cell by the formation of vacuoles or by invagination of apical membrane. (F) A special variation of 
cell hollowing, is the wrapping of a single cell and subsequent cell-self fusion (Baer et al., 2009). 
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4.2 Vascular development 
4.2.1 The vascular system and the zebrafish as a model system 
 In the vertebrate kingdom the vascular system ensures the supply of oxygen and nutrients 
as pure diffusion cannot fulfill this task in larger animals. Performing this task, it is one of the 
first organs to develop in vertebrate systems as it is not only important for the maintenance of 
other organs, but also for the proper development of these organs. 
 Before it can do so, the vascular system has to develop and form an extensive network of 
vessels and capillaries. The vascular system is built up by endothelial cells (EC), which have 
to undergo a number of activities such as cell migration, cell rearrangement, cell polarization, 
cell shape change and cell division to guarantee proper development and function. If all 
these cellular mechanisms are correctly coordinated, morphogenetic events such as vessel 
sprouting, fusion and lumen formation occur in a proper way. 
 During the last decades a number of molecular pathways have been shown to be essential 
for vascular development, the most prominent one being VEGF (vascular endothelial growth 
factor).  
 Different model systems have been used to study the vascular system such as mouse, 
chicken and cell culture systems. In more recent years, the zebrafish has proved to be an 
excellent model organism to study vascular development. Many aspects of vascular 
development and anatomy are conserved among vertebrates. For instance, early vascular 
anatomy in mice and zebrafish is similar including the dorsal aorta (DA), intersegmental 
vessels (ISVs) and the dorsal longitudinal anastomotic vessel (DLAV) (Figure 4.4). Due to its 
optical clarity and experimental accessibility, the zebrafish embryo is especially well suited 
for morphogenetic analysis using live imaging techniques. Endothelial specific transgenic 
lines such as the fli1a:GFP line and microangiography (the injection of a fluorescent dye into 
the circulation) have greatly contributed to our knowledge of vascular anatomy and 
development of the zebrafish (Isogai et al., 2001; Isogai et al., 2003).  
 Another advantage of the zebrafish when studying vascular development is the fact that the 
zebrafish embryo survives up to 5 days post fertilization (dpf) without a functional vascular 
system as enough oxygen is supplied by simple diffusion. This allows the analysis of 
cardiovascular mutants, which would not be possible in mice due to early lethality.  
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4.2.2 Vasculogenesis 
 Vascular development is usually subdivided into two processes, where the initial formation 
of a primary network of vessels from endothelial precursor cells (EPC or angioblast) is 
termed vasculogenesis, and the subsequent formation of new blood vessels from this 
primary network, which leads to the formation of a fine network of capillaries, is called 
angiogenesis. 
 
4.2.2.1 Origin and differentiation of endothelial cells 
 Vasculogenesis can be subdivided into three steps: first angioblasts are differentiated from 
the mesoderm; second, angioblasts migrate and assemble to form cord-like structures, and 
third, a lumen is formed creating an endothelial tube. 
The development of the primary vessels is tightly linked with primitive hematopoiesis. Since a 
long time it has been suggested that endothelial cells and hematopoietic cells arise from a 
common progenitor called hemangioblast (Risau and Flamme, 1995). Fate mapping studies 
in zebrafish revealed that at least some endothelial cells and hematopoietic cells arise from 
common hemgioblasts (Vogeli et al., 2006; Warga et al., 2009). 
 In zebrafish, angioblasts differentiate from the lateral plate mesoderm. On the one hand 
angioblasts that originate from the anterior lateral plate mesoderm (ALPM) give rise to the 
cranial vasculature and, on the other hand, angioblasts that originate from the posterior 
Figure 4.4 
 Conserved vascular anatomy: A number of vessels such as the dorsal aorta (DA), the 
intersegmental vessels (ISV) and the dorsal longitudinal vessel (DLAV) are conserved in the early 
embryo of mouse (A) and zebrafish (B and C) (Ellertsdottir et al., 2010; Walls et al., 2008). 
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lateral plate mesoderm (PLPM) will form the main trunk vessels, the dorsal aorta and the 
cardinal vein (Jin et al., 2005; Proulx et al., 2010).    
 A set of factors such as Bmp, Fli1, an unknown factor encoded by the gene cloche and Scl 
are needed to differentiate the ventral mesodermal cells to angioblasts/hemangioblasts and 
later to endothelial cells (Gupta et al., 2006; Liao et al., 1998; Liao et al., 1997). Activation of 
Scl triggers genes such as vegfr-2 (also known as flk1), the ets transcription fli1 and gata1. 
Later cells acquire a unique combination of scl/flk expression, which segregates endothelial 
cells (flk1+/scl-) from hematopoietic cells (flk1-/scl+) (Gering et al., 1998). 
  Sonic hedgehog (Shh) is expressed in the zebrafish notochord and triggers transcription of 
vegf (vascular endothelial growth factor), the main growth factor acting on endothelial cells 
(Lawson et al., 2002). Interestingly, VEGF does not seem to be essential for the migration of 
angioblasts from the LPM to the midline but is required for the differentiation of angioblasts to 
arterial ECs (Jin et al., 2005). This is in contrast to mouse and Xenopus where VEGF is 
essential for the migration and formation of the primary vessels (Carmeliet et al., 1996; 
Cleaver and Krieg, 1998). 
 
4.2.2.2 Dorsal Aorta, Cardinal Vein formation and arterial venous differentiation 
 Angioblasts migrate in two waves, where the first wave starts to migrate at 14hpf and the 
second wave at 16hpf. The first wave aggregates at the midline between the endoderm and 
the notochord. These cells are not yet polarized and initially do not form junctions among 
each other. Starting at 17hpf these cells start to form adherens junctions and to polarize, 
eventually forming a patent vessel. During this process, endothelial cells change their cell 
shape from a cuboidal to an elongated shape. At 30hpf, when circulation is established, 
junctional proteins such as ZO-1 are present in the DA and in the posterior cardinal vein 
(PCV) (Jin et al., 2005).  
 Although it was initially thought that the PCV forms via the same mechanism using the 
second wave of angioblasts, new insight suggests that only one EC cord is formed at the 
midline, from which cells fated to be venous segregate and sprout ventrally to form the PCV. 
This so called selective cell sprouting mechanism is impaired if arterial-venous differentiation 
is defective (Herbert et al., 2009). 
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 Arterial and venous ECs have to fulfill different tasks and were initially thought to be defined 
by different directions of blood flow. However, recent evidence strongly suggests that the 
differences are genetically specified and determined before onset of blood circulation 
(Lawson and Weinstein, 2002a). One of the first evidence for molecular differences in 
arteries and veins came from a study in the mouse embryo. This study described the 
differential expression of the Ephrinb2-Ephb4 ligand receptor pair in arteries and vein. While 
the ligand Ephrinb2 is only expressed in the arteries, the level of expression of the receptor 
Ephb4 is much higher in the vein (Wang et al., 1998). Since the discovery of these first 
markers, a whole set of markers and pathways have been discovered, which ensures the 
identity of arteries or veins. Shh signaling from the notochord activates VEGF in the somites, 
which in turn activates Notch signaling in arteries due to their closer proximity to the VEGF 
signal (Lawson et al., 2002). Notch signaling activates EphrinB2 and, via Hey/Gridlock, 
suppresses EphB4 (Lawson et al., 2001; Zhong et al., 2001; Zhong et al., 2000). Venous fate 
was initially thought to be the ground state of ECs but recent studies discovered COUP-TFII 
as a transcription factor that represses Notch signaling and thereby actively inhibiting arterial 
differentiation (Swift and Weinstein, 2009; You et al., 2005). 
 In the case of selective cell sprouting described above, changing EphrinB2-EphB4 levels 
and their upstream regulators leads to segregation of all or none of the ECs to venous or 
arterial fate respectively (Herbert et al., 2009).  
 
4.2.2.3 Lumen formation during vasculogenesis 
It is thought that the lumen is formed by a cord hollowing process. Not many factors are 
known to be essential for lumen formation of the zebrafish DA and PCV. EGFL7 has been 
shown to be required (Parker et al., 2004), but mechanistic insight is lacking. Recent studies 
Figure 4.5 
Vasculogenesis in the zebrafish embryo: (A) Endothelial cells differentiate from the lateral plate 
mesoderm and migrate to the midline just above the endoderm (en). (B) Cells aggregate into a 
cord at the midline.(C-D) From there venous fated cells segregate ventrally and engulf blood 
cells, thereby forming the posterior cardinal vein (PCV). The dorsal aorta (DA) forms by cord 
hollowing (Ellertsdottir et al., 2010). s: somite, nc: notochord, nt: neural tube. 
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have revealed the molecular basis of lumen formation of the DA in the mouse embryo. 
Similar to the zebrafish, ECs form cords, which are subsequently lumenized. Initially ECs 
have junctions at multiple positions (sheet of junctions) along their cell-cell contact. In a 
second step proteins of the CD34-sialomucin family (CD34 and Podocalyxin (PDXL)) are 
recruited to the EC cell-cell contact demarking the future apical membrane. The antiadhesive 
extracellular domain of the CD34-sialomucin is important to separate the apposing apical 
membranes from each other. Ve-cadherin is essential for the recruitment of CD34 and PDXL 
to the apical membrane. Moesin, a member of the ERM protein family, is phosphorylated by 
PKC (protein kinase C) and recruits F-actin to the apical membrane. A VEGF driven 
activation of non muscular myosin II initiates EC shape changes and completes vascular 
lumen formation (Strilic et al., 2009). 
A recent study in zebrafish implicates moesin1 in ISV lumen formation, vessels, which form 
via angiogenesis (see below). The dorsal aorta seems to be unaffected as injected dye 
spreads in the dorsal aorta but not in the ISVs. More molecular markers will be needed in the 
zebrafish to prove or disprove a similar mechanism for the lumen formation in the DA of the 
zebrafish embryo (Wang et al., 2010).  
4.2.2.4 More anterior vessels 
The trunk vessels of the zebrafish are the best characterized as the trunk is rather thin and 
easy to image. But vessels at different locations in the embryo may utilize different 
mechanism. Anterior to the zebrafish trunk, the DA splits in two bilateral vessels named 
lateral dorsal aorta (LDA)  (Isogai et al., 2001). Recent work shows, that LDA development is 
dependent on the endoderm (Siekmann et al., 2009), whereas in the trunk the endoderm 
only delays the development of the DA (Jin et al., 2005). The endoderm is expressing the 
chemokine ligand CXCL12 and the ECs in the region of the LDA, but not ECs in the DA, 
express the receptor CXCR4. Mutants for cxcr4 do not complete formation of the LDA and 
connection to the DA (Siekmann et al., 2009). 
 In the head region, the ALPM produces two so called organizing centers, the rostral (ROC) 
and the midbrain organizing center (MOC). Whereas the ROC will form the anterior part of 
the cranial vasculature, the MOC will form the vessels around the midbrain and hindbrain. In 
contrast to the angioblasts of the PLPM, these angioblasts do not migrate to the midline to 
form a single cord at the midline (except for cells of the MOC, which will give rise to 
endocardial cells), but rather stay as bilateral stripes to form the appropriate cranial vessels. 
Still, angioblasts of the ROC and MOC are rather motile and migrate in an angiogenic way to 
form the vessels. It’s not clear yet at what time point these angioblasts become polarized 
endothelial cells and form endothelial tubes. Eventually, the vessels of the ROC and MOC 
will join completing the primary vascular system (Proulx et al., 2010). 
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4.2.3 Angiogenesis 
After the primary vessels have formed via the process of vasculogenesis, new vessels form 
via angiogenesis, a process which involves several cellular activities such as cell migration, 
cell division, cell rearrangement, anastomosis and lumen formation.  
  Angiogenesis has gained particularly high attention since it was first described in the 1970 
due to its relevance in pathological situations. Especially the fact that angiogenesis is 
essential for the growth of tumors and for metastasis in cancer pathologies (Ausprunk and 
Folkman, 1977; Folkman, 1971; Folkman, 1982; Proulx et al., 2010), let the field to explode. 
 Two model systems have emerged and showed to be particularly useful to study 
angiogenesis in vivo. One is the retinal vasculature of the mouse as its development occurs 
after birth, and is thus more accessible. The second one are the intersegemental/intersomitc 
vessels (ISVs) of the zebrafish due to its reproducible pattern and optical clarity of the fish, 
allowing extensive live imaging studies.  
 ISVs form a regular pattern in the zebrafish trunk, positioned at each somite boundary. The 
formation of ISVs has been described in detail by Isogai et.al. in 2003. In an initial step ISVs 
sprout bilaterally from the DA at each somite boundary at around 22 hpf (Figure 4.6 A,A’). 
There is an anterior to posterior delay of sprouting, with more anterior ISVs sprouting earlier. 
ISVs sprouts subsequently grow dorsally following the somite boundary up to the midline 
where they take a more direct path towards the dorsal side of the embryo. Once the ISVs 
reach the dorsal part of the neural tube, they stop growing dorsally and start to make 
projections in anterior and posterior direction, eventually meeting and connecting with their 
neighbouring ISVs at around 30 hpf (Figure 4.6 B,C,B’,C’). These first loops consist of ISVs 
exclusively connected to the DA and are thus not suitable to build up circulation (Isogai et al., 
2003). Therefore, connections to the PCV are established in a second step. New sprouts 
emerge from the PCV approximately at 36 hpf and grow dorsally (Figure 4.6 D,D’). The 
number of sprouts and the timing of sprouting is not as stereotyped as for the initial sprouting 
from the DA. The venous sprouts grow adjacent to existing ISVs, where they either connect 
to the ISV forming a venous ISV, or they contribute and form the parachordal vessel, a 
primordium for the lymphatic vessels (Hogan et al., 2009a; Yaniv et al., 2006) (Figure 4.6 
E,E’). The distribution of arterial and venous ISVs is not regular except for the first 5 sets of 
ISVs. The distribution is likely a result of adaptation to hemodynamic forces in each individual 
embryo and thus changes from embryo to embryo (Isogai et al., 2003). 
This process requires different steps, like sprout formation, vessel growth and guidance, 
fusion and lumen formation as well as vessel stabilization and regression. All of these steps 
need molecular control and a variety of factors to occur properly. 
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4.2.3.1 Sprout formation 
When it comes to the formation of a new vessel, a leading cell is determined, usually referred 
as the tip cell, which guides vessel outgrowth along the correct path.  
 Even though some vessels such as ISVs may form during early development according to 
an inherent blueprint established by a genetic cascade of signaling, the vasculature has to 
react to needs of oxygen and nutrients in the surrounding tissue. Nature has selected for a 
clever system to react upon oxygen shortage by utilizing a O2 sensing system. This system 
consists of the transcription factors Hypoxia Inducible Factor α 1-3 (HIFα 1-3) and the Prolyl 
Hydroxylase protein Domain (PHD1-3). PHDs are the O2 sensing proteins and during 
normoxia they use O2 to hydroxylate proline residues on the HIF-1α protein. These residues 
are then recognized by the von Hippel Lindau (VHL) protein, which targets HIF-1α to the 
proteasome for degradation. Under hypoxic conditions O2 levels are not high enough for 
hydroxylation of HIF1-α and HIF1-α can thus, together with HIF1-β, a non regulatory subunit, 
activate downstream targets (Fraisl et al., 2009; Hanze et al., 2007).  Importantly, one of the 
major target genes is vegf (Liu et al., 1995), important for many angiogenic behaviors of ECs 
and the formation of new vessels (see also Figure 4.7 A).  
VEGF was initially discovered as Vpf1 (vascular permeability factor 1) (Senger et al., 1983), 
and later cloned by Ferrara and colleagues in 1989 and termed VEGF (Leung et al., 1989).  
Figure 4.6 
 Formation of intersegmental vessels (ISVs): ISVs form at each somite (s) boundary and elongate 
towards dorsal following the somite boundaries (A,A’). Once they reach the dorsal side they form 
protrusions and filopodia in anterior and posterior directions (B,B’). Eventually ISVs anastomose 
forming the DLAV (C,C’). From 35 hpf onward sprouts from the PCV form (D,D’). Some of these 
sprouts eventually connect with existing arterial ISV turning them into venous ISVs forming 
circulatory loops in ISVs (E,E’) (modified from Isogai et al., 2003). 
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VEGFs and their tyrosine kinase receptors (VEGFR) are likely the most important regulators 
of angiogenesis and vascular development. The family includes five ligands, VEGF-A (or just 
VEGF), VEGF-B, VEGF-C, VEGF-D and Placental Growth Factor (PLGF). All these ligands 
bind with different specificity to the three main receptors, VEGFR-1 (also called fms-like 
tyrosine kinase 1 (Flt1)), VEGFR-2 (also known as kinase insert domain receptor (KDR) in 
human, fetal liver kinase 1 (Flk1) in mouse or KDR-like (KDRl) in zebrafish) and VEGFR-3 ( 
or Flt4). In addition Neuropilin 1 and 2 can act as co-receptors (Olsson et al., 2006). VEGF 
signaling via VEGFR-2 is responsible for activating angiogenic behavior in ECs. VEGFR-2 
signals via different downstream pathways including the phospholipase C (PLC)γ/ protein 
kinase C (PKC)- MAP-kinase pathway and the phosphoinositide 3-kinase (PI3K)-Akt 
pathway, thereby regulating EC proliferation, migration, survival and permeability (Lohela et 
al., 2009). In contrast, VEGFR-1 has high affinity to the VEGFs but low tyrosine kinase 
activity and thus serves as a VEGF trap. Studies have shown that mice lacking the tyrosine 
kinase domain of VEGFR-1 are viable and show a normal vasculature, whereas knockout 
mice lacking the complete function of VEGFR-1 die early due to disorganized vessels and an 
excess of ECs (Fong et al., 1995; Hiratsuka et al., 2005). VEGF-C mostly signals through 
VEGFR-3 and is important for venous sprouting and for lymphangiogenesis but has also 
been implicated in potentiating VEGFR-2 signaling during angiogenesis(Covassin et al., 
2006; Hogan et al., 2009b; Karkkainen et al., 2004; Tammela et al., 2008).   
 Correct VEGF levels are essential for proper angiogenesis as VEGF heterozygous mutant 
mice die during embryogenesis due to abnormal vascular development. In contrast, 
heterozygous mutants for the receptors VEGFR-1 and 2 are viable and show a normal 
vasculature (Carmeliet et al., 1996; Ferrara et al., 1996).  
 Studies in the mouse retinal system have shown that a gradient of VEGF is essential to 
specify a normal amount of tip cells. Changing the amount or the gradient of VEGF results in 
loss or gain of tip cell identity (Gerhardt et al., 2003). A recent study shows that tip cell 
selection is dependent on relative amounts of VEGFR-1 and VEGFR-2. In chimeric assays in 
vitro and in vivo using heterozygous cells for VEGFR-1 or 2, VEGFR-1 heterozygous cells 
show a higher probability to contribute to tip cells (VEGF signaling is higher due to lack of 
one copy of VEGFR-1), whereas VEGFR-2 heterozygous cells contribute more to stalk cells 
(Jakobsson et al., 2010). VEGF signaling activates Dll4, which activates Notch in neighboring 
cells. Notch signaling down-regulates VEGFR-2 and 3, but up-regulates VEGFR-1. This 
means that Notch signaling limits angiogenic behavior of cells next to tip cells. Thus cells 
sensing the highest amount of VEGF will become tip cells and via Notch instruct its 
neighboring cells to become stalk cells. Losing a single dll4 allele or loss of Notch results in 
increased sprout formation and increased number of tip cells (Hellstrom et al., 2007; Lobov 
et al., 2007; Suchting et al., 2007; Tammela et al., 2008) (Figure 4.7 B). 
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 Similar studies in zebrafish showed that upon suppressing the Notch pathway in dll4 
knockdown embryos or with chemical inhibitors, ISVs show excessive filopodia formation and 
at later stages increased vessel formation in the DLAV and other regions such as the gut 
vasculature (Leslie et al., 2007). In addition, down-regulation of the Notch pathway, results in 
increased EC number and proliferation (Leslie et al., 2007; Siekmann and Lawson, 2007). 
 
 
 In the zebrafish trunk, sprout formation is restricted to the somite boundaries. This is 
achieved by PlexinD1 signaling, which accounts for the out of bound (obd) mutant phenotype 
in zebrafish. The receptor PlexinD1 is expressed in ECs whereas the ligand, Semaphorin3a, 
is expressed in somites. Upon ligand binding of Sema3a to the receptor PlexinD1, a 
repulsive signal is activated, inhibiting ECs to move in the somite region and thus restricting 
the sprout to the somite boundary as described in Isogai et. al., 2003 (Childs et al., 2002; 
Torres-Vazquez et al., 2004) (Figure 4.7 B). 
 In addition, Plexin-Semaphorin signaling has an effect on the timing of the formation of a 
new sprouts during zebrafish ISV formation in addition to their role in vessel guidance. 
Where the absence of Plexin D1 results in precocious sprouting of ISVs  (Childs et al., 2002; 
Torres-Vazquez et al., 2004), a new study investigating the role of Sema3E and PlexinB2 
showed that morphants of either gene show delayed sprouting (Lamont et al., 2009).  
Figure 4.7 
 Tip cell selection: (A) VEGF-A via its receptor VEGFR-2 will activate ECs and form angiogenic 
sprouts. VEGF can be activated upon hypoxia by activation of HIF1-α or by other means such as 
Shh in the developing zebrafish embryo (Lawson). (B) Lateral inhibition through Notch signaling 
limits number of sprouts by selecting for tip and stalk cells. The tip cell sense a higher degree of 
VEGF signaling, which in turn will increase production of Dll4 and result in stronger Notch 
signaling in neighboring cells. Notch will inhibit transcription of vegfr-2 and activate transcription 
of the VEGF trap flt-1 and its soluble variant. In addition sprout formation in the zebrafish ISVs is 
also limited by Semaphorin-Plexin interaction from the somite(A)  (Phng et al., 2009). 
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 Once a tip cell is determined it does not necessarily mean that it will stay a tip cell for the 
entire period of the formation of the vessel. Work in allantoic explants of the mouse shows 
that sprouting vessel can in fact change its leading cell (Perryn et al., 2008). A recent study 
shows similar results in the mouse retina and in zebrafish vessels and suggests a constant 
re-evaluation of the VEGF-VEGFR-Dll4-Notch-VEGFR signaling loop during shuffling of tip 
cells (Jakobsson et al., 2010). 
 
4.2.3.2 Vessel outgrowth and guidance. 
 Tip cells are thought to be the actively migrating cell of a growing vessel. In different model 
systems such as mouse retina and zebrafish as well as in cell culture experiments tip cells 
show extensive amounts of filopodia searching their environment (Gerhardt et al., 2003; 
Isogai et al., 2003; Ruhrberg et al., 2002). The tip cell migrates towards a source of growth 
factors, usually VEGF or members of the VEGF family, dragging along its stalk cells.    
  In an effort trying to find differences in gene expression between tip and stalk cells, 
microarray data were acquired, comparing wt mouse retinas to dll4 heterozygous mouse 
retinas, in which most of the ECs have tip cell identity (Suchting et al., 2007). A set of factors 
were found to be enriched in tip cells including extracellular matrix (ECM) degrading but also 
forming factors as well as secreted factors (Del Toro et al., 2010).   
 Several Metallomatrixproteinases are important to degrade ECM to allow the sprouts to 
invade the tissue. For instance, Mt1-mmp has been shown to be important for the 
degradation of collagen type IV and other ECM proteins in mouse explant culture and in vivo. 
Mt1-mmp is activated upon VEGF signaling and other stimulating factors whereas it is down-
regulated by factors which promote vessel stabilization such as shear stress (van Hinsbergh 
and Koolwijk, 2008).  
 Important for a new sprout is that it does not immediately fall back on its parental vessel. 
This is controlled by VEGFR-1. As mentioned above, VEGFR-1 has high affinity to VEGF but 
in contrast to VEGR-2 its kinase activity is low and it thus serves as a VEGF trap. In addition 
VEGFR-1 is present in two different isoforms, one being a transmembrane receptor and one 
being a secreted soluble version lacking the kinase and transmembrane domain and thus 
creating a VEGF sink around the expressing cell. Since VEGFR-1 is expressed at higher 
levels by stalk cells due to activation by Notch, a VEGF sink is produced behind the tip cell 
and so ensures that it does not fall back on the parental vessel (Chappell et al., 2009). 
 When the vasculature is growing, branches are elongating to reach distant places. This can 
involve several mechanisms. Cells can rearrange and change their shape to a more 
elongated form. This scenario is found during the development of the embryonic tracheal 
system of Drosophila melanogaster, where paired cells of branches undergo an intercalation 
mechanism to end up in a head-to-tail manner (Ribeiro et al., 2004). To what extent such a 
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mechanism is involved during angiogenesis is not clear and remains to be elucidated (see 
also results). A more prominent mechanism for branch elongation is cell division, which is 
found in most vertebrate tube formation models (Andrew and Ewald, 2010). Cell division is 
very prominent during angiogenesis, but interestingly, there seem to be different patterns of 
cell division in different model systems of different vessels. In an ex vivo explant culture 
using murine tissue, only endothelial tip cells which express Mt1-mmp do divide (Yana et al., 
2007). In the mouse retina, tip cells do not divide but stack cells undergo cell proliferation 
(Gerhardt et al., 2003). In zebrafish cell division occurs in tip and stalk cells in the developing 
ISVs (Blum et al., 2008). Cell division and cell migration are regulated by VEGF signaling 
and its two receptors VEGFR-1 and -2 (Ferrara et al., 2003). It remains to be elucidated how 
different sets of signaling result in these different patterns of cell division. 
  Zeng et. al. could show that the plane of cell division is oriented perpendicular to the vessel 
long axis in cell culture and in in vivo rat retinas, therefore increasing the length of a vessel 
rather than its diameter. In VEGFR-1 loss of function assays, this orientation was lost and 
random, indicating that VEGF via VEGFR-1 regulates orientation of cell division. The fact 
that the cell culture assay is flow-independent shows that shear stress induced by flow is not 
a main regulator of orientation of cell division (Zeng et al., 2007).   
  The zebrafish ISVs are an excellent model to study guidance of blood vessel 
morphogenesis, because ISVs have a reproducible pattern in the trunk and follow 
stereotyped pathways. ISVs form at each somite boundary and follow it up to the myoseptal 
midline; from thereon they leave the somite boundary and grow more directly to the dorsal 
side where they subsequently branch in anterior and posterior direction (Isogai et al., 2003).  
This pattern is established by guidance cues, notably the same guidance systems which 
guide neuronal axons to their correct position (Eichmann et al., 2005). 
  As mentioned above, Plexin-Semaphorin signaling is important to guide vessels between 
somites. In obd mutant fish, vessels grow into somites establishing a plexus of vessels in the 
trunk (Childs et al., 2002; Torres-Vazquez et al., 2004). Sema3E and Plexin D1 control 
vascular development and vessel guidance in mice and similarly guide ISVs in mice along 
their track (Gu et al., 2005; Zhang et al., 2009). A second system to guide axons and vessels 
is the Unc-Netrin family. Unc5b is expressed in zebrafish as well as in murine endothelial 
cells. Zebrafish knockdowns of unc5b and netrin-1a results in altered branching patterns and 
an increased number of filopodia. Especially the dorsal part of ISVs shows miss patterning. 
In a mouse retinal and hindbrain vasculature study Netrin-1-Unc5b signaling was shown to 
regulate the number of tip cell filopodia and branchpoint (Lu et al., 2004). In contrast to this 
study, another study proposes a proangiogenic role for Netrin-1 (Park et al., 2004). More 
recently Netrin-4 was shown to be up-regulated in VEGF activated endothelial cells and 
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thereby inhibiting angiogenesis by signaling via Neogenin and Unc5B (Lejmi et al., 2008). 
Thus, Netrins not only regulate guidance but also the migratory potential of ECs 
 When ISVs reach the dorsal part of the trunk, tip cells branch in anterior and posterior 
direction. A recent study showed that this branching of endothelial (tip) cells is dependent on 
local down-regulation of myosin II, at branchpoints. Further, a stiff ECM reduces ability of 
branching. Hence, Mmps are needed to reduce stiffness of the ECM and allow branching of 
ECs (Fischer et al., 2009).  
 
4.2.3.3 Vessel anastomosis 
As soon as ISVs have branched rostrally and caudally at the roof of the neural tube, the 
branches elongate and subsequently connect with their adjacent ISVs (Isogai et al., 2003). 
So far, we lack insight into the process of vessel anastomosis. Based on antibody stainings 
and single cell live imaging, we propose that tip cells make initial contacts and subsequently 
increase their contacts by “crawling” over each other (Blum et al., 2008). This scenario 
recently gained support from experiments using stacks of electron microscopy images 
(Armer et al., 2009).  
  Fusion of tubes has best been described in the tracheal system of Drosophila 
melanogaster.   The tracheal system develops from 20 metameres that undergo remodelling, 
branching and fusion (Samakovlis et al., 1996a). Some of these branches, the dorsal 
branches, grow dorsally and ultimately fuse with their contra-lateral dorsal branches. 
Interestingly, these branches are lead by two different tip cells. The terminal cell will 
ultimately produce a tree of fine tubules, whereas a special genetically determined fusion cell 
will carry out the fusion process (Samakovlis et al., 1996b). It has been demonstrated that 
fusion is initiated with a spot of adherens junctions (AJ) between the two fusion cells 
establishing a first contact. This spot is subsequently elaborated into a ring, which is 
accompanied by cell shape change of the fusion cell forming a donut-like structure 
(Samakovlis et al., 1996b; Tanaka-Matakatsu et al., 1996). The fusion cell forms a track of 
microtubules connecting the pre-existing and the novel apical membranes, presumably 
allowing invagination of these two juxtaposed apical membranes (Lee and Kolodziej, 2002). 
These two apical membranes eventually fuse opening a lumen at the fusion point. The initial 
formation of tight contacts of fusion cells is dependent upon Drosophila E-cadherin, the 
counterpart of vascular endothelial cadherin in ECs. Drosophila null mutants for E-cadherin 
fail to connect adjacent tracheal branches. 
 A recent study in zebrafish shows a role for Ve-cadherin in vessel fusion. In loss of function 
experiments knocking down Ve-cadherin, it was observed that ISVs have trouble to fuse and 
make only weak or no contact (Montero-Balaguer et al., 2009). 
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  Interestingly, vessels still appear to make some contacts in Ve-cadherin morphants, 
indicating that redundant or additional factors could be important for contact formation during 
anastomosis. One important family of proteins could be the Nectin and Nectin-like proteins. 
Nectins are immunoglobulin-like transmembrane proteins which undergo homo- and 
heterophilic interactions among each other. Nectins are ubiquitously expressed and part of a 
multiprotein family suggesting a certain degree of redundancy. Nectins have been shown to 
be important for the formation of new adherens junctions by making initial contacts between 
cells, which trigger a signaling cascade and subsequently recruits Cadherins to the new 
junction site (Takai et al., 2008). Therefore they could play a major role in vessel contact 
formation and explain why ISVs in ve-cadherin morphants still connect partially.  
  A recent study suggests a role for macrophages during vessel fusion. Tip cells in the murine 
hindbrain vasculature associate with tissue macrophages and pu.1 homozygous mutant mice 
lacking macrophages show a decreased number of intersections and branch points. In 
addition macrophages interact with tip cells during ISV fusion in zebrafish. Whether they play 
a mechanistic role during ISV anastomosis remains to be elucidated (Fantin et al., 2010).  
 
4.2.3.4 Lumen formation 
When a new vessel is formed it has to be lumenized to allow blood flow. Lubarsky and 
Krasnow in 2003 proposed different mechanisms to form epithelial tubes, including blood 
vessels (Figure 4.3). From these, budding, cord hollowing and cell hollowing are presumably 
the most relevant mechanisms during vascular development (Adams and Alitalo, 2007). 
Whereas a variation of cord hollowing has been shown to be involved in vasculogenesis 
(Strilic et al., 2009), cell hollowing has received quite a bit of attention as a major process 
involved in lumen formation during angiogenesis. This comes mainly from studies in 2D and 
3D cell culture. In cell culture, vacuoles form via a pinocytic mechanism in ECs and 
subsequently coalesce to form lumens in capillaries (Davis and Bayless, 2003). The 
formation of these pinocytic vacuoles is dependent on interaction of integrins with the ECM 
(Bayless et al., 2000; Davis and Camarillo, 1996). Furthermore, small GTPases like Cdc42 
and Rac1 are required for cytoskeleton reorganization (Bayless and Davis, 2002).  
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   Indications for the presence of vacuoles in vivo have been observed in TEM thin sections 
of rat capillaries (Dyson et al., 1976). In zebrafish, the cellular architecture of ISV was 
described as single cells arranged in a head to tail fashion (Childs et al., 2002). More recent 
study proposed a model where vacuoles form in these single cells; the vacuoles of individual 
stalk cells fuse together and form an intracellular lumen in ISVs with cells arranged in a head 
to tail fashion (Kamei et al., 2006) (Figure 4.8 B). In contrast to this, we have shown that 
ISVs consist to a large extent of multicellular tubes with an extracellular lumen. We have also 
shown that ISVs extend as multicellular tubes and therefore possibly already have a 
prelumenal apical surface during outgrow suggesting a budding mechanism for ISV lumen 
formation (Blum et al., 2008) (Figure 4.8 A). Moesin1 has recently been implicated in ISV 
lumen formation possibly suggesting a similar mechanism as proposed for the DA formation 
in mouse by Strilic et al. (Wang et al., 2010). Vacuoles could still play a role in increase the 
apical side of the extracellular lumen. Seamless tubes have been observed in capillaries of 
different tissues, like in the rat brain microvasculature (Bar et al., 1984). If and to what 
degree seamless tube are present in ISVs and how they are generated is one of the aims of 
this thesis.  
  
Figure 4.8 
 Lumen formation in ISVs: Two different ways how the lumen may form in ISVs. (A) The lumen 
may form by budding; a multicellular tube with an extracellular lumen would form concomitantly 
while the branch elongates (Blum et al., 2008). (B) Alternatively a row of single cells is lumenized 
by the fusion of large vacuoles with the growing lumen resulting in a seamless tube (Kamei et al., 
2006). Possibly, both models are involved in lumen formation.  
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4.2.3.5 Vessel stabilization and integrity 
During and after blood vessel formation, vessels have to maintain their integrity and regulate 
permeability. Integrity and permeability are regulated by cell-cell junctions between 
endothelial cells. A variety of different adherence junctions (AJ) and tight junctions (TJ) 
protein are present in endothelial cells (for a review see (Bazzoni and Dejana, 2004). AJ and 
TJ have different functions. The main task of AJ is to form new cell-cell contact and maintain 
the integrity of the endothelium, whereas TJ regulate the passage of ions and molecules 
through the paracellular path. Both AJ and TJ utilize transmembrane protein, such as 
Cadherins (AJ) and Claudins (TJ), respectively, which undergo homophilic interactions to 
establish junctions along the lateral cell boarder. Endothelial cells express specific versions 
of Cadherins (vascular endothelial cadherin (Ve-cadherin)) and Claudins (Claudin-5). In 
addition a number of intracellular adapter proteins, such as β-catenin, α-catenin or ZO-1 are 
important for the formation and maintenance of junctions as well as for signal transduction 
(Bazzoni and Dejana, 2004; Dejana et al., 2009).  
  Ve-cadherin has been shown to be essential for mouse development; ve-cadherin mutant 
mice die at midgestation. Although an initial vascular plexus forms in mutant mice, it fails to 
mature and remodel, which ultimately leads to endothelial apoptosis (Carmeliet et al., 1999).  
Ve-cadherin not only ensures cell-cell contact, it is also involved in downstream signlling and 
thereby controls cell behaviors such as migration or cell division. Ve-cadherin can form 
complexes with VEGFR-2 and does limit the internalization of VEGFR-2, thereby reducing 
signaling essential for cell proliferation and migration (Lampugnani et al., 2006). Ve-cadherin 
knock down experiments on quiescent vessels in an organotypic cell culture assay induces 
formation of protrusion and sprouting. Sprouting appears to be VEGF-A driven and 
dependent on Rac1 and is suppressed by Ve-cadherin downstream signaling in quiescent 
vessels (Abraham et al., 2009). Similar hyper sprouting phenotypes can be observed in Ve-
cadherin knockdown experiments in the zebrafish embryo (Abraham et al., 2009; Montero-
Balaguer et al., 2009). In contrast, a Ve-cadherin/VEGFR-2 complex together with β-catenin 
is important to inhibit apoptosis via PI3kinase and Akt signaling (Carmeliet et al., 1999). Two 
recent studies implicate micro RNA miR-126 in the fine tuning of vascular integrity. miR-126 
post-transcripionally down-regulates spred1 and pik3r2, two negative regulator of PI3K, Akt 
(pik3r2) and MAP-kinase (spred1) (Fish et al., 2008; Wang et al., 2008). Thus Ve-cadherin 
seems to tightly regulate VEGF signaling, thereby allowing survival signals but down-
regulating proliferative and migratory signals in a quiescent endothelium.  
 Junctions are not static structure but are very dynamic. While this seems to be obvious for a 
remodeling epithelium where junctions have to form and dissolve, this is also true for resting 
confluent layers of cells. Ve-cadherin shows a flow like movement from basal to apical 
(Kametani and Takeichi, 2007). 
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 Not only the typical AJ and TJ proteins are required to maintain integrity and stabilize the 
vasculature but also proteins of the cerebral cavernous malformations (CCM) family and 
angiopoetins and their appropriate Tie receptors.  
 Cerebral cavernous malformations (CCM) are vascular lesions showing dilated, slow flow 
capillaries in the brain. They have sporadic form in 80% of the cases and a familial 
autosomal dominant form in 20% of the cases. Familial cases have been associated with 
three ccm genes; krit1/ccm1, osm/ccm2 and pdcd10/ccm3. Recently, the Heg1 receptor has 
been shown to be involved in a Heg1-Ccm signaling pathway regulating blood vessel 
integrity (see Kleaveland et al., 2009 in appendix; Dejana et al., 2009). 
Tie receptors and their corresponding Angiopoetin (Ang) ligands represented the second EC 
specific Tyrosine kinase signaling system to be discovered in vascular development. 
Components are the two receptors Tie1 and Tie2 and several Ang and Ang-like ligands 
among which Ang1 and Ang2 are the best studied. The system is thought to be essential for 
vessel maturation and regulates vessel quiescence. Ang1 is predominantly expressed by 
mural cells and thus thought to be important for EC-mural cells interaction. In contrast, Ang2 
is an antagonist of Tie2 and leads to vessel destabilization and allows new sprout formation 
in the presence of VEGF or vessel regression in the absence of VEGF (Augustin et al., 2009; 
Saharinen et al., 2010).  
  Blood vessels are surrounded and stabilized by mural cells. For larger caliber vessels these 
cells are called vascular smooth muscle cells, which form dense multiple layers around larger 
arteries and veins. Smaller diameter vessels and capillaries recruit pericytes, which form 
loose layers or are sometimes only present as solitary cells around capillaries (Gaengel et 
al., 2009).  
  
4.2.3.6 Vessel remodeling 
New vessels formed by vasculogenesis or sprouting angiogenesis will remodel and adapt to 
the local inputs. One of the most prominent remodeling processes is termed intussusceptive 
angiogenesis (IA). This process is characterized by the formation of an endothelial wall pillar 
in the vascular lumen, ultimately splitting a single tube into two (Figure 4.9). Once the pillar is 
formed it is fortified by pericytes and fibroblasts. While molecular control of IA is not well 
defined, hemodynamic forces and shear stress appears to be important (Makanya et al., 
2009). An increase of blood pressure on the chicken chorioallantoic membrane (CAM) 
microvascular bed increases speed of IA pillar formation (Djonov et al., 2002). In contrast, 
the mouse yolk sac vascular plexus fails to remodel into a vascular tree when blood cells are 
trapped in acryl amide (Lucitti et al., 2007).   
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 Vascular pressure and shear stress plays an important role in vascular development, also in 
zebrafish. Already some time ago, it has been shown that the DLAV fails to remodel in silent 
heart morphant embryos, where heart beat is not present (Isogai et al., 2003). More recently, 
it was found that also the aortic arches (AA) require flow to correctly interconnect (Nicoli et 
al., 2010). Aortic arches connect to the LDA after onset of circulation (Isogai et al., 2001). 
Using different drugs, which stop heart beat, Nicoli et al. showed that the connection to the 
LDA fails to form. Interestingly, in contrast to the mouse yolk sack, contribution of blood cells 
is not necessary as the connection forms in gata1 morphant embryos, which lack blood cells. 
Hence the process is dependent on shear stress effects from plasma flow. Genetic analysis 
revealed that flow is required to activate klf2 (krüppel-like factor), a sensor of shear stress, 
which in turn allows transcription of the micro RNA miR-126. This micro RNA is a negative 
regulator of spred1, which itself is a negative regulator of the VEGF signaling pathway (Nicoli 
et al., 2010). Thus VEGF is required for the vessel formation and flow is required to allow 
VEGF signaling.  
 
 
 
Figure 4.9 
 Intussusceptive angiogenesis: IA is characterized by the formation of pillars in endothelial tubes. 
The different steps are demonstrated in this Figure. The opposing walls of an endothelial 
protrude towards the inside of the tube (A,A’,B,B’). Ultimately the two walls contact and form a 
pillar (C, C’). The exact cellular mechanism is not known, but presumably, EC rearrange to seal off 
the two tubes. The pillar is then reinforced by pericytes (Pr) and fibroblasts (Fb)(D,D’) (Makanya 
et al., 2009) . 
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4.3 Aim of this thesis 
 The vascular system is a vital organ for the function of a vertebrate animal. Especially 
angiogenesis, the formation of new vessels from pre-existing ones, has attracted much 
attention also due to its importance in cancer pathology. During the past decades, a number 
of molecular pathways controlling the development of the vascular system have been 
identified (Adams and Alitalo, 2007; Carmeliet, 2005; Coultas et al., 2005). However, tube 
architecture and cellular mechanism driving morphogenesis of the vascular system are ill 
characterized.  
 The zebrafish embryo is an ideal model system to study morphogenetic mechanisms in vivo 
during development. It is optically, it has a fast development and a number of transgenic 
lines and transgenic techniques are available (Lawson and Weinstein, 2002b). In recent 
years, the zebrafish ISVs have served as a paradigm to study angiogenesis in vivo.  
 Our aim was to use similar approaches as were used to understand morphogenesis of the 
tracheal system in Drosophila melanogaster (Ribeiro et al., 2004). We wanted to label EC 
junctions to follow individual cells in the context of angiogenesis. Initially using Ab stainings, 
and ultimately with transgenic lines expressing fluorescently tagged junctional proteins to 
monitor cellular mechanisms during angiogenesis. 
 The main focus was to understand cellular mechanisms during anastomosis, the formation 
of new connections between blood vessels. Even though anastomosis is an essential step to 
form a functional vascular network, molecular and cellular mechanisms driving anastomosis 
remain completely obscure. 
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5 Materials and Methods 
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5.1 Molecular biology protocols 
5.1.1 Standard protocol  
5.1.1.1 Restriction enzyme digestion 
DNA 1-2 µg 
Restriction buffer  5 µl 
Restriction enzyme(s) 1 µl of each (Roche or NEB) 
Q-H2O  up to 50 µl 
 
  Reagents were mixed in a 1.5 ml Eppendorf tube and placed on a 37°C warm heat block for  
1 – 2 hours. Double digest were performed in the buffer according to the list of NEB or/and 
Roche. 
5.1.1.2 Dephosphorylation with Alkaline Phosphatase  
  Dephosphorylation of the vector was performed to avoid self ligation. Dephosphorylation 
was performed immediately after restriction enzyme digestion. To the 50 µl restriction mix 5.5 
µl of a 10 x phosphatase buffer and 0.5 µl of Shrimp Alkaline Phosphatase (SAP, Roche) 
was added. Reaction was put back onto the 37°C heat block for half an hour. 
5.1.1.3 PCR mix 
For all PCR done in this work the following mix was done: 
 
Template DNA 100-200 ng 
Primers (10µM) 1 µl of each (ordered by Sigma) 
DNA polymerase buffer 10x 5 µl 
DNA polymerase 0.5 µl  (Taq (NEB), Pfu (Sigma), Phusion (Finnzyme)) 
dNTPs (2.5 mM) 5 µl 
Q-H2O up to 50 µl  
5.1.1.4 Agarose Gel 
  Agarose (Eurogentec or Sigma) gels were poured by mixing 0.5 g of agarose with 50 ml 
1xTAE into an Erlenmeyer flask. Agarose was dissolved by heating it in the microwave until it 
boiled. Then it was stirred and 5 µl of ethidium bromide was added. After, it was poured into 
a gel chamber and let polymerize with a desired comb. After polymerization the comb was 
removed and the gel was put in the running chamber (Amersham Bioscience) in 1xTAE. Gels 
were loaded with marker DNA (1Kb (+) Ladder Invitrogen) and DNA fragments with loading 
buffer. Gels were run at 100 mV (Biowerk). 
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5.1.1.5 Gel extraction 
  Gels were analyzed under an UV lamp. Desired bands were cut out and put into a 2 ml 
Eppendorf tube. The extraction was made following the QIAGEN or Sigma Gel Extraction 
protocol. 
5.1.1.6 Ligation 
Vector 50-100 ng 
Insert 150-300 ng (at least 3 times amount of vector DNA) 
T4 DNA Ligase buffer 10x (NEB) 1 µl 
T4 DNA Ligase 1 µl 
Q-H2O  up to 10 µl 
 
  For easy ligations (small insert, vector 3-5 kb) reaction took place at room temperature for 
about 20 min. For difficult ligations (insert bigger than vector, large vector >10kb, other 
issues) reaction took place at 16°C over night. 
5.1.1.7 Transformation 
  Electrocompetent E. coli bacteria were used for transformation. The whole procedure was 
performed on ice. Frozen E. coli (50 µl in Eppendorf tubes) from the -70°C freezer were 
thawed on ice. 1 µl of the DNA ligation was added and mixed. Then the bacteria were 
transferred to a 1 mm electroporation cuvette (Bio Rad). The bacteria were electroporated 
(Bio Rad 1.8 mV, 200 ohm, 25 µF) and then transferred with 0.5 ml LB medium to a 2 ml 
Eppendorf tube. Bacteria were grown at 37°C on a shaker or rotator for 1 hour and then 
plated on an agar plate with the appropriate antibiotic. Colonies were grown over night in the 
37°C breeding room. 
5.1.1.8 Miniprep 
  Clones were picked from the agar plate and grown in 2 ml LB medium with the appropriate 
antibiotic on a shaker at 37°C over night. Then minipreps were performed following the 
SIGMA GenEluteTM Plasmid Miniprep Kit. 
5.1.1.9 Midiprep 
  10 µl of a positive miniprep culture or a clone from an agar plate was put into 30 ml LB 
medium with antibiotic. Culture was grown over night and then centrifuged for 15 min in the 
Heraeus centrifuge at 4°C. Then the QIAGEN or the Sigma Plasmid Midi Kit was followed. 
Purity and amount were measured with a spectrometer. 
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5.1.2 Plasmids 
To produce a plasmid containing an EGFP-NLS sequence downstream of the flk1 promoter, 
EGFP-NLS cDNA was cloned from the pStinger vector (Barolo et al., 2000) into pBSII-SK 
with BamHI and SpeI. From there, EGFP-NLS was cloned into a modified pG1 vector with 
EcoRI and SacII (details available upon request). The flk1 promoter was cloned from the 
pCRII-TOPO vector containing the flk1 promoter into the modified pG1 (Henry Belting) 
containing the EGFP-NLS sequence with SalI and EcoRI. 
To allow easy cloning of cDNAs under the control of the flk1 promoter, a multiple cloning site 
and a SV40-polyA tail was cloned downstream of the flk1 promoter. The SV40 
polyadenylation signal sequence was amplified by PCR using the following primers, one 
containing the MCS (EcoRI, KpnI, XhoI, EcoRV, BamHI, SacII and NotI): forward (containing 
MCS): 
5′ACTGAGAATTCGGTACCCTCGAGGATATCGGATCCCCGCGGGCGGCCGCGATCATAA
TCAGCCATAC-3′, rev: 5′-CTAGTGCGCGCGTTAAGATACATTGATGA-G-3′. The PCR 
fragment was then cloned into the pG1 flk1:EGFP-NLS vector using EcoRI and BssHII giving 
rise to the pG1 flk1:MCS-SV40 vector. 
The mCherry coding sequence was cloned from pRSET-B mCherry vector (Tsien lab) into 
pCRII-TOPO vector containing the flk1 promoter with BamHI and EcoRI. This vector was 
used to clone mCherry into the pG1 flk1:MCS-SV40 vector using BamHI and NotI (Lukas 
Herwig). The fli1:GFF and the UAS:EGFP-hZO1 constructs were cloned by Lukas Herwig in 
the lab. 
 
5.2 Fish protocols 
 
5.2.1 Maintenance and strain 
Zebrafish were maintained and bred using standard protocols (Westerfield, 2000). The 
following zebrafish strains were used: 
 
Wildtypes  
 AB/EK (W. Driever, Freiburg) 
 AB/TL (W. Driever, Freiburg) 
 
Transgenic 
 fli1:EGFP  (Lawson and Weinstein, 2002b) 
 flk1:EGFP (Jin et al., 2005) 
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 flk1:EGFP-NLS (Blum et al., 2008) 
 fli1:GFF (Lukas Herwig); UAS:Kaede (ZIRC) 
 fli1:GFF (Lukas Herwig); UAS:RFP  (Asakawa et al., 2008) 
 UAS :EGFP-hZO1 (Lukas Herwig) 
 
5.2.2 DNA and morpholino injecting 
  Capillaries were pulled to produce thin glass needles (Sutter instruments). Injection plates 
were made by pouring 1% agarose into a petridish and putting a mold with rills on the 
agarose. The mold was removed after polymerization of the agarose. The plate were stored 
at 4°C and covered with eggwater (0.3g seasalt in 1l ddH20).  
  Freshly laid eggs (1-4 cells for morpholino, 1-2 cells for DNA) were gently pressed into the 
rills of the injection plate. Needles were filled with the DNA solution using Eppendorf 
Microloader. Needles were mounted on the Eppendorf FemtoJet injector or hand injector. 
The tips of the needles were broken with a forceps to allow outflow. Small drops (2-3 nl) were 
injected trying to hit the cells.  
 
 
5.2.3 Generation of flk1:EGFP-NLS transgenic fish line 
Approximately 200 embryos (AB/EK strain) were injected at one cell stage. Embryos were 
screened for transient GFP expression at 24 hpf. 24 embryos showed strong transient 
expression in the developing vasculature and were raised separately. Founders were 
crossed and screened for germ line transmission. From 7 pairs, we recovered two transgenic 
carriers which displayed different levels of EGFP expression. The strongest expressing 
carrier was propagated to establish the flk1:EGFP-NLS line. 
 
 
5.3 Immunofluorescence and Live imaging 
5.3.1 Ab stainings 
To inhibit pigmentation, PTU (propylthiouracil) was used. Egg water of 24 hpf old embryos 
was exchanged with PTU egg water. PTU egg water was produced by adding 10 ml of a 40x 
PTU stock solution to 390 ml of egg water. 
Embryos from 22–48 hpf were fixed in 4% paraformaldehyde for 2 h at room temperature. 
Embryos were then washed 4×5 min in PBST (PBS+0.1% Tween20) and once in PBSTX 
(PBS+0.1% Tween20+0.1% Triton ×100). Embryos were then blocked in PBSTX+10% 
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BSA+1% NGS for 2 h. Embryos were incubated with primary antibodies (in PBSTX+1% 
BSA+0.1% NGS) overnight at 4 °C. Embryos were then washed 6×1 h in PBSTX+1% BSA+ 
0.1% NGS and then incubated with the secondary antibody (in PBSTX+1% BSA+0.1% NGS) 
overnight at 4 °C. Embryos were finally washed several times in PBST. All steps were 
performed at RT except for antibody incubations. The following antibodies were used: mouse 
anti human ZO-1, 1:200 (Zymed); rabbit anti-zf-CDH5 (Henry Belting), 1:1000; Alexa-568 
goat anti-rabbit IgG, 1:1000; Alexa- 568 goat anti-mouse IgG, 1:1000; Alexa-633 goat anti-
mouse IgG, 1:1000 (All secondary antibodies were purchased from Invitrogen.). 
 
5.3.1.1 Mounting and confocal microscopy of Ab stained embryos 
 The head and yolk bulb were severed from the trunk with a razorblade and the trunk was 
mounted in Vectashield. Images were taken with a Leica SP1 confocal microscope. For ZO-1 
immunofluorescence, confocal stack sizes are 100–200 optical sections per stack at a step 
size of 0.1221 μm (as recommended for the 100× lens). For CDH5 staining the step size was 
increased to 0.2442 μm (50–100 sections) due to a weaker signal and faster bleaching. 
 
5.3.2 Live imaging (Leica Sp1 confocal microscope) 
Embryos were embedded in a drop of 0.7% low melting agarose (Sigma) containing 0.01% 
tricaine (pH 7.5) on a cover slip. This cover slip was put up side down on an aluminum 
depression slide containing egg water with 0.01% tricaine (brand) and. Temperature was 
kept at approximately 28.5 °C. Stacks were taken with a Leica Sp1 confocal microscope (40x 
lens) every 8 min with a slice number between 30 and 50 having a space of 1.5–2.0 μm. 
Movies were processed using Imaris (Bitplane) and ImageJ. 
 
5.3.3 Single cell labeling using Kaede 
2dpf old fli1:GFF; UAS:Kaede transgenic embryos were anaesthetized with tricaine and 
mounted in 0.7% low melting agarose. Using the confocal software, a region of interest was 
drawn around EC nuclei. EC nuclei were easily discernible in 2 dpf ISVs with inflated lumen 
due to much higher amount of Kaede in the nucleus compared to the very thin cytoplasm of 
ECs (see also Figure 6.1). This region of interest was then illuminated for 20 seconds using 
100% UV laser power. Subsequently high resolution x,y,z stacks were acquired with a 63x 
glycerol immersion lens using the suggested slice thickness. Slice numbers ranged from 80  
to 200 slices. Images were analyzed using Imaris software (Bitplane).  
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5.3.4 Live imaging with fli1:GFF; UAS:EGFP-hZO1; UAS:RFP embryos (Leica 
Sp5) 
First triple transgenic embryos were selected using a Leica MZ FLIII fluorescent 
stereomicroscope. Embryos were selected for RFP ensuring the presence of the fli1:GFF 
and UAS:RFP and for the heart marker cmlc2:EGFP (green heart) present on the 
UAS:EGFP-hZO1 transgenic line. EGFP-hZO1 was to faint to detect under the fluorescent 
stereomicroscope. The selected embryos were anaesthetized using tricaine and mounted in 
35 mm special petri dishes with a 0.17mm coverslip glass on the bottom (MatTek), using 
0.7% low melting agarose (sigma) with 0.01& tricaine and 0,003% PTU. Mounted embryos 
were then analyzed for good expression (due to mosaic’ of EGFP-hZO1) under a widefield 
Leica DM6000 fluorescent microscope.  
Embryos with suitable expression were then imaged over night on the Leica Sp5 using a 63x 
glycerol immersion lens with a numerical aperture of 1.2 with additional zoom of 1-1.3x 
depending on the situation. All movies have an initial frame size of 512x512 pixels. Stacks 
were ranging from 50-80 slices always keeping a slice thickness of 1 µm. For all movies on 
the Sp5 (all movies in chapter II and II), timepoints were 5 minutes apart except if noted 
differently.   
 
5.3.4.1 QD-injection 
705 nm QD (Invitrogen) were injected directly in the sinous venosus of mounted embryos at 
a concentration of 1:2. Special manufactured glass needles with tip opening of 10 µm and 
beveled tip were utilized to reduce damage to the embryo.  
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Results preface 
The result section is divided in three chapters: 
Chapter I covers our paper published in 2008: “complex cell rearrangements during 
intersegmental vessel sprouting and vessel fusion in the zebrafish embryo” 
Chapter II quantifies different tube architectures in the ISV and the DLAV 
Chapter III describes cellular mechanisms we found during ISV formation and anastomosis.  
 
As some of the fluorescent signals were weak and are difficult to see on printed paper, all 
Figures of Chapter II and III can be found as high resolution Tiff files on the enclosed DVD. In 
addition all movies can be found as uncompressed avi files. The Quicktime player appears to 
show a better quality compared to Windows media player. Windows media player also shows 
some compatibility issues on certain pc. 
 
Additional results from collaborations can be found in the appendix as published papers. 
 
 
 
 
 
6.1 Chapter I: Blum et al., 2008 
Previous work on cellular architecture of ISVs in the zebrafish embryo has proposed that 
ISVs consist of three types of cells lined up behind each other. A T-shaped cell located in the 
DLAV, an inverted T-shaped cell in DA and a cell connecting these two cell (Childs et al., 
2002). More recently it was proposed that these cells form an intracellular lumen (Kamei et 
al., 2006). This cellular architecture suggested a junctional pattern, which would only show 
loops at the interface between cells. To test this, we used Ab stainings against junctional 
proteins combined with single cell labeling. We also generated a new transgenic line 
expressing a nuclear localized version of EGFP under the control of the endothelial specific 
promoter flk1. This line allowed us to follow some of the dynamics during ISV development.  
My contribution to this work was: I made all Figures except for Figure 2A-F. I generated the 
transgenic line flk1:EGFP-NLS. The flk1:mCherry plasmid was cloned by Lukas Herwig and 
Florian Lüders in the lab and the Ve-cadherin (CDH5) Ab was generated by Henry Belting in 
the lab. 
Complex cell rearrangements during intersegmental vessel sprouting and
vessel fusion in the zebrafish embryo
Yannick Blum 1, Heinz-Georg Belting⁎,1, Elin Ellertsdottir, Lukas Herwig,
Florian Lüders, Markus Affolter⁎
Biozentrum der Universität Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland
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Abstract
The formation of intersegmental blood vessels (ISVs) in the zebrafish embryo serves as a paradigm to study angiogenesis in vivo. ISV
formation is thought to occur in discrete steps. First, endothelial cells of the dorsal aorta migrate out and align along the dorsoventral axis. The
dorsal-most cell, also called tip cell, then joins with its anterior and posterior neighbours, thus establishing a simple vascular network. The vascular
lumen is then established via formation of vacuoles, which eventually fuse with those of adjacent endothelial cells to generate a seamless tube with
an intracellular lumen. To investigate the cellular architecture and the development of ISVs in detail, we have analysed the arrangement of
endothelial cell junctions and have performed single cell live imaging. In contrast to previous reports, we find that endothelial cells are not
arranged in a linear head-to-tail configuration but overlap extensively and form a multicellular tube, which contains an extracellular lumen. Our
studies demonstrate that a number of cellular behaviours, such as cell divisions, cell rearrangements and dynamic alterations in cell–cell contacts,
have to be considered when studying the morphological and molecular processes involved in ISV and endothelial lumen formation in vivo.
© 2008 Elsevier Inc. All rights reserved.
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Introduction
Branched tubular organs are widely used to transport and
distribute liquids, nutrients or gas within multicellular animals.
In many cases, ramified tubular organs arise from pre-existing
epithelial structures via branching morphogenesis. Cell migra-
tion and cell division are key processes underlying branch
formation. In addition, cell rearrangement and the control of cell
shape play important roles in shaping the outgrowing branches.
In invertebrates, one of the best characterized organs formed
by branching morphogenesis is the tracheal system of Droso-
phila melanogaster. In recent years, a large number of
mutations affecting the branching process has been identified
and characterized. Using forward and reverse genetic as well as
4D-live imaging approaches at cellular resolution, the corre-
sponding genes were found to control directed cell migration,
cell rearrangement, branch-specification, tube size regulation
and branch fusion. A large number of key molecules has been
identified, including chemotactic ligands, their respective
receptors, transcriptional regulators, junctional components
and luminal proteins, which either act at the top or at the
bottom of the regulatory network that controls the branching
process (reviewed in Affolter et al., 2003; Ghabrial and
Krasnow, 2006; Uv et al., 2003).
In vertebrates, the molecular pathways controlling the
development of the vasculature have attracted much attention
in the past decade (Adams and Alitalo, 2007; Carmeliet, 2005;
Coultas et al., 2005; Lawson and Weinstein, 2002a; Ny et al.,
2006). The vascular anatomy of the developing trunk is both
reproducible from animal to animal (Isogai et al., 2001) and
conserved in the vertebrate body plan with some species-
specific variation. The first blood vessels that form in the
embryo are the large midline artery and vein, which arise
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through vasculogenesis, a process involving the migration,
differentiation and assembly of angioblasts. After the establish-
ment of the major axial blood vessels, smaller vessels such as
the trunk intersegmental vessels (ISV) are formed through
sprouting angiogenesis, which involves the migration of
endothelial cells from the existing large vessels. The processes
by which these sprouts develop appear similar to those involved
in branching morphogenesis of other tissues and include a
remodelling of pre-existing epithelial structures. However, the
temporal and spatial coordination of events such as cell
migration, cell rearrangement, cell division or lumen formation,
which eventually lead to the establishment of correctly
interconnected vascular tubes of distinct size and shape, remains
ill characterized (Adams and Alitalo, 2007).
The genetic amenability, the experimental accessibility and
the optical clarity make the zebrafish embryo an excellent
model system for deciphering the cellular mechanisms under-
lying angiogenesis (Beis and Stainier, 2006; Lawson and
Weinstein, 2002b). Because of their metameric arrangement and
relative anatomical simplicity ISVs are ideally suited to study
the cues and mechanisms leading to the ordered formation of
new blood vessels. Single cell labelling experiments have
shown that the ISVs consist of three types of cells: (1) a ventral
cell embedded in the dorsal aorta carrying a sprout oriented
towards dorsal, (2) a dorsal T-shaped cell in the dorsal
longitudinal anastomotic vessel (DLAV) and (3) an elongated
cell linking these two (Childs et al., 2002). Because of the
stereotypic location and behaviour of these cells, it was
suggested that ISVs are made up by three cells that originate
from the dorsal aorta and migrate between somites to their final
position in the ISV and the DLAV (Childs et al., 2002) (Fig.
1A). By live imaging of transgenic zebrafish embryos,
Weinstein and colleagues have shown that the ISVs indeed
form via angiogenesis, and that cells migrate out of the dorsal
aorta to form, in a first phase, the DLAV and its connections to
the dorsal aorta (Isogai et al., 2003; Lawson and Weinstein,
2002b). More recently, elegant live imaging studies revealed
that the lumen in the ISVs is built in vivo via the formation of
endothelial vacuoles that undergo intracellular and intercellular
fusion to generate a patent lumen (Kamei et al., 2006). ISV
formation in the early zebrafish embryo is thus characterized by
cell migration to generate a stereotyped cell arrangement,
followed by a hollowing process of single cells and subsequent
lumen connection, resulting in an interconnected luminal
pathway from the dorsal aorta to the DLAV. Recent studies
have shown that endothelial cells also divide as they migrate out
of the dorsal aorta and form the ISVs (Leslie et al., 2007;
Siekmann and Lawson, 2007), adding another cellular process
to ISV formation.
To characterize the cellular architecture of the developing
ISVs in the zebrafish in more detail, and to better define the
cellular events that contribute to ISV formation, we have used
single cell imaging in vivo combined with the analysis of the
distribution of proteins at the endothelial adherens junctions
Fig. 1. Complex distribution of junctional proteins in ISV. (A) Cellular model of ISVs according to Childs et al. (2002). (B) Putative distribution of cell junctions (red
rings) in an ISV in which endothelial cells are arranged in a head-to-tail fashion forming a seamless tube. (C–E) Confocal projection of 36 hpf fli1:EGFP (red)
embryos labeled with an anti-ZO-1 antibody (green). ZO-1 protein is mostly detected as two “stripes” (arrows in panels C and D) along the stalk of the ISV, and also in
parts of the DLAV. Sometimes, ZO-1 is absent from short regions of the ISVs, including the DLAV (E, arrowheads). (F–I) ZO-1 outlines single cells. 30 hpf wild-type
fish injected with flk1:RAS-GFP (red) plasmid and labeled with anti ZO-1 antibodies (green). (F and G) Putative single stalk cells are entirely lined by ZO-1. (H and I)
Putative tip cells show ring-like ZO-1 pattern at their base, where they make contact with stalk cells (arrows). Abbreviations: da: dorsal aorta, nc: notochord, sb: somite
boundary. Scalebars: 20 μm.
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(AJs) and tight junctions (TJs). Our studies show that the
architecture of the ISV is significantly different from what has
been proposed previously. Furthermore, we suggest that a
number of additional cellular activities have to be taken into
consideration when studying the molecular processes involved
in ISV sprouting angiogenesis in the zebrafish embryo.
Materials and methods
Fish maintenance and stocks
Zebrafish were maintained at standard conditions (Westerfield, 2000).
Embryos were staged by hours post-fertilization (hpf) at 28.5 °C (Kimmel et al.,
1995). Embryos derived from wild-type fish (AB/EK), TG(fli1:EGFP)y1
(Lawson and Weinstein, 2002b), TG(flk1:EGFP)S843 (Jin et al., 2005) and TG
(flk1:EGFP-NLS) (this study) were used.
Generation of TG(flk1:EGFP-NLS) transgenic fish line
Approximately 200 embryos (AB/EK strain) were injected at one cell stage.
Embryos were screened for transient GFP expression at 24 hpf. 24 embryos
showed strong transient expression in the developing vasculature and were
raised separately. Founders were crossed and screened for germ line
transmission. From 7 pairs, we recovered two transgenic carriers which
displayed different levels of EGFP expression. The strongest expressing carrier
was propagated to establish the TG(flk1:EGFP-NLS) line.
Live imaging
Embryos were embedded in a drop of 0.7% low melting agarose containing
0.01% tricaine (pH 7.5) on a cover slip. This cover slip was put up side down on
an aluminum depression slide containing egg water with 0.01% tricaine.
Temperature was kept at approximately 28.5 °C. Stacks were taken with a Leica
Sp1 confocal microscope every 8 min with a slice number between 30 and 50
having a space of 1.5–2.0 μm. Movies were processed using Imaris (Bitplane)
and ImageJ.
Generation of anti-CDH5 antibodies
A cDNA fragment encoding a polypeptide comprising the extracellular
domain of zebrafish CDH5 (Ala22 to Lys464) was cloned into pET22b and
expressed in E. coli using the T7 expression system. The protein was purified on
Ni-charged IMAC resin (BioRad) under denaturing conditions. Antiserum was
raised in a rabbit by Eurogentec (Seraing, Belgium) using standard immuniza-
tion procedures. Prior to use, the anti-CDH5 antiserum was diluted 1:1000 in
blocking solution (PBS, 1% BSA, 5% normal goat serum, 0.2% TritonX-100)
and incubated with fixed zebrafish embryos (10 embryos/ml) to reduce non-
specific activity.
Immunofluorescence
Embryos from 22–36 hpf were fixed in 4% paraformaldehyde for 2 h at
room temperature. Embryos were then washed 4×5 min in PBST (PBS+0.1%
Tween20) and once in PBSTX (PBS+0.1% Tween20+0.1% Triton ×100).
Embryos were then blocked in PBSTX+10% BSA+1% NGS for 2 h. Embryos
were incubated with primary antibodies (in PBSTX+1% BSA+0.1% NGS)
overnight at 4 °C. Embryos were then washed 6×1 h in PBSTX+1% BSA+
0.1% NGS and then incubated with the secondary antibody (in PBSTX+1%
BSA+0.1% NGS) overnight at 4 °C. Embryos were finally washed several
times in PBST. All steps were performed at RT except for antibody incubations.
The following antibodies were used: mouse anti human ZO-1, 1:200 (Zymed);
rabbit anti-zf-CDH5, 1:1000; Alexa-568 goat anti-rabbit IgG, 1:1000; Alexa-
568 goat anti-mouse IgG, 1:1000; Alexa-633 goat anti-mouse IgG, 1:1000. (All
secondary antibodies were purchased from Invitrogen.) The head and yolk bulb
were severed from the trunk with a razorblade and the trunk was mounted in
Vectashield. Images were taken with a Leica SP1 confocal microscope. For ZO-
1 immunofluorescence, confocal stack sizes are 100–200 optical sections per
stack at a step size of 0.1221 μm (as recommended for the 100× objective). For
CDH5 staining the step size was increased to 0.2442 μm (50–100 sections) due
to a weaker signal and faster bleaching.
Plasmids
To produce a plasmid containing an EGFP-NLS sequence downstream of the
flk1 promoter, EGFP-NLS cDNAwas cloned from the pStinger vector (Barolo et
al., 2000) into pBSII-SK with BamHI and SpeI. From there, EGFP-NLS was
cloned into a modified pG1 vector with EcoRI and SacII (details available upon
request). The flk1 promoter was cloned from the pCRII-TOPO vector containing
the flk1 promoter into the modified pG1 containing the EGFP-NLS sequence
with SalI and EcoRI.
To allow easy cloning of cDNAs under the control of the flk1 promoter, a
multiple cloning site and a SV40-polyA tail was cloned downstream of the flk1
promoter. The SV40 polyadenylation signal sequence was amplified by PCR using
the following primers, one containing the MCS (EcoRI, KpnI, XhoI, EcoRV,
BamHI, SacII and NotI): forward (containing MCS): 5′-ACTGAGAATTCGG-
TACCCTCGAGGATATCGGATCCCCGCGGGCGGCCGCGATCATAAT-
CAGCCATAC-3′, rev: 5′-CTAGTGCGCGCGTTAAGATACATTGATGA-G-3′.
The PCR fragment was then cloned into the pG1 flk1:EGFP-NLS vector using
EcoRI and BssHII giving rise to the pG1 flk1:MCS-SV40 vector.
The mCherry coding sequence was cloned from pRSET-B mCherry vector
(Tsien lab) into pCRII-TOPO vector containing the flk1 promoter with BamHI
and EcoRI. This vector was used to clone mCherry into the pG1 flk1:MCS-
SV40 vector using BamHI and NotI.
Results
Complex junctional organization of ISVs
It has previously been shown that the ISVs in the early
zebrafish embryo consist of three types of endothelial cells
(Childs et al., 2002; Fig. 1A). Based on their stereotypic
location it has been assumed that these cells line up in a head-to-
tail fashion with no or very little overlap along the dorsoventral
extent of the ISV. Recently, this view has gained support by live
imaging studies suggesting that the lumen of ISVs is formed via
the formation and fusion of intracellular vacuoles that will fuse
with those of neighbouring endothelial cells to generate a
seamless tube with an intracellular lumen (Kamei et al., 2006).
To examine the cellular architecture of ISVs in more detail,
we visualized the junctional complexes between individual
endothelial cells using an antibody directed against human Zona
Occludens 1 (ZO-1) (see Materials and methods). Tight
junctions and adherens junctions form between cells at the
apical side of an epithelium and are excellent indicators for
cellular contacts within epithelial tissues. Moreover, junctional
patterns between epithelial cells have been used to determine
the cellular architecture of tubular structures (Lubarsky and
Krasnow, 2003; Ribeiro et al., 2004). For instance, a seamless
tube in which the cells are arranged serially would most likely
result in a junctional “ring” pattern as illustrated in Fig. 1B.
Because the anti-ZO-1 antibody labels cell junctions in many
epithelial tissues in zebrafish embryos, including notochord and
spinal cord, we performed our analysis on transgenic TG(fli1:
EGFP) embryos to independently visualize the developing
trunk vasculature (Lawson and Weinstein, 2002b). To ensure
reproducible observations we focused our study on the ISVs
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located in the posterior region of the yolk extension. We first
analysed embryos after 1.5 days of development, when ISVs
have formed in much of the trunk region and their lumen is
about to become patent (Isogai et al., 2001). At this stage we
observed a complex pattern of ZO-1 (Figs. 1C–E). Whereas the
dorsal aorta showed a mesh-like distribution of ZO-1, which is
typical for multicellular tubes (Lubarsky and Krasnow, 2003),
in most ISVs, the medial region was lined by two “stripes” of
ZO-1 along the tube axis. On the dorsal side, we also observed
two or more lines of ZO-1 staining in the DLAV. Owing to the
heterogeneity of ISVs at this stage, ZO-1 distribution was
slightly variable between individual ISVs within a single
embryo. For example, sometimes no ZO-1 staining was seen in
short regions along the tube extension (arrowhead in Fig. 1E)
most likely reflecting the dynamic behaviour of endothelial
cells during angiogenic remodelling. Thus, the ZO-1 pattern we
observe in ISVs is contrasting the pattern that would have been
predicted from the current models of ISV architecture and is
most readily explained if two endothelial cells make up the tube
in most regions of the ISV.
To unambiguously link individual endothelial cells within
developing ISVs to the complex pattern of ZO-1, we examined
the distribution of ZO-1 in embryos that had been injected with
a plasmid encoding a membrane-bound form of GFP (RAS-
GFP) under the control of the flk1 promoter (Jin et al., 2005).
Because injected DNA is mosaically transmitted in the zebrafish
embryo, it is possible to label single endothelial cells with this
technique. When examining single, RAS-GFP positive stalk
cells, we found that the circumference of stalk cells was entirely
lined by ZO-1 protein, suggesting that they indeed contacted
another cell(s) over their entire extent along the tube axis (Figs.
1F, G). RAS-GFP labelled tip cells showed a circular staining of
ZO-1 at their ventral base, where they contacted the stalk cells
(Figs. 1H, I). At the tip of their anteroposterior extensions,
where these cells contacted each other, ZO-1 staining was also
prominent, presumably as a result of novel cell–cell contacts
established between adjacent ISVs. Taken together, our
immunofluorescence and single cell studies demonstrate that
the ISVs are made up by endothelial cells sharing extensive
cell–cell contacts with neighbouring endothelial cells, rather
than by cells that are arranged in a head-to-tail fashion.
Endothelial cells appear paired in ISVs
While the distribution of cell junctions indicates a complex
pattern of spatial relationships between endothelial cells, it does
not reveal directly the cellular architecture of ISVs. We
therefore generated a plasmid encoding a cytoplasmic mCherry
protein under the control of the flk1 enhancer. We injected this
plasmid into fli1:EGFP transgenic embryos to differentially
label a single (or a subset of) cells within an ISV. As expected,
we found mCherry labelled either dorsal cells of the DLAV,
basal cells contacting the aorta, or, most frequently, medial cells
linking these two (Figs. 2A–D; the green and red colours of the
fluorescent proteins were inverted to obtain better contrast).
However, in most of the medial cells analysed (12/15), we
found that mCherry-labelled cells did not appear to extent over
the entire circumference of the tube, but aligned with one or
more only EGFP positive cell(s) along the tube axis (see arrows
in Figs. 2B–D). We analysed the Z-stacks of such double-
labelled vessels and discovered that two cell bodies were
surrounding the luminal space, one mCherry/EGFP double-
labelled endothelial cell and an EGFP-positive, mCherry
negative cell (Figs. 2D–F). To confirm this observation, we
re-examined the distribution of ZO-1 in cross sections of ISVs
and detected ZO-1 protein between adjacent cells in close
proximity to the lumen (Figs. 2G, H). The number of cells
surrounding the lumen of the ISV does not appear to be fixed.
At different proximodistal levels within a single ISV we were
able to find either 2 or 3 junctional complexes in a cross section
(Figs. 2G, H) corresponding to 2 or 3 endothelial cells enclosing
the vascular lumen, respectively.
In summary, these findings show that the three types of cells
that have previously been described as the building blocks of
the ISV are not arranged in a simple head-to-tail fashion.
Instead, they align over extended regions with neighbouring
cells resulting in tubes that consist of two or more cells
surrounding the luminal circumference, thus forming a multi-
cellular tube.
Dynamic behaviour of junctional proteins during ISV sprouting
Because ZO-1 is not only present in junctional complexes of
endothelial cells but also in the epidermis, the neural tube and
other tissues, we wanted to use an endothelial-specific
junctional marker to confirm our findings. Therefore, we raised
antibodies against zebrafish VE-Cadherin (CDH5), which is
expressed exclusively in the developing vasculature (Larson et
al., 2004). We analyzed the distribution of the CDH5 protein by
immunofluorescence and found that it was limited to the
vasculature (Fig. 3A); no CDH5 was seen in the notochord or in
the neural tube. The antiserum appeared to recognize a different
cadherin in the pronephric duct (data not shown). Staining in the
pronephric duct persisted upon morpholino inhibition of cdh5,
while the staining in the endothelial cells disappeared (H.B. and
M.A.; unpublished results). Immunofluorescent colabelling of
ZO-1 and CDH5 proteins in fli1:EGFP embryos demonstrated
that the two proteins co-localized in the developing vasculature,
both in the dorsal aorta and in the caudal veins (not shown), as
well as in ISVs (Fig. 3). In the developing ISVs, the distribution
ZO-1 and CDH5 was indistinguishable, suggesting that they
both label junctional complexes of endothelial cells during the
sprouting process.
To obtain a better idea of how endothelial cells connect to
each other during ISV formation, we analysed the distribution of
ZO-1 (Figs. 4A–D) and CDH5 (Figs. 4E–H) at different stages
of ISV development (from 22 hpf to 36 hpf). A differential
distribution of cell junctions in ISVs was already apparent at the
onset of angiogenic sprouting (Figs. 4A, E). While cells within
the dorsal aorta were labelled around their entire circumference,
both proteins were absent from the dorsal most part of the
leading cell as it appears to migrate out of the dorsal aorta. At
this stage cell junctions appear to be restricted to the base of the
leading cell, which is in contact with trailing endothelial cells.
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Slightly later (Figs. 4E, F), when more cells have left the aorta,
the junctional pattern becomes more complex. While the dorsal
part of the tip cell was largely devoid of ZO-1 and CDH5, we
saw extensive junctions between the tip cell and the following
cells, as well as among the latter. At 30 hpf, we already detected
the predominant distribution pattern of CDH5 and ZO-1,
namely the occurrence of two parallel lines extending along
the tube axis (arrowheads in Figs. 4C, G).
Fig. 3. CDH5 colocalizes with ZO-1 in endothelial cells. (A–C) Confocal projections of 36 hpf fli1:EGFP (blue) transgenic embryos labelled with anti CDH5 (red)
and anti ZO-1 (green) antibodies. (A) CDH5 and the GFP show that CDH5 labels exclusively junctions of endothelial cells. (B) ZO-1 labels endothelial cells as well as
cells in the notochord and the neural tube. (C) CDH5 and ZO-1 show co-localization (yellow) of the two junctional proteins in endothelial cells. Scalebars: 20 μm.
Fig. 2. Endothelial cells are paired in the ISV. (A–D) Confocal projection of single cells expressing mCherry under control of the flk1 promoter (shown in green for
better contrast) in fli1:EGFP transgenic embryos (red) in ISVs at 36 hpf (A–C) and 48 hpf (D) of development. (B) T-shaped cell embedded in the DLAV, (C, D)
extended stalk cells. In all cases, mCherry-expressing cells appear to make up only part of the circumference of the tube (arrows), and appear paired or aligned with
cells expressing EGFP only. (E) Single section (X–Yplane) of the cell shown in panel D. (F) Single cross section (Y–Z plane) of the ISV showing the lumen and the
surrounding cells. (G, H) Single cross sections of ISVs at 48 hpf showing ZO-1 staining (arrows) between cells surrounding the lumen (2 cells in panel G, 3 cells in
panel H). (G′, H′) Schematic representation of the cellular arrangement shown in panels G and H. Scalebars: 20 μm.
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To visualize junctions relative to the localization of cell
nuclei, we examined the distribution of CDH5 (Figs. 4I–L) and
ZO-1 (data not shown) in embryos carrying a flk1:EGFP-NLS
transgene which labels the nucleus of endothelial cells (see
below and Materials and methods). As in the previous
experiments, we found that the leading cell remains in close
contact with the trailing cell(s) during EC sprouting. During
sprouting, cell junctions of the leading cell were largely
restricted to its proximal portion (Figs. 4I, J), while distal
junctions were formed during establishment of the DLAV (Figs.
Fig. 4. Dynamic expression of junctional proteins during ISV formation. Confocal projections of fli1:EGFP embryos labelled with anti-ZO-1 (A–D) or CDH5 (E–H)
antibodies and of flk1:EGFPnls embryos labelled with CDH5 (I–L) antibody at different developmental stages. (A, E, I) 22–24 hpf, (B, F, J) 26–28 hpf, (C, G, K)
30 hpf, (D, H, L) 36 hpf. Already at early stages (A, E) both proteins are localized along the stalk of the ISVs, presumably between putative tip cells on the one hand,
and between stalk cells on the other hand. Spots and lines (arrows in panels C, F and J) of ZO-1 and CDH5 are visible when tip cells start to extend in anterior and
posterior direction to eventually form the DLAV. Arrowheads point to parallel junctions running along the axis of the ISV. Abbreviations: see Fig. 1, nt: neural tube.
Scalebars: 20 μm.
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4K, L). Moreover, in the basal part of the ISV nuclei can be
found in direct apposition to each other (Figs. 4K, L), thus
further illustrating that the parallel lines of junctional complexes
represent cell contacts between paired endothelial cells.
Complex cell rearrangements during vessel fusion in the DLAV
During formation of the DLAV the distribution of CDH5 and
ZO-1 in the tip cell is highly dynamic. When the tip cells have
reached the dorsal side of the embryo, they start to extend
cellular processes in anterior and posterior direction. At this
stage, before they make contact with their neighbouring
endothelial cells, spots and lines of ZO-1 and CDH5 protein
became evident (arrows in Figs. 4F, J). As soon as two tip cells
of adjacent sprouts contacted each other, a prominent localiza-
tion of ZO-1 (Fig. 5A) and CDH5 (data not shown) was
apparent at the contact site. During further development, this
contact point expanded (Figs. 5B, C) and eventually appeared as
an extended oval along the axis of the DLAV. Thereafter, the
pattern became more complex with time (see Figs. 1 and 4),
suggesting extensive cell rearrangements (see below).
To investigate the behaviour of endothelial cells during
DLAV formation in more detail, we performed time-lapse
analyses. By injecting flk1:mCherry plasmid into transgenic
flk1:EGFP embryos we were able to observe the interaction
between differentially labelled tip cells from adjacent segments.
We found that tip cells from neighbouring ISVs “crawl” over
each other after having made contact (Fig. 5D; supplementary
Fig. 5. Endothelial cell behaviour during formation of the DLAV. The figure depicts different ISVs within a single embryo. (A–C) ZO-1 pattern during vessel fusion.
Confocal projections of 30 hpf fli1:EGFP fish (red) labeled with anti ZO-1 (green). (A) ZO-1 accumulates at the contact site of two putative tip cells, which then crawl
over each other resulting in a small (B) oval-shaped ZO-1 pattern, which eventually expands to an extended oval (C). (A′–C′) Schematic representation of the ZO-1
pattern shown in panels A–C. (D, E) Picture series of supplementary movies 1 and 2 showing dynamic cell behaviour during ISV formation. Movie (D) shows a tip cell
expressing mCherry in a flk1:EGFP embryo. Within 5 h, the tip cell migrates dorsally and expands in anterior and posterior direction to fuse and form the DLAV. After
first contact (D″) tip cells “crawl” over each other to some extent (arrow in panel D′″). Movie (E) shows a single stalk cell migrating dorsally to contribute to the DLAV
(arrow in panel E′″). Scalebars: (A–C) 20 μm; (D–D′″) 50 μm; (E–E′″) 100 μm.
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movie 1). This behaviour is consistent with the localization
ZO-1 upon tip cell contact (see above). When we followed
individually labelled stalk cells, we found that these cells moved
dorsally and ultimately contributed to parts of the DLAV (Fig.
5E; supplementary movie 2). Clearly, the movement of stalk
cells into the DLAV must be accompanied by the reorganiza-
tion of cell–cell contacts, and account in part for the com-
plexity of the junctional pattern within the DLAV, such as seen
in Figs. 1 and 2.
Sprouting of ISVs is accompanied by extensive cell divisions
Our studies using single cell labelling and localization of cell
junction components have shown that throughout the ISV,
several cells appear to make up the apical surface of the luminal
circumference. This is particularly surprising in the DLAV,
which is thought to arise by the fusion of tip cells from adjacent
ISVs and the formation of an intracellular lumen (Kamei et al.,
2006). While cellular rearrangements and cell migration play a
crucial role in this process (see above), it is also clear that
additional cells have to be generated in order to contribute to the
DLAV. Tip cells could divide either shortly before or after the
fusion with the adjacent metamer. It has indeed been shown that
tip cells do divide, but they appear to do so during the dorsal
migration, before single tip cells contact each other (Leslie et
al., 2007; Siekmann and Lawson, 2007).
To monitor such cell divisions, we generated a transgenic
fish line expressing a nuclear localized GFP under the control of
the flk1 promoter (flk1:EGFP-NLS). These fish allowed us to
analyze the number of nuclei in different ISVs and to monitor
the behaviour of the nuclei during ISV formation. The GFP
protein expressed in these transgenic lines translocates from the
nucleus into the cytoplasm shortly before cell division, and then
re-enters the daughter nuclei after nuclear division. This
property makes it possible to study cell behaviour also, because
the outline of the cells that are going to divide can be visualized
shortly before cell division (see arrow in Fig. 6A). Shortly after
the establishment of the DLAV (36 hpf), we determined the
number of cells per ISV by counting the nuclei located within
the ISVs. We found that ISVs contained between 3 and 7 nuclei.
The majority of ISVs, however, contained 4 or 5 nuclei (43 out
of 55). When we observed the endothelial cell nuclei during ISV
formation in vivo, we found that in all segments, nuclei divided
as they were migrating towards the dorsal side, similar to what
has been recently reported (Leslie et al., 2007; Siekmann and
Lawson, 2007) (see movie 3; Fig. 6). However, and consistent
with the variations in ZO-1 or CDH5 distribution in different
ISVs, we found considerable variability in the “nuclear behav-
iour” of different ISVs. In most cases, three cells (as visualized
by three nuclei) migrated out of the dorsal aorta. Divisions were
often observed in the dorsal most nuclei (representing the lead-
ing cell of the outgrowing branch), arguing that tip cells divide
as they migrate out. In many branches, we observed that the
stalk cells also divided, before the tip cell of the same ISV did so
(Fig. 6; supplementary movies 3 and 4). We also observed that
nuclei arising in a given ISV could end up in the stalk of an
adjacent ISV (supplementary movie 5). Based on the analysis of
five different time-lapse movies, two to three cells migrated out
of the dorsal aorta, and, in most cases, two of them underwent
another round of cell division (one tip cell and one stalk cell),
Fig. 6. Non-stereotyped behaviour of nuclei in ISVs. Picture series taken from supplementary movies 3 (A) and 4 (B) showing sprouting ISV in flk1:EGFP-NLS
embryos. (A) A stalk cell (arrow) divides prior to the tip cell (arrowhead). Outline of the cell can be visualized during cell division. (B) A tip cell nucleus ends up in an
adjacent ISV (arrows are following the nuclei). Scalebars: 20 μm.
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eventually giving rise to the 4 or 5 endothelial cells present in
the majority of ISVs. Thus, the process of ISV formation is
accompanied by cell migration and cell division, but these
processes do not appear to be stereotyped and we observed a
high degree of variation, suggesting that they are not under strict
genetic control.
Discussion
A model for the cellular architecture of ISVs in the trunk region
in the zebrafish embryo
The formation of the ISV in the trunk of the zebrafish
embryo serves as a paradigm to study how endothelial tubes
form in an in vivo model system. To better characterize the
cellular architecture of ISVs, we have studied the organization
of their intercellular junctions. For this purpose, we generated
antibodies against the CDH5 protein, an endothelial-specific
VE-type cadherin in the zebrafish. Furthermore, we have used
two-colour, single cell imaging to differentially label endothe-
lial cells within a given ISV. Together, these approaches have
allowed us to define the spatial relationships between
neighbouring endothelial cells. Based on our findings, we
propose that the architecture of the ISV is different from what
has been suggested previously. Instead of being arrayed in a
serial fashion, we demonstrate that in most regions, endothelial
cells are paired along the axis of the ISVs. In this modified
cellular model of ISVs, the luminal space appears to be in-
between endothelial cells. The ISV thus qualifies as a multi-
cellular tube containing an “extracellular” lumen (Lubarsky and
Krasnow, 2003). This model has considerable implications on
several aspects of ISV formation, such as cell behaviour and
lumen formation.
How is the lumen formed in the ISVs?
Lumen formation in ISVs has previously been studied using
two-photon confocal time-lapse imaging (Kamei et al., 2006).
This study provided strong support for a model in which the
vascular lumen is formed de novo by formation and intracellular
and intercellular fusion of endothelial vacuoles. Vessels formed
in this fashion consist of a “seamless” tube containing an
intracellular lumen. This interpretation was based on a previous
model proposing that ISVs consist of three cells arranged in a
linear fashion (Childs et al., 2002). However, based on our
analyses, we conclude that endothelial cells in the ISV share cell
junctions over the entire vessel length. This strongly argues that
the luminal space is in-between adjacent cells, and therefore
“extracellular”, and not contained within the cytoplasm of
single cells (“intracellular”). It appears likely that the lumen of
ISV is formed in such a way that intracellularly generated
vacuoles are exported through exocytosis into a common
intercellular space bounded by at least two endothelial cells that
are joined together by junctional contacts. This process
eventually leads to the formation of a common intercellular
luminal space as suggested by Kamei et al. (2006) for larger
calibre vessels. It may be advantageous for ISVs to be made up
by a multicellular tube; it is difficult to imagine how tubes made
of chains of cells with an intracellular lumen would ramify later
during development through sprouting angiogenesis. In the
Drosophila embryo, terminal cells of the trachea do form an
extensive intracellular luminal network, these terminal cells do
not divide anymore during later stages of development
(Samakovlis et al., 1996).
Dynamic tip cell rearrangements during vessel fusion
The dynamic cell behaviour during ISV formation in the
zebrafish embryo is exemplified by the behaviour of the tip cells
during the process of vessel fusion. During dorsal migration of
the tip cells, “dot-like” and short “line-like” ZO-1 and CDH5-
containing structures are already visible in these cells.
Immediately upon the first contact between tip cells from
adjacent ISVs, ZO-1 and CDH5 localize to the contact point.
This is reminiscent of the initial steps in branch fusion in the
developing tracheal system in the Drosophila embryo, where
filopodial contacts of specialized fusion cells from adjacent
metameres result in the immediate localization of DE-cadherin
to the contact site (Samakovlis et al., 1996; Tanaka-Matakatsu et
al., 1996). In the absence of DE-cadherin, branch fusion does
not occur in the tracheal system (Uemura et al., 1996).
However, the branch fusion process in the tracheal system
appears to be rather different after this initial step when
compared to the fusion of the ISVs in the zebrafish. In the
tracheal system, the highly specialized fusion cells ultimately
develop into so-called doughnut cells, which are made up of
Fig. 7. Putative cellular architecture of ISVs in the zebrafish trunk. According to
our model ISVs are multicellular tubes consisting of 4–6 cells per vessel. These
cells are arranged in such a way that they overlap in a staggered fashion in the
ISV as well as the DLAV. This arrangement allows extensive cell–cell contacts
(coloured lines), which correspond to a complex pattern of intercellular
junctions.
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two apical sides and a seamless lumen in-between (Uv et al.,
2003). Fusion points within the mature tracheal system can thus
easily be identified using markers for adherens junctions. In the
ISVs of the zebrafish embryos, it appears that endothelial tip
cells first contact each other and establish a CDH5-containing
interface. However, and in contrast to the Drosophila tracheal
system, this interface is then enlarged such that adjacent tip cells
make more and more extensive contact until they are paired
over much of their extent (see model in Fig. 7). In addition, stalk
cells move up to the DLAV and increase their contact surface
with tip cells. In general, it appears that adjacent endothelial cell
maximize their contact surfaces. It is possible that they do so
because the intracellular vacuoles preferentially fuse with pre-
existing apical membrane patches, resulting in their extension
and the generation of a larger and larger surface surrounding the
luminal space.
Our analysis of a transgenic line expressing a nuclear version
of GFP also showed that both tip and stalk cells divide as they
migrate during the process of ISV formation. It has been
previously argued that the division of the tip cell is a unique
feature of this particular cell imposed to it via the Dll/Notch and
the Vegfr signalling pathways (Leslie et al., 2007). Our results
do not favour the simplest version of such a model, and suggest
that tip and stalk cells are more similar in their behaviour than
anticipated: both can and do eventually divide as they migrate,
and do so rather independently and not in a well established
choreography. It will be important to study how lumen
formation proceeds in such a dynamic cellular environment,
in which cells even divide during the process of lumen
formation.
Endothelial cells rearrange extensively as the ISVs form and
eventually fuse. They migrate out of the dorsal aorta, divide as
they migrate, and can even migrate into neighbouring ISV
sprouts. We also find a lot of variation between individual ISV
in respect to junctional organization and cell number,
suggesting that cell behaviour during ISV formation is very
plastic and cannot be easily stereotyped. To accurately describe
these cell rearrangements, the formation of intercellular
junctional complexes has to be imaged at high-resolution in
live transgenic zebrafish embryos at the single cell level,
similar to what has been done during tracheal development in
the Drosophila embryo (Neumann and Affolter, 2006; Ribeiro
et al., 2004). In addition, the formation and fusion of vacuoles
and the formation of cell–cell contacts have to be imaged in
parallel in the same live embryos, to find out whether there is
coordination between the two processes, such that lumen
formation eventually leads to the proper assembly of con-
tinuous vascular tubes.
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6.2 Chapter II: Distribution of different tube architecture in ISVs 
and the DLAV 
We have previously shown that ISVs are to a large extent multicellular tubes; however, we 
didn't exclude that parts of the ISVs have a different tube architecture, such as unicellular 
tubes with autocellular junctions or tubes with an intracellular lumen as proposed by Kamei et 
al.. We do see lack/gaps of ZO1/CDH5 expression in ISV in stainings at 36 and also at 48 
hpf suggesting the presence of intracellular lumens. But, as this tissue is fixed and a potential 
lumen would mostly collapse in fixed tissue, we cannot discriminate between a collapsed 
lumen and a non-lumenized vessel. 
  To clearly discriminate between these two possibilities we used live embryos at 2dpf, where 
the lumen is clearly inflated seen by the darker spaces in the middle of the tube or by cross-
sections (see Figure 6.1). We used the photo-convertible protein Kaede to label individual 
cells in the ISV and the DLAV. We expressed Kaede with the Gal4/UAS system using a 
fli1a:GFF transgenic driver line, which was established by Lukas Herwig in the lab, and a 
UAS:Kaede responder line (ZIRC). Kaede can be easily converted from green to red using 
an UV laser (405 nm). To label single cells, we illuminated a region of interest, which 
encompassed a cell nucleus, for 20 seconds with 100% UV laser power. The turnover of the 
converted Kaede between cytoplasm and nucleus appeared to be very fast, as immediately 
after photo conversion of the cell nucleus the cytoplasm turned red as well, clearly discerning 
borders between 2 cells (see Figure 6.1 and movie 1-4).  
  As previously shown with transient expression (Figure 2 in Blum et al., 2008), we found 
labeled cells, which were paired with one or more unlabeled cells (Figure 6.1 A, A’ movie 1 
(x,y slices) and 4 (y,z slices)). But we also found cells where the whole circumference of the 
lumen was encompassed by one single red labeled cell (Figure 6.1 B, B’). To ensure that the 
lumen was entirely engulfed by this individual cell we made movies through x,y slices and y,z 
slices of what we thought represented single cells around the lumen (movie 3 and 4). The x,y 
slices movie clearly showed the border between the red cell and the green cells, where the 
green cells in none of the x,y slice spans over the whole vessel/cell length. Going through the 
y,z  slices, we found that in a set of slices only the red labeled cell was surrounding the 
lumen. In this assay we were not able to discriminate between a cell with autocellular 
junction and a cell with an intracellular lumen. But as we only very rarely saw stretches of 
autocellular junctions in stainings, our finding suggested that these cells have an intracellular 
lumen.  
 In another assay, we injected fluorescent high molecular weight dextran, and fixed embryos 
at 2 dpf. The dextran got fixed and stayed partially in the luminal spaces. We found stretches 
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where dextran was present, suggesting a lumen, but no junctions were visible, strongly 
suggesting an intracellular lumen (see arrows in Figure 6.2).  
 Having obtained good evidence that intracellular lumens are present, we wanted to get a 
rough idea of the quantitative distribution of these different kinds of tubes 
  
  
We decided to quantify separately the ISV stalk and the DLAV and used two approaches to 
quantify the amount of seamless tubes. On the one hand we randomly labeled single cells in 
transgenic fli1a:GFF; UAS:Keade embryos and on the other hand we used antibody 
stainings and measured the extent of vessel length without junctions compared to the entire 
vessel length, giving an idea of the percentage of intracellular lumen in ISV and DLAV (see 
Figure 6.3 A for an example). ISVs were measured form the DA to the DLAV and DLAV 
sections were measured from ISV to ISV. All quantifications were made in an area of 5-6 
ISVs anterior to the end of the yolk extension. 
ISV stalk 
In 36 labeled cells, 9 had stretches of intracellular lumen (or autocellular junctions). When we 
looked at the distribution of junctions within the stalk, we found that within a total length of 44 
Figure 6.1 
Tube variation in ISVs at 2 dpf: Kaede converted single cells (red). (A) shows 
a cell in a multicellular context, (B) shows a unicellular tube with. 
Representative cross-sections at the level of the white bars are shown in A’ 
and B’ (see also movies of slice through x,y (movie 1 for A and movie 3 for B) 
and y,z slices (movie2 for A and movie 4 for B)) . 
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measured ISVs, 88% of the total length showed a multicellular pattern of junctions. 50 % of 
  
the ISVs were entirely multicellular from the DA/PCV up to the DLAV. In the other 50%, we 
found 1-2 gaps per vessel, meaning one or two cells per vessel with intracellular lumen. The 
length of intracellular stretches varied from 5 to 45 microns at an average ISV length of 130 
microns (see Figure 6.3). 
DLAV 
When considering the DLAV, the story looked quite different. In the DLAV, 16 from 24 cells 
had an intracellular lumen, thus 66 percent of the cells compared to 25% in the stalk. 
Compared to the stalk, an intracellular lumen is the predominant form of lumen in the DLAV 
at least at 2 dpf. This was also confirmed with staining where only 63 % of the DLAV showed 
a multicellular pattern of junctions, but more importantly only 7 out of 36 measured DLAV 
sections (from ISV to ISV) were entirely multicellular. 14 sections had one gap and 15 
showed two gaps, which varied in length from 8 to 47 microns at an average DLAV section 
length of 75 microns. We also observed more autocellular junctions in the DLAV (see Figure 
6.3 B-D). 
 Taken together, the majority of the ISV stalk consists of multicellular tubes with an 
extracellular lumen, whereas the DLAV has more intracellular lumen and thus suggests a 
different mechanism for lumen formation. 
Figure 6.2 
Dextrane injection revealed 
intracellular lumen: 2dpf 
dextrane (red) injected 
embryos showed a filled 
lumen in regions were VE-
cadherin was not present 
(arrows). 
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Figure 6.3 
ISV stalk and DLAV have different distribution of tube architecture at 2 dpf: (A) shows an example 
of quantification of junctions. The measurement points A-E is the total length of the ISV stalk and A-B 
the length of intracellular lumen as 1 gap. (B) shows percentage of multicellular tube in ISV and 
DLAV. (C) shows percentage of cells showing an intracellular lumen using Kaede conversion. (D) 
shows number of ISVs/DLAV, which have 0,1 or 2 gaps. 
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6.3 Chapter III: Cellular mechanisms during ISV formation and 
anastomosis 
  Using antibody staining and single cell labeling we have shown that ISVs have for a high 
percentage of their extent a different architecture then formerly proposed in Kamei et al, 
2006. The stalk appeared to consist predominantly of multicellular tubes suggesting a 
budding mechanism for lumen formation. The DLAV, in contrast, had a high portion of 
seamless tubes with intracellular lumen, suggesting a cell hollowing mechanisms for lumen 
formation. Interestingly, the DLAV is the location where anastomosis of ISVs takes place and 
this might explain the degree of seamless tubes.  
 
6.3.1 Cellular mechanisms during anastomosis 
 Cellular mechanisms during anastomosis have remained ill described despite the 
importance of anastomosis to form a proper and functional vascular system. ISVs have been 
shown to anastomose at around 28-30 hpf (Isogai et al., 2003). Before anastomosis, tip cells 
of ISVs extend filopodia and protrusions in anterior and posterior direction exploring their 
environment (see arrow in Figure 6.4 A). Protrusions from adjacent tip cells eventually 
contact each other forming a stable bridge between two stalks (Figure 6.4 B). The lumen 
extends from the stalk (arrow in Figure 6.4 C) and eventually reaches the DLAV, thus 
completing anastomosis (Figure 6.4 D, movie 5). 
We have characterized a few aspects of anastomsis of ISVs using antibody staining against 
ZO-1 and Ve-cadherin in fixed embryos (Blum et al., 2008). At 30 hpf, we found different 
patterns including dots, small loops and larger loops in the DLAV at presumptive locations of 
anastomosis. In addition, tip cells appeared to crawl of over each other during anastomosis 
suggesting a mechanism, whereby the interface between two tip cells is increased (see 
Figure 5A-C and D-D’’’ as well as suppl. movie 1 in Blum et al., 2008). Unfortunately, we lack 
either time (fixed embryos) or cellular resolution in these experiments making it impossible to 
prove the proposed model and to evaluate further steps during anastomosis.  
To circumvent these limitations, the idea was to use similar methods, which were used 
earlier in the lab to study the traechal system of Drosophila melanogaster. The use of 
transgenic flies expressing an α-cateninGFP localizing to the junctions of tracheal epithelial 
cells, has unambiguously revealed the cellular mechanism during branch elongation (Ribeiro 
et al., 2004). 
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 In an effort to establish the UAS-Gal4 system for the vascular system in the zebrafish, Lukas 
Herwig in the lab established the above mentioned fli1:GFF driver line (GFF is a variation of 
Gal4 less toxic to the zebrafish (Asakawa et al., 2008)) and a UAS responder line controlling 
a N-terminally EGFP tagged version of human ZO-1 (Riesen et al., 2002). A UAS:RFP 
responder line (Asakawa et al., 2008) was used for cytoplasmic labeling of endothelial cells. 
While the GFF protein was expressed in all endothelial cells and some ectopic locations such 
as muscles as visualized by RFP expression (see below), expression of the EGFP-hZO1 
fusion protein was only seen in a mosaic fashion when the two constructs were brought 
together upon crossing the driver and the responder lines. Although such mosaic expression 
makes it more difficult to identify embryos with tip cells expressing EGFP-hZO1 at the right 
stage (before anastomosis, during ISV sprouting), the mosaics’ can be used to 
unambiguously identify which one of two contacting tip cells expresses the fusion protein 
and, accordingly, from which tip cell the labeled junctional complexes arise.  
Figure 6.4 
Anastomosis of ISVs in flk1:EGFP zebrafish embryos:  Series of pictures taken from movie 5.  High 
resolution movie (63x lens, 2x zoom, 2 minutes between timepoints) shows steps during DLAV 
formation. Tip cells reaching the dorsal part of the embryo showed protrusion and filopodia in 
anterior and posterior direction (A, arrow).  Tip cells made an initial contact forming the DLAV (B).  
The lumen opened from the stalk  and proceeded through the DLAV (arrow in C and D). 
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 We first verified whether the expression of EGFP-hZO1 co-localized with endogenous AJ 
complexes. In wild type embryos, endogenous ZO1 and VE-cadherin staining overlapped 
(see Figure 3 in Blum et al., 2008). We therefore stained double transgenic fli1:GFF, 
UAS:EGFP-hZO1 embryos with Ve-cadherin antibodies. In a stalk cell EGFP-hZO1 
recapitulated and co-localized with the Ve-cadherin Ab staining. EGFP-hZO1 did show some 
cytoplasmic labelling but clearly enriched at junctions (Figure 6.5 A-C). Quite remarkably, 
EGFP-hZO1 was apparent in a number of dots and short lines in proximal regions of tip cells. 
Even these dots did co-localize with endogenous Ve-cadherin (see arrow in Figure 6.5 A’-C’) 
and such patterns were also found for endogenous ZO1 (see Figure 4 C and F in Blum et al., 
2008). Thus, EGFP-hZO1 faithfully reflected the distribution of endogenous Ve-cadherin and 
ZO1 containing cell junction complexes in live embryos and therefore allows us to follow 
individual cells and their behavior by monitoring their AJ in vivo using high resolution 4D 
confocal microscopy.  
Figure 6.5 
EGFP-hZO1 co-localizes with endogenous VE-Cadherin:  A-C show a stalk cell 
and A’-C’ show a tip cell, where even dots do co-localize (arrow).  
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 In the following set of movies we used triple transgenic embryos (all movies have the same 
colour code: fli1:GFF; UAS:RFP(red); UAS:EGFP-hZO1(green); if present, QD(blue)) to 
follow the formation of tip cell contacts and the elaboration of these contacts during the 
process of ISV anastomosis and lumen formation in the DLAV. While cell contacts were 
monitored by the EGFP-hZO1, lumen inflation was observed using the cytoplasmic RFP, 
which upon lumen inflation got pushed to the side of the vessel resulting in a fainter RFP 
signal in the middle of the vessel (see also arrows in Figure 6.4 C and D as well as movie 5). 
Alternatively quantum dots (QD) were injected in the sinus venosus, which are carried by the 
blood plasma throughout the vasculature, unambiguously labeling open lumens with a 
connection to the DA. Observing only the RFP channels in such movies confirmed that these 
fainter, almost black areas in vessels were indeed inflated lumens as they were filled with QD 
(Figure 6.6 and movie 6 A,B,C).  
 
 
Figure 6.6 
Fainter areas in ISVs correlate with 
lumen formation:  QD injected in the 
sinus venosus spread in the 
circulation demarking open lumens.  
Initially, QD were restricted to the DA 
and ISV did not show fainter areas 
(A,A’,A’’). Later the lumen filled from 
the DA and first smaller fainter areas 
were visible and later, as the lumen 
extended, these areas became larger 
(arrows in B’ and C’). These areas 
were concomitantly filled with QD 
(arrowhead in B’’ and C’’). A-C shows 
the merge of both channels (see 
movie 6 A,B,C). 
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6.3.1.1 Initial contact formation 
 The first aspect of anastomosis we analysed was the formation of the initial contacts 
between two contacting tip cells and how such contacts refined. To our delight, already the 
very first movie we did with the UAS:EGFP-hZO1 line showed a tip cell which already had 
made contact to its neighbor, visible by a spot of EGFP-hZO1 (see arrow in Figure 6.7A). 
This spot was then elaborated into a small loop which subsequently became larger (see 
arrow in Figure 6.7B and then C, movie 7), confirming our suggested model for initial contact 
of tip cells. We found this mechanism in virtually all movies we analyzed. Thus, after a tip cell 
has formed its initial contacts (from then on called fusion cell) with the adjacent tip cells, 
these cells have contacts with at least three if not more cells. The two new contacts with the 
neighboring fusion cells as well as one or more cells of the ISV stalk (depending on the 
architecture of the stalk, multicellular or head to tail organization) the tip cell was dragging 
along during outgrow. Interestingly, these fusion cells also presumably have three 
independent apical membranes, one at the connection with the stalk cells and one each at 
the fusion points encompassed by the newly formed AJ loops.  
 
 
 
 
6.3.1.2 Intracellular lumen formation 
After contacts between ISVs have been established we wanted to follow how the lumen 
opens in the newly formed DLAV. In other words: how are the three separated apical 
membranes of a fusion cell brought together to form a continuous lumen through the DLAV?  
 Movie 8 revealed one possible mechanism of lumen formation. A fusion cell, which just 
made contact with its neighbors was seen as spots of EGFP-hZO1, which then further 
elaborated to loops as described above. Due to the mosaics’ of EGFP-hZO1 only the fusion 
cell and one or two stalk cells were labeled; the stalk appeared to be of multicellular nature 
showing the reminiscent junctional pattern of lines along the ISV stalk (arrowhead in Figure 
6.8B). The lumen (dark space) was open (inflated) in the multicellular part of the stalk (waved 
arrow in Figure 6.8B) and then invaginated into the fusion cell and eventually reached one of 
Figure 6.7 
Initial contact formation during anastomosis:  An initial contact spot of EGFP-hZO1 ( arrow in A) was 
elaborated into a small (arrow in B) and subsequently into a larger loop (arrow in C), thereby 
stabilizing the fusion cell contact (see movie 7). 
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the two loops at the contact points (follow arrow in Figure 6.8C-E and see movie 8). When 
the lumen reached the junctional loop at the contact point, the loop was immediately 
lumenized (one time point difference, 5’) and the lumen proceeded in the unlabeled adjacent 
fusion cell (arrow Figure 6.8F and G). Note that before doing so, the lumen transiently 
collapsed (even in the stalk) and subsequently reopened (see movie 8 between 3:00 and 
5:20). Later, a red blood cell (occasionally labeled with RFP) squeezed through the vessel 
(see arrowhead in Figure 6.8G-J and movie y, note: timepoints are 5’ apart, thus the red 
blood cell is rather slow even though in the movie it passes relatively fast). Thus, a seamless 
tube with an intracellular lumen was generated in this fusion cell (no junctions were identified 
in the DLAV except for the loop at the fusion point). To unambiguously prove that such 
invaginating lumens into fusion cells were connected to the lumen of the DA, a similar movie 
with QD injected embryos was acquired (movie 9A and B, Figure 6.9). In movie 9A, QD 
complemented with the dark areas and filled the invagination into the fusion cell, better seen 
in the separate channel of the QD (arrows in Figure 6.9B and C and arrowheads in Figure 
6.9B’ and C’). Remarkably, the QD also leaved the vessel when the lumen collapsed and 
immediately reappeared when the lumen reopened (see movies 9A and B). In our set of 15 
movies analyzed we found that the fusion cell hollowing process as just described occurred 
in 12 movies. Thus, this mechanism is a very common way to generate a lumen in the DLAV.  
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6.3.1.3 Extracellular lumen formation 
  We also found a different mechanism involved in the lumen formation process in the DLAV. 
Movie 10 showed again a fusion cell right after it made contact. Interestingly the fusion cell 
only had contact with one cell from its stalk seen as a loop (arrow in Figure 6.10A, see below 
Figure 6.15 for mechanism). This loop and the loop at the fusion point to the right 
subsequently increased in size. This means that the contact of the fusion cell with its stalk 
cell and the neighboring fusion cell increased, meaning that these two putative apical 
membranes of the fusion cell enlarged. So far there was no lumen apparent. Eventually, 
these two loops joined together (arrow Figure 6.10C). In other words; the two apical 
membranes of the fusion cell joined and concomitantly the stalk cell and the other fusion cell 
to the right contacted and made new junctions together (see also Figure 7.3 in discussion). 
At the same moment we observed that the lumen opened up. When the two loops contacted 
Figure 6.9 
QD injections confirms intracellular lumen formation: Series of pictures of movie 9A and B. As in 
Figure 6.8 the lumen invaginated and reached one of the fusion points. Doing so, the lumen was 
permanently filled with QD (arrow and arrowhead in B and B’) and QD filled the loop at the contact 
point as soon as the lumen reached it (arrow and arrowhead in C and C’).  
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each other, there appeared to be an increase of EGFP-hZO1 possibly accounting for the new 
contact between the stalk cell and the other fusion cell.  
 
The new contact between these two cells was then presumably enlarged, seen as a line 
between the now single loop of junctions of the fusion cell (see arrow in Figure 6.10D, and 
movie 10, and see the marked contribution of junctions of the different cells in Figure 6.10A’-
D’, colour code is: fusion cell: yellow, stalk cell: green, other fusion cell on the right: red; the 
yellow line in D’ shows the single loop of junctions of the fusion cell). This mechanism, which 
involves cell rearrangements, resulted in the incorporation of the fusion cell as a part of a 
multicellular tube, and is thus fundamentally different from the first mechanism described 
above. Such a mode of lumen formation has previously been described during notochord 
Figure 6.10 
Extracellular lumen formation: Series of pictures of movie 10. A fusion cell formed a junctional 
loop with an adjacent fusion cell (on the right) and with a stalk cell (arrow in A). These loops 
extended and eventually met (B,C). A’-D’ show contribution of junctions of the different cells 
(yellow: fusion cell, green: stalk cell, red: fusion cell on the right). Thus, the stalk cell and the 
adjacent fusion cell met and formed a new contact/ junctions (arrow in D, green/red line in D’). 
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formation in Ciona intestinalis (Dong et al., 2009). We found this mechanism to be less 
prominent than the fusion cell hollowing process, as we only observed it 7 times. 
6.3.1.4 Blood pressure is not important for initial contact formation and extracellular 
lumen formation but might be important for intracellular lumen formation 
 We found ISVs where the lumen did not form from the DA into the ISV stalk but from the 
DLAV. In such movies we observed that the lumen formed from the DA into an ISV and 
DLAV, and from there expanded into an adjacent ISV stalk (Figure 6.11). EGFP-hZO1 
showed that the same invaginating mechanism required for intracellular lumen formation, 
was involved in this situation, suggesting that this mechanism is depend on luminal pressure.  
(follow arrows in Figure 6.11 and see movie 11, movie from Lukas Herwig).  
 
 
Thus, luminal pressure might play a key role in extending apical membranes through a fusion 
cells. In silent heart (sih) mutants (or in sih MO injected embryos), the heart fails to contract 
and blood pressure fails to be established. Unfortunately, lumen formation could not be 
monitored in such embryos, since the lumen in ISVs did not open (inflate). However, we 
found that tip cell contacts as well as enlargement of contact points into larger loops did 
occur in sih MO-injected embryos (arrow in Figure 6.12A, movie 12). We also observed the 
second mechanism described above, where cell rearrangements lead to a multicellular tube. 
(arrows in Figure 6.12B and C).  
 
 
Figure 6.12 
Junctional remodelling is not dependent on circulation: Series of pictures from movie 12. Fusion 
spots are still elaborated into loops in sih morphant embryos (arrow in A) and the extracellular lumen 
formation mechanism is functional as well (arrows in B and C) 
Figure 6.11 
Luminal pressure might be important for lumen formation: Series of pictures from movie 11. The 
lumen opens from the right ISV (arrowhead) over the DLAV into the stalk of the left ISV (follow arrow 
in A-C). 
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These results demonstrate that the initial steps in the fusion process do not require blood 
pressure, and that one of the two mechanisms of lumen formation is still functional. To 
investigate whether apical membrane extension through fusion cells occurs in the absence of 
blood pressure will require monitoring fluorescent apical markers. 
 
6.3.2 Other mechanisms observed during ISV formation 
6.3.2.1 EGFP-hZO1 during cell division 
  Initially we were focussing on the leading tip cells describing the fusion event and the 
subsequent lumen formation process in the DLAV. These observations led to two different 
mechanisms described above, forming either an intracellular lumen as a result of cell 
hollowing or an extracellular lumen as a result of cell rearrangements. These two different 
mechanisms show that endothelial cells within the vascular system can use different ways to 
form a patent lumenized vascular system, mostly likely depending on their internal and 
external inputs such as signaling and blood pressure.  
  Looking at the movies in detail, we found other interesting activities during ISV formation. 
ISV sprouting is, as shown in Blum et al., accompanied by extensive cell division. Most of the 
cells that migrate out of the aorta divide at least once. One interesting question is to 
understand how the junctions behave during cell division. In a regular sheet epithelium, when 
a cell divides, junctions are formed at the cleavage plane starting from the already existing 
junctions of the dividing cell (Kim and Raphael, 2007). We observed different situations of 
cell division of endothelial cells during ISV formation. 
 During all cell divisions we observed that EGPF-hZO1 partially delocalized, which resulted in 
a more or less evenly green cell. EGFP-hZO1 localized back to the junction during 
cytokinesis, thus right after cell division. It’s not clear whether the junctions indeed 
disintegrate to such a degree or whether this is a property of ZO1/EGFP-hZO1. A transgene 
with Ve-cadherin or another transmembrane junctional protein might reveal to what degree 
the junction dissolve during cell division (Figure 6.13B and movie 13 ).  
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 We found that tip cells in a sprouting ISV (app. 24 hpf), right after cell division, formed a new 
loop of ZO1 between the two daughter cells. This new loop did not have any connections to 
the junctions the initial tip cell had with the stalk cells (arrow in Figure 6.13C). Thus, 
presumably a new apical interface was established between the two daughter cells, 
somewhat similar to a fusion point. Afterwards, this loop met up with the other junctions and 
underwent cell rearrangements in a way as described above (Figure 6.13D and E, movie 13). 
  We also found a stalk cell dividing, which was part of a multicellular tube and had junctions 
with other cells, which resulted in two parallel lines of EGFP-hZO1 usually seen for such tube 
architecture (arrows in Figure 6.14A and A’). Upon division, a new line of EGFP-hZO1 
formed between the two daughter cells. This line was connected with the two parallel lines, 
thus forming a bridge between the two lines (arrow in Figure 6.14C,C’ and D,D’, movie 14A 
and 14B). This is the way how one would expect cell division in an epithelial sheet (Kim and 
Raphael, 2007). Interestingly at the beginning of cell division the lumen appeared to be 
inflated, but shortly collapsed during the cell division and re-inflated again after cell division 
(Figure 6.14B and B’, timepoint 1:30). This behaviour might depend on the maturity of the 
vessel. 
 
Figure 6. 14 
Cell division in a multi-
cellular tube: Series of 
pictures from movie 14. A 
cell in a multicellular tube 
(two lines in Figure 
A’(arrows)) divided (B) and 
formed a new junction 
between the two daughter 
cells. This junction was 
connected to the two 
parallel lines (arrows in 
C,C’D,D’). The lumen 
collapsed during cell 
division (B). 
Figure 6.13 
Tip cell division: Series of pictures from movie 13. A tip cell divided and formed an isolated new 
small loop of EGFP-hZO1 between the two daughter cells after division (arrow in C). The loop then 
contacted the other junctions and enlarged as the sprout grew (D and E). EFGP-hZO1 delocalized at 
the onset of cell division (B). 
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In early ISVs (29 hpf) we also found stalk cells, which were not in a multicellular context and 
thus aligned in a head-to-tail fashion for instance with the tip/fusion cell and other stalk cells 
(see Figure 6.10A and 6.15D). Interestingly, movie 15A and B also showed us how this 
organization came about. Prior to cell division of this stalk cell we saw an interesting behavior 
of this cell. This cell underwent the reverse mechanism of extracellular lumen formation 
described above (see Figure 6.15A-D, movie 15A and 15B).  
 
 
 In this scenario the stalk cell, which at the onset of the movie was arranged in a multicellular 
tube (EGFP-hZO1 expression along the vessel in Figure 6.15A and B, hard to see in the 
pictures, follow junction in movie 15A and movie 15B, which only shows the EGFP-hZO1), 
underwent rearrangements to end up in a head to tail manner, showing one loop with the 
fusion cell and one with underlying stalk cells (arrows in Figure 6.15D, the loop at the bottom 
Figure 6.15 
Cell division is compatible with cell rearrangements: Series of pictures from movie 15A. In the first 
part, a stalk cell went from a multicellular to a head-to-tail arrangement forming a loop with the 
fusion cell and another with underlying stalk cells (A-D, arrows in D show the two loops). 
Subsequently the stalk cell divided, formed a junctional interface between the two daughter cells 
(arrow in F,G) and concomitantly the underlying stalk cell and the fusion cell formed a new contact. 
The end result were parallel lines from dorsal to ventral (arrows in H) and a loop at the location of 
cell division (arrowhead in H). At the same time the lumen opened (asterix in H). 
Results   54 
arrow looks like two loops but 3D analysis reveals that it is one (not shown)). This cell 
subsequently divided and first EGFP-hZO1 formed a spot between the two daughter cells 
(arrow in 6.15F and G), after EGFP-hZO1 localized back seen as dots and small stretches 
aggregating together, (see Figure 6.15G). At the end EGFP-hZO1 showed two lines from 
dorsal to ventral and a small loop at the location of cell division (arrows in Figure 6.15H show 
parallel lines, arrowhead shows the loop). Thus, while the stalk cell divided and formed new 
junctions between the new daughter cells, the fusion cell on top and a stalk cell on the 
bottom presumably made contact. This means that during cell division the stalk cell had 
undergone the cell rearrangement mechanism described in Figure 6.10. So presumably the 
loop demarks junctions of the two daughter cells and junctions of the fusion cell on top and 
the stalk cell on the bottom (following movie 15A and 15B makes it easier to figure out the 
mentioned loop). The lumen opened right after this process was completed (asterix in Figure 
6.15H).  
  
6.3.2.2 Endothelial cells undergo intercalation and cell self fusion 
  In the Drosophila melanogaster tracheal system, cells of the dorsal branches undergo 
intercalation going from a paired to a head-to-tail arrangement, where the individual cells 
form autocellular junctions revealed as one line connecting to two little rings at each end of a 
cell. To accomplish this, cells reach around the lumen, where they form an initial autocellular 
junction. From this point the cells zips up extending its autocellular junction and the junction 
with the formerly pairing cells is reduced to a little ring (Ribeiro et al., 2004). We were 
interested whether we would see a similar behavior with endothelial cells. 
  We indeed saw intercalation events in ISVs (see Figure 6.16, Figure 6.17 and the 
corresponding movies; movie 16A, 16B and 17). Initially two parallel lines of EGFP-hZO1 
and a short line connecting these two parallel lines were visible in the ISV stalks (arrowheads 
show the parallel lines in Figure 6.16A and A’ and Figure 6.17A; arrow shows the connecting 
line in Figure 6.16A, A’ and 6.17A, the line is not really visible in Figure 6.16 but clear in 
Figure 6.17). The two parallel lines of EGFP-hZO1 met into one point where the line of 
EGFP-hZO1 was connecting these two lines, in other words, where two cells contacted 
(arrow in Figure 6.17B, in 6.16B and B’). This is the reaching around the lumen of the 
intercalating cell forming the initial auto-cellular junction. From this point, intercalation went 
on, resulting in a single line of EGFP-ZO1 (Figure 6.16C,C’,D,D’ and Figure 6.17C and D). 
Most strikingly this line eventually dissolved, leaving a cell arranged in a head-to-tail manner 
(Figure 6.16E,E’,F,F’ and 6.17E and F). We observed slightly different variations of this 
cellular mechanism during ISV formation. 
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 In movie 16A the lumen collapsed (no “dark” areas in the vessel) at the end of intercalation 
event when the junction dissolved (arrows in Figure 6.16D and E). Then this cell appeared to 
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undergo an intracellular lumen formation process as described above (arrow in Figure 
6.16F).  
  In movie 17, a movie where we used QD to mark the lumen, the lumen opened after 
initiation of intercalation and clearly remained open when the junction dissolved (Figure 
6.17C-F). 
 
 
 
Taken together our results show that ECs are very plastic and can use a variety of cellular 
mechanisms to form functional lumenized blood vessels.     
 
 
Figure 6.17 
Intercalation and cell self fusion II: Series of pictures from movie 17. Similar situation as in Figure 
6.16. Two parallel lines of EGPF-hZO1 merged into one (arrows in A,B). this line extended and 
eventually dissolved (B-E). In contrast to Figure 6.16 the lumen did not collapse when the line 
dissolved seen by injected QD (D-F). 
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7.1 Different tube architectures in ISVs 
 Biological tubes can have three different tube architectures: multicellular, unicellular with 
autocellular junctions, and seamless (Baer et al., 2009; Lubarsky and Krasnow, 2003). 
Endothelial tubes consist of multicellular and seamless tubes. Capillary beds of mouse 
retinas show a dense network of junctions when stained with a junctional marker such as 
Claudin 5 suggesting multicellular tubes (Phng et al., 2009). However, seamless tubes have 
been found in a number of tissues and are known to exist since 1964 (Bar et al., 1984; Wolff, 
1964). The architecture of zebrafish ISV has been described as a linear arrangement of 
single ECs forming seamless tubes (Childs et al., 2002; Kamei et al., 2006). 
 In this study we performed single cell labeling using transgenic lines expressing the photo-
convertible protein Kaede, combined with stainings of junctions to quantify the distribution of 
multicellular and seamless tubes in ISVs. We have shown that the ISV stalks are mostly 
multicellular tubes. 88% of the extend of ISV stalks show a multicellular pattern of junctions 
and 75% of ECs pair over their whole extend with one or more cells. In contrast, the DLAV 
shows an almost opposite distribution, with 66% of the cells having at least some stretches of 
seamless tube at 2 dpf (Figure 6.3). Even though Kaede converted cells, which entirely 
surround the lumen, could also be cells with an autocellular junctions, the fact that we only 
very rarely see autocellular stretches in staining makes this possibility unlikely. Possibly, 
unicellular tubes with autocellular junctions are only a transient morphology and are 
subsequently transformed into seamless tubes as seen in Figure 6.16 and 6.17 and the 
corresponding movies. 
 Remarkably, our data correlates nicely with a study from 1984, where several capillary beds 
(mostly rat but also human capillary beds) were analyzed for their content of seamless ECs 
(Bar et al., 1984). This study used silver impregnation of endothelial cell junctions as well as 
electron microscopy to reveal seamless ECs. Depending on the capillary bed they find 30% - 
50% of seamless endothelial cells. These seamless ECs are preferentially found at 
branching point and thus their abundance increases with number of branching point (Bar et 
al., 1984). Indeed also we also find more seamless ECs in the DLAV, which are the only 
branching points of ISV due to guidance cues restricting outgrow to the somite boundary. 
Most likely, branch numbers correlate with fusion points (Fantin et al., 2010) and thus 
seamless ECs correlate with fusion points. This makes sense, since regardless of whether 
the vessel stalk forms using a multicellular budding mechanism or another mechanism, the 
tip/fusion cell will have at least one protrusion of its cell body, which will have to be 
lumenized during anastomosis (see Figure 3A in Blum et al., 2008 and Figure 6.7). And, our 
study shows that one way to generate a lumen in these parts of the cell body of a fusion cell 
is by an invaginating mechanism forming a seamless section in the fusion cell (see Figure 
6.8 and 6.9 and movie 8, 9A and B). It would be interesting to see whether obd mutant 
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embryos, which show a plexus like organization in the trunk due to their inability to restrict 
ISVs to the somite boundaries (Childs et al., 2002; Torres-Vazquez et al., 2004), have a 
higher degree of seamless tubes.  
 Seamless endothelial tubes are not found in all capillary beds (Bar et al., 1984). For instance 
seamless ECs are found in the fenestrated (round transcellular holes found in fenestrated 
and discontinuous (sinusoidal) endothelium with a diameter ranging from 60-170nm) 
capillaries of the renal glomeruli with up to 50% contribution but have not been found in 
sinusoidal vasculature of the liver, spleen or bone marrow (Bar et al., 1984). It is not clear 
whether slight differences in gene expression between these capillary networks account for 
these differences (Lalor et al., 2006; Satchell and Braet, 2009). Alternatively, different 
mechanical properties such as pressure could account for these differences. Seamless tubes 
are also not found in larger capillaries like arterioles and venules (Bar et al., 1984) indicating 
that seamless tubes most likely have a size limit.  
  Taken together, our study reports similar cellular morphologies as found in many 
mammalian, including human, capillary beds, and therefore substantiate the relevance of 
zebrafish ISVs as a model to study formation of capillary beds. 
 
7.2 Cellular mechanisms during sprouting angiogenesis and 
anastomosis 
7.2.1 Some considerations on using fli1:GFF; UAS:EGFP-hZO1 transgenic fish 
 The UAS:EGFP-hZO1 transgenic fish line, in combination with the fli1:GFF transgenic line 
represented an invaluable tool in unraveling the cellular mechanisms during ISV outgrow and 
anastomosis. Nonetheless, working with these transgenic embryos has some drawbacks and 
a few issues have to be considered in order to avoid misinterpretation of data.  
 EGFP-hZO1 expression is highly mosaic, meaning that even though the transgene is 
present (seen by the expression of cmlc2:EGPF, see materials and methods), expression in 
ECs can go from no expression at all to almost even expression throughout the endothelium.  
Mosaics’ can help to make it easier to understand junctional remodeling and prove behavior 
of single cells but can also lead to misinterpretation especially when suggesting intracellular 
lumen formation due to the presence of non-expressing cells in the region analyzed. 
Fortunately, the UAS:RFP transgenic line is expressed throughout the endothelium and 
helps to spot potential non-expressing cells (for EGFP-hZO1).  In addition, only junctions 
formed between two unlabeled cells will remain unlabeled. Figure 7.1 shows such an 
example: there are two EGFP-hZO1 labeled cells, the fusion cell on the dorsal side and a 
stalk cell on the ventral left part of the ISV (see arrows in Figure 7.1). The lumen is open and 
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one could conclude that there is an intracellular lumen between the two labeled cells as there 
are no junctions between the fusion cell and the stalk cell. But the RFP channels reveals the 
presence of two more unlabeled cells in the ISV (arrowhead), which potentially have 
junctions together since they are located in close proximity to each other. Therefore, we 
might oversee some junctions and a clear statement about the tube architecture in this 
region cannot be made.  
 
 
 
 Moreover, levels of expression differ and can change during ongoing time-lapse imaging. 
Especially cells with high expression also show some non-junctionally localized EGFP-hZO1 
in the cytoplasm (not in the nucleus). Due to the thin morphology of ECs, this cytoplasmic 
labeling can look similar to junctions in the region around the nucleus and when the lumen is 
open. All the movies were thoroughly analyzed with regard of these potential artifacts to 
avoid misinterpretations. 
 
7.2.2 Contact formation 
Anastomosis starts with the formation of an initial contact between two tip cells. ISVs form 
these contacts around 30 hpf after they reached the dorsal roof of the neural tube and extend 
Figure 7.1 
 Avoiding misinterpretation: Pictures demonstrate mosaic property of the UAS:EGFP-hZO1 
transgenic line. (A) shows the overlay of (B) (EGFP-hZO1)and (C) (RFP). Two cells express EGFP-
hZO1 (arrows) and two other cells do not express EGFP-hZO1 (arrowheads). The two non 
expressing cells could have contacts together. Thus, we might not see all the relevant junctions in 
this ISV to faithfully interpret vessel architecture and cellular mechanisms. 
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protrusions and filopodia in anterior and posterior direction to find the neighboring ISV (Isogai 
et al. 2003; Figure3 D (Blum et al., 2008) and Figure 6.4). We have shown, using antibody 
stainings with junctional markers and live imaging using EGFP-hZO1, that upon contact, new 
junctions are localized to the contact spot. This spot is then elaborated into a small loop, 
which subsequently increases in size (Figure 3 A,B,C (Blum et al., 2008)  and Figure 6.7). 
Spots and stretches of junctions are seen before contact formation in the tip cell (Figure 2 
(Blum et al., 2008) and 6.5) but observing these spots in live imaging shows that they will not 
necessarily transform into contact spots. Because of the 5 minutes spacing between time 
points we may lack some information, and the relevance of these spots during contact 
formation is not clear. Taken together,  the results propose a model, in which the two tip cells 
contact and then form a de novo apical membrane when extending their contact (see Figure 
3 A’,B’,C’ (Blum et al., 2008)). 
 This contact formation preceding ISV anastomosis appears to be very similar to contact 
formation during tracheal branch fusion in Drosophila melanogaster. Concomitantly with 
branch fusion in the trachea, DE-cadherin is localized to the contact spot and elaborates into 
a ring (Tanaka-Matakatsu et al., 1996). Branch fusion does not occur in the absence of DE-
cadherin (Uemura et al., 1996). Ve-cadherin knockdown experiments in zebrafish show a 
somewhat weaker phenotype; contacts in ISVs are partially formed but may dissociate and 
reform again (Montero-Balaguer et al., 2009). Whether this is an artifact of incomplete 
knockdown or additional or redundant players are involved is unclear. 
 Apical membrane formation is a essential mechanism of cells during tube formation 
mechanism. 3D culture of MDCK (Madin-Darby canine kidney) cells represents an excellent 
model system to investigate molecular pathways during epithelial polarization and lumen 
formation. Individual MDCK cells assemble and form a polarized monolayer of cells with a 
central lumen called cysts (Bryant and Mostov, 2008). Recently, new insight revealed 
molecular mechanisms during early polarization of these cysts. Using different markers of 
apical membrane and of the exocyst complex, Bryant et al. have shown that polarization 
requires two critical steps (Bryant et al., 2010). In an initial step, Podocalyxin is transported in 
vesicles using the exocyst complex to the so-called apical membrane initiation site (AMIS). 
Occuldin, a tight junction protein marking the border between cells of the early cyst is initially 
localized at the AMIS. Localization of Podocalyxin to the AMIS results in the formation of the 
pre-apical patch (PAP). The PAP is apical membrane without a visible lumen in the cyst. 
Later the lumen is filled with the help of ion pumps (Bryant et al., 2010). It will be interesting 
to see whether ECs use a similar mechanism of polarization during anastomosis. 
Presumably, the initial spot of junction can be used as AMIS to drive apical membrane 
formation. New transgenic lines expressing various marker proteins will hopefully shed light 
on polarization mechanisms during anastomosis. 
Discussion   62 
 Macrophages associate with tip cells and potentially play a role in helping tip cells to contact 
other tip cells before anastomosis. Branch points are reduced in mice lacking macrophages. 
Macrophages do associate with tip cells in zebrafish as well but their functional role remains 
obscure (Fantin et al., 2010).  
 
7.2.3 Lumen formation 
Lumen formation in ISV starts at 27-29 hpf from the DA and forms in a stepwise manner 
towards the DLAV (Kamei et al., 2006). One possible reason why the lumen only starts to 
form when ISVs have already reached the dorsal side is that heart contraction starts between 
24 and 26 hpf (Isogai et al., 2001). As ISVs start budding around 22 hpf (Isogai et al., 2003), 
there is potentially no pressure to open up the lumen and make it visible in transgenic lines 
such as flk1:EGFP or fli1:GFF; UAS:RFP.  Also in sih morphant embryos the lumen is to a 
large extent not apparent (Figure 6.12 and movie 12, (Montero-Balaguer et al., 2009). 
Therefore, we have to discriminate between an open inflated lumen (seen as darker areas in 
flk1:EGFP or by filling with QD) and a pre-lumen or collapsed lumen. ECs are polarized cells 
where apical and basal membranes are separated by junctions. Therefore apical membranes 
can be assumed at areas, which are encompassed by junctions. Thus, a pre-lumen can be 
considered as apical membrane of one or more ECs sticking to each other. These pre-lumen 
open up very fast to a lumen (usually from one to the next time point) indicating that pressure 
might be enough to separate the apical membranes in ISVs (seen in several movies, for 
instance movie 8 and 9A). This may also explain the stepwise opening of the lumen in ISVs 
described by Kamei et al., 2006. Interestingly a recent study suggests a mechanism using 
repulsive electrostatic forces to open a pre-lumen. Negatively charged proteins on the apical 
membrane, such as Podocalyxin, are essential to separate the apical membranes from each 
other in the mouse DA and in cell culture assays (Strilic et al., 2010). It is not clear how 
relevant such a mechanism is in ISV lumen formation as sih morphants show very limited 
lumen (Figure 6.12 and movie 12). Possibly the apical membrane is not mature enough and 
such a mechanism would occur later. 
 
7.2.3.1 Intracelullar lumen formation 
Using the fli1:GFF and the UAS:EGFP-hZO1 transgenic line, we have shown that ECs can 
use different mechanisms to form a patent lumen in the DLAV.  
 We see the lumen invaginating into the fusion cell towards one (possibly also both) of the 
fusion points. Upon reaching the fusion point, the lumen breaks through and continues its 
way in adjacent cells (Figure 6.8 and 6.9). The invagination of the lumen suggests 
invagination of apical membrane into the fusion cell. This apical membrane grows until it 
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reaches the apical membrane of the pre-lumen at the fusion point. Here the two apical 
membranes of the fusion cell will have to fuse and form a continuous apical membrane. This 
continuous apical membrane will engulf the newly formed intracellular lumen of the fusion 
cell (see Figure 6.8, 6.9 and Figure 7.2 for a representative model).  
 
 
 Fusion cells of the Drosophila melanogaster tracheal system invaginate their apical 
membrane along F-actin tracks to eventually fuse and establish an intracellular lumen in the 
fusion cell. In contrast to the vascular system, fusion cells in the tracheal system are thin and 
donut-shaped. The extent of apical membrane invagination is short (Kakihara et al., 2008; 
Lee and Kolodziej, 2002).  In Drosophila, this process is genetically controlled and a number 
of genes are specifically expressed in fusion cells (Kakihara et al., 2008; Tanaka-Matakatsu 
et al., 1996). DE-cadherin recruits the plakin Short stop, which will allow the formation of F-
actin tracks connecting the two apical membranes (Lee and Kolodziej, 2002). These tracks 
are supposed to facilitate vesicle fusion with the apical membrane and thus drive membrane 
invagination. Membrane fusion is thought to require the small GTPase Arf-like 3 to correctly 
localize exocyst complex and vesicle to the apical membrane (Kakihara et al., 2008).  
Figure 7.2 
 Schematic representation of intracellular lumen formation: (A and B) A fusion cell (blue) has 
made contact adjacent fusion cells (white) and formed junctional loops and apical membrane 
with a pre-lumen(red)(in B). (B) The lumen (red) is invaginating from the stalk into the fusion cell. 
(C) The lumen eventually reaches the pre-lumen. This means that two separate apical membranes 
of the fusion cell meet and eventually fuse to open the pre-lumen to a lumen which then 
continues to form in the DLAV (D) (see Figure 6.8 and 6.9 and movie 8 and 9A). 
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 In a previous study, large vacuoles have been associated with intracellular lumen formation 
in zebrafish ISVs (Kamei et al., 2006). However, we did not observe such extensive vacuoles 
during the process of apical membrane invagination. But, it is clear that new apical 
membrane has to be generated at the site of invagination. Whether vesicles or smaller 
vacuoles (as suggested by the work of Wang et al. in 2010) are involved will need to be 
investigated with additional transgenic lines specifically marking such compartments. Such 
markers could be components of the exocyst pathway as well as apical membrane marker 
such as Podocalyxin. Generating such transgenic lines is part of ongoing work in the lab.  
 We suggest that luminal pressure plays a role in lumen formation and apical membrane 
invagination. Our results show that the lumen can open in one ISV, making its way through 
the DLAV, and then from the DLAV, invaginate into a stalk cell in the adjacent ISV (Figure 
6.11 and movie 11). Further, invagination of the lumen always progresses up to the loop at 
the contact point in Figure 6.8 and 6.9 before an apparent breakthrough occurs. Invagination 
of apical membrane without luminal pressure would suggest the formation of a not visible 
pre-lumen from invagination of apical membrane from contact points (for instance from the 
contact points in Figure 6.8 and 6.9). As soon as the lumen (visible) invaginating from the 
stalk into the fusion cell would reach this pre-lumen, we would expect a sudden inflation of 
the pre-lumen before the lumen reaches the loop at the contact point. We have not observed 
such situations but cannot excluded them as our ability to obtain quantitative data is limited 
for the moment (due to the mosaics’ of UAS:EGFP-hZO1 line). However, our results so far 
propose that apical membrane invagination can only occur where pressure is applied on the 
membrane. To unambiguously prove this point, we will have to show that apical membrane 
does not invaginate into fusion cells in sih morphant embryos. The lack of an apical marker 
makes this analysis impossible to date as sih morphant do not show a lumen and a possible 
pre-lumen is not visible in the RFP channel.  
 
7.2.3.2 Extracellular lumen formation 
 We have also uncovered a different mechanism involved in lumen formation during DLAV 
anastomosis (Figure 6.10 and movie 10). The model in Figure 7.3 highlights the different 
steps during this mechanism. A fusion cell (blue) contacts a stalk cell (purple) and an 
adjacent fusion cell (yellow). The contribution of junctions of each cells are marked as blue, 
red and yellow lines. For instance, junctions between the purple and the blue cell are marked 
as a loop of blue and red. In addition, longitudinal sections along the black line are shown in 
A’ to D’ where orange lines mark apical membranes. The yellow and the purple cells slide 
over the blue cell, thereby increasing their contact with the blue cell resulting in larger loops 
(Figure 7.3 A-B). Concomitantly, the apical membranes of the blue cell are extended (Figure 
7.3 A’-B’). Once the yellow and the purple cell meet, the two apical membranes of the blue 
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cell will meet and connect (Figure 7.3 C and C’). There might be a moment when the blue 
cell makes contact with the yellow and the purple cell, and in addition, the purple cell makes 
contact with the yellow cell (Figure 7.3 C’). This might explain the short increase in EGFP-
hZO1 fluorescence when the two loops contact (Figure 6.10C). From there on, presumably, 
the junctions of the blue cell with the yellow and the purple cell at the new contact point 
between the yellow and purple cell retract and possibly dissolve, which merges the two 
apical membranes of the blue cell (Figure 7.3 D’) . The contact between the yellow and the 
green cell is increased seen as the yellow and purple line (Figure 7.3 D).  
 
 
Figure 7.3: 
Schematic representation of extracellular lumen formation: A’-D’ shows longitudinal sections following 
the black line in (A). Junctions between cells are marked as double lines with the colors of the 
appropriate cells and as spots in the longitudinal sections. Apical membrane is marked as orange line in 
longitudinal sections. A fusion cell (blue) has formed a pre-lumen with a stalk cell (purple) and an 
adjacent fusion cell (yellow) (see also Figure 6.10 and movie 10) (A and A’). The stalk cell and the 
adjacent fusion cell extend their contacts with the fusion cell. The pre-lumens are increased and the two 
apical membranes of the fusion cell are brought closer together (B and B’). Eventually the stalk cell and 
the adjacent fusion cell meet. At this point the fusion cell might still have junctions with its two partner 
and in addition the stalk cell and the adjacent fusion cell already have made junctions (see C’). 
Ultimately the fusion cell will retract its junctions at this point joining its two apical membranes to a 
single one. Concomitantly the stalk cell and the adjacent fusion cell elaborate their new junction (D and 
D’) (see Figure 6.10 and movie10). 
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  The notochord of Ciona intestinalis uses a similar mechanism during development to form a 
multi-cellular tube. Notochord cells are initially arranged as non polarized serial row of round 
columnar cells. Cells then polarize forming an extracellular lumen at each cell-cell interface 
resulting in cells having to apical membranes similar to a fusion cell after contact formation. 
Cells then lose their radial symmetry, elongate on one side of the circumference and narrow 
down on the opposite side. Adjacent cells undergo complementary cell shape changes, 
thereby tilting the lumens and bringing the two apical sides of individual cells closer together. 
These cell shape changes are thought to come about by active crawling movements of the 
cells. Then the individual lumens join, resulting in a continuous lumen surrounded by a multi-
cellular tube. This process is characterized by the joining of the two apical membranes of 
cells and new contacts between cells (for detailed information see (Dong et al., 2009). 
Molecules controlling this cellular mechanism remain mostly obscure in notochord 
development of Ciona intestinalis. Actin inhibitor and morpholino knockdown of Ciona ERM, 
an actin modulator, leads to failure of convergence of the lumens suggesting that crawling 
relies on active movements of the cells (Dong et al., 2009; Hotta et al., 2007).  
   
7.2.4 Cell division during vascular development 
We have shown that cells undergo extensive cell divisions during ISV formation (Blum et al., 
2008). We further analyzed the behavior of junctions during cell division and found different 
ways of junction remodeling during and after cell division (Figure 6.13-6.15, movie 13-15).   
 Tip cells migrating towards the dorsal side can divide in such a way that a new junctional 
spot is established between the two emerging daughter cells. This spot is then elaborated  
into a junctional  loop, very similar to what has been observed during contact formation 
between ISVs during DLAV formation (Figure 6.13, movie 13 and Figure 7.4 for a model). 
This is a rather new concept of cell division, but cells in the developing neural tube of the 
zebrafish have been shown to polarize during cell division resulting in mirror-image daughter 
cells with regard to apicobasal polarity (Tawk et al., 2007). Most of the cells executing this 
process during neural tube development will lose contact and will not form junctions with their 
daughter cell but rather move to the opposite side of the circumference of the neural tube 
with regard to their daughter cell (Tawk et al., 2007). In the case of a tip cell in the vascular 
system, the daughter cells have to keep contacts to avoid detaching from each other. 
 Stalks cells, which are part of an ISV organized as a multicellular tube, form a new junction 
between the daughter cells upon division, thus keeping the integrity of the multicellular tube 
(Figure 6.14, movie 14 and see Figure 7.5 for a model). Different studies have shown that 
epithelial cells keep their integrity during cell division. Junctions of a dividing cell are brought 
closer together at the plane of division during cytokinesis and subsequently a new junction is 
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formed between the two daughter cells when cytokinesis is completed (Gibson et al., 2006; 
Kim and Raphael, 2007), see also movie 14A and B and Figure 6.14 C). 
 EGFP-hZO1 appears to delocalize from the junctions to some extend during cell division 
(Figure 6.13B). However, ZO1 has been shown to remain at junctions of epithelial cells 
during cell division (Baker and Garrod, 1993; Kim and Raphael, 2007). Thus, it is not clear 
whether this is a property of ECs or a property of the transgene we use in our studies.    
 
 
Figure 7.4 
Schematic representation of Figure 6.13:  Junctions between cells are marked as double lines 
with appropriate colors. A tip cell (green) has junctions with the stalk, which not defined in terms 
of cellular organization and junctions. The tip cell divides and new junctions are formed between 
the two daughter cells (green and purple) (B and C). These new junctions are then elaborated 
into a loop, which suggests apical membrane and a pre-lumen between the two daughter cells 
(D). The cells subsequently rearrange using the extracellular lumen formation mechanism 
described above in Figure 7.3 (E).  
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Most interestingly, we observed that cell division can occur concomitantly with cell 
rearrangements (see Figure 6.15, movie 15A and B, Figure 7.6 shows a model). This shows 
that ECs have a high degree of plasticity, at least during early steps of vessel formation. 
     
ECs appear to partially retain their shape during cell division. This is seen during cell division 
using the flk1:EGFP-NLS transgenic line. Upon division of a tip cell in an ISV sprout, EGFP-
NLS loses nuclear localization and is seen in the protrusions of the tip cell, demarking the 
elongated shape during cell division. EGFP-NLS localizes back to the nucleus after cell 
Figure 7.5 
Schematic representation of Figure 6.14: Junctions between cells are marked as double lines with 
appropriate colors. A stalk cell (green) has junctions over its whole circumference and is thereby 
forming a multi-cellular tube with other stalk cells (blue, no specification of exact arrangement) (A). 
The stalk cell (green) divides (B). During cytokinesis the junctions are brought together at the plane 
of cell division (C) and new junctions are formed between the two daughter cells (green and purple) 
upon completion of cytokinesis (D). This junction is seen as a “Bridge” of junctions between the 
former junctions of the mother stalk cell (green in A) and the rest of the stalk cell/cells (blue).  
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division (Figure 6 in Blum et al., 2008). In contrast, epithelial cells round up during cell 
division (Gibson et al., 2006).  
 
 
Figure 7.6 
Schematic representation of Figure 6.15: Junctions between cells are marked as double lines with 
appropriate colors. A stalk cell (green) is arranged in a head-to-tail fashion with a fusion cell (orange) 
and the stalk (blue, no specification of exact arrangement) (A). The stalk cell divides (B) and during 
cytokinesis a new junction forms between the two daughter cells. Concomitantly the fusion cell and 
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7.2.5 Intercalation and cell self fusion 
We only found very few auto-cellular junctions in Ab stainings. Thus, we didn’t really expect 
to see intercalation events during ISV development. Live-imaging revealed that intercalation 
does occur during ISV formation. Cells do reach around the lumen and make auto-cellular 
junctions. These auto-cellular junctions then extend using a similar zipping mechanism as 
shown in the Drosophila tracheal system (Figure 6.16, 6.17 and movie 16A, B and 17, 
Ribeiro et al., 2004). In the tracheal system apically secreted zona pellucida proteins such as 
Dumpy and Piopio are required to avoid the complete intercalation of tracheal cells. In 
mutants for these genes, cells fail to stop intercalation and separate from the epithelium 
(Jazwinska et al., 2003). One could have thought that luminal pressure would play a similar 
role in the vascular system, but as the lumen collapses in one case (Figure 6.16D and E), 
this seems not to be the case. In the tracheal system, intercalation is driven by forces and 
tension, which are generated by the tip cell migration during branch outgrowth (Caussinus et 
al., 2008). However, all intercalations we observe in ISVs occur after anastomosis and thus a 
major pulling force from the tip/fusion cell is unlikely. Rather, local changes of tension in 
cells, which potentially lead to retraction of cell extensions, might be the driving force of 
intercalation in the vascular system. 
 A reason why we do not see a lot of autocellular junctions in ISVs might be our observation 
that cells, which have intercalated undergo a cell self fusion process thereby eliminating their 
autocellular junctions; this ultimately results in seamless tubes with an intracellular lumen 
(Figure 6.16E, F, E’, F’, 6.17E, F and movie 16A, B and 17). Two adjacent cells in the C. 
elegans digestive tract have been shown to undergo cell self fusion to form seamless tubes 
(Rasmussen et al., 2008). These cells express so-called fusogenes such as eff-1 and aff-1, 
which are essential for cell-cell or cell self fusion. Interestingly, because these two cells are 
adjacent to each other, they express different versions of fusogenes to avoid fusion between 
the two cells (Rasmussen et al., 2008). It will be interesting to find out whether ECs express 
similar proteins and especially how they are regulated. As all ECs appear to have a similar 
potential to undergo intercalation and cell self fusion, it is unlikely that all ECs express 
the stalk (blue) have extended their contact with the dividing cell thereby coming closer to each 
other (C). The exact mechanism during the next steps remains obscure in Figure 6.15 and movie 15. 
It is not clear whether the fusion cell and the stalk first make new contact or whether the two 
daughter cells first form loop as in Figure 6.10 and 7.3 and the cell rearrange afterwards. However, 
the end result are parallel lines of junctions going from dorsal to ventral and loop of junctions at the 
plane of cell division, which is connected with the parallel lines (D). The parallel lines are formed 
from the contact of the fusion cell (orange) and the purple daughter cell, and from the stalk (blue) 
and the green daughter cell. The loop is formed from contacts of the two daughter cells (green and 
purple) and from contacts of the fusion cell (orange) and the stalk (blue)(seen as blow up in D). 
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fusogenic proteins as this would result in cross fusion of all ECs. It is reasonable to propose 
that autocellular junctions potentially trigger activation of fusogenic proteins. Obviously 
fusogenic proteins first have to be identified and potentially ECs might use a different 
mechanism, not involving fusogenic proteins for cell self fusion.  
 
7.3 Conlusions  
 This study shows that ECs have a high degree of plasticity and can use a whole set of 
different cellular mechanism to form a lumenized functional vascular system. Cells can 
divide, rearrange or form an intracellular lumen. Molecular mechanisms driving these cellular 
mechanisms remain largely unknown. The high variance and unpredictability of behavior of 
ECs indicates that at least for a given vascular bed, no genetically unique ECs exist; this 
might be in sharp contrast to the tracheal system, in which specialized fusion cells exist. The 
only specialized cells, the tip cells, lose their identity upon contact formation (Leslie et al., 
2007). Therefore ECs most likely use general molecular pathway to drive these cellular 
processes. This will make it difficult to sort out important components for a given mechanism 
as inactivating these components might disrupt general EC functions. Thus, advanced 
genetic techniques will be required to manipulate gene function in time and space such as 
the inducible CreERT-Lox system in combination with dominant negative factors. In addition 
new transgenic lines expressing different sets of fluorescently tagged markers such as apical 
markers will be required to unambiguously prove some of the concepts proposed in this 
study.  
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9 Appendix 
9.1 Kleaveland et al., 2009 
Regulation of cardiovascular development and integrity by the heart of glass-cerebral 
cavernous malformation protein pathway. 
 
Contribution: I injected heg1 and ccm2 morpholinos and did Ab stainings of CDH5 on 2d wt 
and morphant embryos (see supplementary Figure 9A). I also did movies of QD injected wt 
and morphant fli1:cdc42GFP embryos (supplementary Figure 7E). 
 
 
9.2 Li et al., 2010  
A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. 
 
Contribution: I injected tie1 and tie1AS-lncRNA and did Ab stainings on 24 hpf wt and 
morphant embryos, thereby quantifying disintegrated junctions (see Figure 3B and C). 
 
 
9.3 Review: Ellertsdottir et al., 2010 
Vascular morphogenesis in the zebrafish embryo 
 
Contribution: I wrote an initial draft on angiogenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regulation of cardiovascular development and integrity
by the heart of glass–cerebral cavernous malformation
protein pathway
Benjamin Kleaveland1, Xiangjian Zheng1, Jian J Liu2, Yannick Blum3, Jennifer J Tung4, Zhiying Zou1,
Shawn M Sweeney1, Mei Chen1, Lili Guo1, Min-min Lu1, Diane Zhou1, Jan Kitajewski4, Markus Affolter3,
Mark H Ginsberg2 & Mark L Kahn1
Cerebral cavernous malformations (CCMs) are human vascular malformations caused by mutations in three genes of unknown
function: KRIT1, CCM2 and PDCD10. Here we show that the heart of glass (HEG1) receptor, which in zebrafish has been linked
to ccm gene function, is selectively expressed in endothelial cells. Heg1–/– mice showed defective integrity of the heart, blood
vessels and lymphatic vessels. Heg1–/–; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mice had more severe cardiovascular defects and died early
in development owing to a failure of nascent endothelial cells to associate into patent vessels. This endothelial cell phenotype was
shared by zebrafish embryos deficient in heg, krit1 or ccm2 and reproduced in CCM2-deficient human endothelial cells in vitro.
Defects in the hearts of zebrafish lacking heg or ccm2, in the aortas of early mouse embryos lacking CCM2 and in the lymphatic
vessels of neonatal mice lacking HEG1 were associated with abnormal endothelial cell junctions like those observed in human
CCMs. Biochemical and cellular imaging analyses identified a cell-autonomous pathway in which the HEG1 receptor couples to
KRIT1 at these cell junctions. This study identifies HEG1-CCM protein signaling as a crucial regulator of heart and vessel
formation and integrity.
CCMs are a common vascular malformation, with a prevalence of
0.1%–0.5% in the human population1. CCMs arise primarily in the
brain as thin-walled, dilated blood vessels that cause seizures, head-
aches and stroke in midlife, often in association with focal hemor-
rhage1,2. Familial CCM shows an autosomal dominant pattern of
inheritance and is caused by loss-of-function mutations in three genes:
KRIT1 (also known as CCM1)1,3,4, CCM2 (also known as malcalver-
nin and osm)5,6 and PDCD10 (also known as CCM3)7. The
CCM proteins are putative adaptor proteins that interact biochemi-
cally8–10 and participate in a signaling pathway that is not yet
fully characterized. The mechanism by which loss of CCM protein
signaling results in the development of vascular malformations is
not known.
A clue to the role of CCM protein signaling in the cardiovascular
system comes from genetic studies in zebrafish, which reveal that loss
of krit1, ccm2 or heg (encoding the type I transmembrane receptor
heart of glass) results in a dilated heart phenotype early in develop-
ment11,12. This phenotype is characterized by heart failure associated
with enlarged cardiac chambers in which the endocardium is covered
by a thin layer of myocardial cells. Expression of heg, krit1 and
ccm2 mRNA has been detected in the endocardium, but not the
myocardium, of zebrafish embryos11,12, suggesting that these proteins
operate in an endothelial cell–autonomous signaling pathway. An
endothelial role for this pathway is also supported by studies of
KRIT1-deficient mice, which show lethal vascular defects at embry-
onic day 9 (E9); however, these studies did not detect high-level Krit1
or Ccm2 gene expression in the mouse cardiovascular system, leading
to the proposal of cell-nonautonomous mechanisms of CCM patho-
genesis such as a requirement for CCM protein signaling in adjacent
neuronal cells13,14.
Here we used mice and zebrafish lacking the HEG1 receptor and the
CCM2 adaptor to investigate the role of this pathway in the cardio-
vascular system. Our studies support an endothelial cell–autonomous
mechanism in which the HEG1 receptor couples to CCM proteins to
regulate endothelial cell-cell junctions required for the formation and
maintenance of the heart and vessels. Complete loss of function in this
pathway resulted in an inability of emerging endothelial cells to
associate into a functional cardiovascular system in mouse and
zebrafish embryos. Less-complete loss of function permitted heart
and vessel development but resulted in integrity defects manifested by
cardiac rupture, vascular hemorrhage and lymphatic leakage. These
cardiovascular defects arose in conjunction with abnormal endothelial
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junctions similar to those observed in human CCMs15–17 and asso-
ciated with KRIT1 depletion in human endothelial cells in vitro18,
suggesting a common mechanism by which loss of this signaling
pathway confers a spectrum of vertebrate cardiovascular defects in
developing and mature animals. Our studies indicate that the signaling
pathway implicated in human CCM regulates endothelial cell-cell
association and suggest that agents designed to promote endothelial
cell association may be effective treatments for CCM.
RESULTS
Heg1 is expressed in the developing cardiovascular system
It has been unclear how CCM proteins function in cardiovascular cell
types and whether it is loss of CCM protein function in cardio-
vascular or other cell types that causes human vascular disease. To
determine whether HEG1 receptors have a direct role in regulating
CCM protein signaling, we cloned the mouse Heg1 gene (Supple-
mentary Fig. 1 online) and characterized Heg1 mRNA expression in
mice. Using in situ hybridization, we detected Heg1 expression in the
endothelium of the developing heart and aorta and in the neural tube
at E10.5 (Fig. 1a), and in the arterial endothelium, smooth muscle,
endocardium of the heart and brain vasculature at E14.5 (Fig. 1b and
Supplementary Fig. 2 online). In contrast to Heg1, Ccm2 expression
was low and detected primarily in the developing neural tube at E10.5
(Supplementary Fig. 3 online).
HEG1 deficiency results in lethal hemorrhage in mice
To address the role of the HEG1 receptor in mammals, we generated
HEG1-deficient mice by targeting Heg1 exon 1 in embryonic stem
cells (Supplementary Fig. 4 online). In mice with genetic back-
grounds of 50% SV129 and 50% C57Bl/6 or 495% C57Bl/6,
HEG1 deficiency resulted in embryonic and postnatal lethality (Sup-
plementary Table 1 online). Midgestation HEG1-deficient embryos
showed cardiac defects characterized by invagination of the ventricular
cavity into, and often through, the compact layer of ventricular
myocardium (Fig. 1c–f). The septal myocardium was similarly honey-
combed by endothelial-lined extensions from the ventricular cavity
(Fig. 1d), a defect accompanied by the presence of ventricular septal
defects in most late-gestation embryos. TUNEL and Ki67 staining
revealed that HEG1-deficient myocardial defects were not caused by
an increase in myocardial apoptosis or a decrease in myocardial
proliferation (Supplementary Fig. 5 online and data not shown).
Although most HEG1-deficient mice survived to birth, approximately
half died before weaning as a result of pulmonary hemorrhage
(Fig. 1g–i). Neonatal HEG1-deficient mice also showed defective
cardiac integrity manifested by a blood-filled pericardial sac, a
phenotype that arose as a result of rupture of the low-pressure atrial
chamber of the heart (Fig. 1j). Cardiac or pulmonary integrity defects
were observed in 50% of HEG1-deficient mice. These findings indicate
that HEG1 deficiency results in a loss of cardiac and pulmonary
vascular integrity, resulting in lethality.
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d Figure 1 Heart and blood vessel integrity defects in HEG1-deficient
mouse embryos and neonates. (a,b) Heg1 was selectively expressed in the
developing cardiovascular system. Radioactive in situ hybridization revealed
Heg1 expression in the vascular endothelium, cardiac endocardium and
neural tube at E10.5 (a). By E14.5, Heg1 was expressed in both endothelial
and smooth muscle cells in major arteries (b). ao, aorta; h, heart; nt, neural
tube. (c–f) E15 Heg1–/– embryos showed deep invaginations of the
ventricular chamber into the compact zone of the ventricular wall and
into the septum, often associated with the presence of blood between
the epicardial and myocardial cell layers of the heart (arrow in f). e,f show
magnification of boxed regions in c,d. (g–i) Pulmonary hemorrhage in
Heg1–/– neonates (h,i) but not in Heg1+/+ littermates (g) was manifested
by the presence of erythrocytes and fibrin in alveolar air spaces. (j) Cardiac
rupture in P4 Heg1–/– neonate. Hemopericardium (left, middle) associated
with cardiac rupture and formation of a transmural thrombus (right) was
observed in Heg1–/– mice. VSD, ventricular septal defect. Scale bars,
200 mm in a–d and j (middle), 20 mm in e–i and j (right).
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Figure 2 Lymphatic vessel dilatation and leakage in Heg1–/– neonatal mice.
(a,b) HEG1-deficient neonates showed chylous ascites, manifested by the
accumulation of white chyle in the peritoneal space. (c–f) Lymphatic
malformations in Heg1–/– mice. Neonatal mesenteric lymphatic vessels of
Heg1–/– mice were dilated (arrows) and leaked chyle into the intestinal wall
and peritoneum. (g,h) Immunostaining for LYVE1 confirmed the lymphatic
identity of the dilated mesenteric vessels (arrows). SMA, a-smooth muscle
actin. Scale bars, 100 mm.
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HEG1 deficiency causes dilated lymphatic vessel malformations
Neonatal mammals transport absorbed fat through the intestinal and
mesenteric lymphatic vessels in the form of white chyle. A distinct
phenotype observed in approximately 10% of HEG1-deficient neo-
natal mice was the appearance of chylous ascites shortly after their first
feeding (Fig. 2a,b). Chylous ascites was invariably associated with
severely dilated intestinal and mesenteric lymphatic vessels that leaked
chyle into the intestinal wall and peritoneal space (Fig. 2c–f). The
dilated mesenteric lymphatic vessels were lined with endothelial cells
that expressed the lymphatic molecular marker LYVE1 and were
associated with smooth muscle cells typical of collecting lymphatic
vessels (Fig. 2g,h). These findings indicate that loss of HEG1 receptors
is associated with a loss of integrity of lymphatic vessels as well as of
blood vessels and the heart. Because lymphatic vessels are not subject
to the hemodynamic forces generated by the beating heart, these
findings further suggest that loss of integrity arises as an intrinsic
defect in the heart and vessels of HEG1-deficient mice.
Heg1 and Ccm2 interact genetically in mice
Identical big-heart phenotypes arise in zebrafish embryos lacking heg,
krit1 (also known as santa) or ccm2 (also known as valentine), and
gene-knockdown experiments using morpholinos have shown strong
interactions among these genes in zebrafish12. In contrast, human
CCMs have been linked to loss-of-function mutations in KRIT1 and
CCM2, but not HEG1, and HEG1-deficient mice do not experience
the early embryonic lethality reported for KRIT1-deficient mice13. To
determine whether—and to what extent—HEG1 interacts genetically
with CCM genes in mammals, we intercrossed Heg1+/–; Ccm2lacZ/+
mice. The Ccm2lacZ allele is predicted to be a null allele because the
Ccm2lacZmRNA transcript lacks the 3¢ half of the Ccm2mRNA (exons
6–10, Supplementary Fig. 6 online), and Ccm2lacZ/lacZ embryos
experience early embryonic lethality that phenocopies Krit1ÿ/ÿ
embryos (see below and ref. 13). In contrast to Heg1–/–; Ccm2+/+
mice, which showed no abnormalities before midgestation, both
Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ embryos died before E10 (Sup-
plementary Table 2 online). Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ
embryos were indistinguishable from littermates of all other genotypes
until E9, when the mutants showed identical phenotypes of growth
retardation and marked pericardial edema despite the presence of a
visibly normal heartbeat (data not shown). Histologic examination
revealed normal development of the ventricular chamber and bulbus
cordis (future right ventricle) but aberrant formation of a dilated
aortic sac (Fig. 3 and Supplementary Fig. 7 online). Compared to
control embryos, the paired dorsal aortas of E9 Heg1–/–; Ccm2lacZ/+
and Ccm2lacZ/lacZ embryos were small or undetectable and completely
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Caudal Figure 3 Heg1–/–; Ccm2 lacZ/+ mouse embryos do
not establish a patent blood vascular network.
Transverse sections of E9 Heg1+/–; Ccm2 +/+
(control) and two Heg1–/–; Ccm2 lacZ/+ embryos at
three levels are shown. H&E staining revealed the
presence of blood-filled dorsal aortas (DA),
cardinal veins (CV) and branchial arch arteries
(BAA) of normal caliber in the Heg1+/–; Ccm2+/+
control embryo (top) but not in Heg1–/–; Ccm2 lacZ/+
littermates (bottom). Staining for Flk1 in adjacent
sections at the level of the first two branchial
arch arteries is shown. Flk1+ endothelial cells
were present at the dorsal aortas, cardinal veins
and branchial arch arteries (arrows) in Heg1–/–;
Ccm2 lacZ/+ embryos, but these cells did not form
vessels of normal caliber with patent lumens. AO
SAC, aortic sac; SV, sinus venosus. Scale bars,
50 mm.
Control
Control
Wild type
heg MO
ccm2 MO
ccm2 MO
ccm2
mutant
heg MO
a
b
cFigure 4 Endothelial cells of zebrafish lacking heg or ccm2 form vessels
that are normally patterned but not patent. (a) Fli1-GFP–transgenic,
heg- and ccm2-morphant (MO) embryos showed dilated hearts (arrows) and
normal vascular patterning. (b) Angiography revealed a proximal circulatory
block in heg- and ccm2-morphant zebrafish. Fluorescent microspheres were
distributed throughout the vasculature of control, but not heg- or ccm2-
morphant, zebrafish after venous injection. (c) FITC-dextran was distributed
throughout the vasculature in wild-type, but not ccm2-mutant, zebrafish
after venous injection. Scale bars, 250 mm.
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lacked luminal blood cells (Fig. 3 and Supplementary Fig. 7). Analysis
of serial transverse sections revealed that the aortic sac did not connect
to a lumenized first, second or third branchial arch artery in the
mutant embryos, suggesting that blood in the heart did not enter the
dorsal aortas despite the presence of a normal heartbeat (Fig. 3 and
Supplementary Fig. 7). When visible, the cardinal veins of E9Heg1–/–;
Ccm2lacZ/+ and Ccm2lacZ/lacZ embryos were also devoid of blood,
except at the point where they connected to the sinus venosus of
the heart (Fig. 3). In contrast to the lack of blood in the vessels,
extravasated blood cells were frequently present in the dilated peri-
cardial cavity (Fig. 3 and data not shown), a finding that may reflect a
primary defect in the integrity of the heart; alternatively, this finding
may arise from the heart beating against a closed circulatory system
and/or from reduced embryonic viability at this point in development.
To determine whether the lack of blood-filled vessels in E9 Heg1–/–;
Ccm2lacZ/+ and Ccm2lacZ/lacZ embryos is due to a lack of endothelial
cells, we used Flk1 immunostaining to identify endothelial cells. We
found endothelial cells at sites where the branchial arch arteries and
dorsal aortas are normally located, but in all Heg1–/–; Ccm2lacZ/+ and
Ccm2lacZ/lacZ embryos studied these cells were not organized into
lumenized vessels as they were in control embryos (Fig. 3). Thus,
circulation in Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ embryos was
blocked by an inability of mutant endothelial cells to form lumenized
vessels capable of carrying blood. These findings indicate a strong
genetic interaction between HEG1 receptors and the CCM protein
signaling pathway during formation of the primary vasculature
in mammals.
heg and ccm2 are required for vessel patency in zebrafish
In contrast to E9 Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ mouse
embryos, zebrafish embryos lacking heg or ccm2 show primarily
cardiac defects11,12. To determine whether HEG1 and CCM proteins
have differing roles in cardiovascular development in zebrafish and
mice, we examined vascular patterning and function in heg-morphant,
ccm2-morphant and ccm2-mutant zebrafish embryos at 48 hours post
fertilization (h.p.f.). Morpholino knockdown of heg or ccm2 in Fli1-
GFP transgenic fish (which have GFP-labeled endothelium) resulted in
dilated heart chambers but no abnormalities in vessel patterning
(Fig. 4a). However, we noted visually that blood cells in the hearts
of heg- and ccm2-morphant zebrafish did not circulate despite
detectable contraction of the dilated heart, a finding similar to the
circulatory block we observed in E9 Heg1–/–; Ccm2lacZ/+ and
Ccm2lacZ/lacZ mouse embryos.
We used angiography to functionally test the patency of the
vasculature of heg- and ccm2-morphant zebrafish. Fluorescent beads
injected into the sinus venosus of zebrafish embryos treated with
control morpholinos circulated throughout the body and outlined the
developing vasculature of the head and tail (Fig. 4b). In contrast,
injection of heg- or ccm2-morphant zebrafish revealed a complete or
near-complete circulatory block immediately distal to the heart
(Fig. 4b), the same point at which circulation was blocked in E9
Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ mouse embryos. We also
observed a complete circulatory block in all ccm2-mutant zebrafish
embryos injected with FITC-dextran (Fig. 4c). These findings indicate
a conserved role for HEG1 and CCM2 in the formation of a patent
vertebrate circulatory system.
HEG1-CCM signaling regulates endothelial tube formation
The inability of nascent endothelial cells to form patent branchial arch
vessels in Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ mouse embryos and
heg- or ccm2-morphant zebrafish embryos suggested that HEG1-CCM
protein signaling is required for endothelial cells to form lumenized
tubes during early vascular development. To assess the role of CCM2
in endothelial tube formation, we used a fibrin bead assay to
examine the ability of human umbilical vein endothelial cells
(HUVECs) expressing CCM2-specific or scrambled control small
hairpin RNAs to form tubes19. CCM2-specific small hairpin RNA
resulted in an 85%–90% reduction in CCM2 mRNA expression and
had no effect on endothelial cell size, proliferation or migration
(Supplementary Fig. 7 and data not shown). Although control
HUVECs generated multicellular structures with clearly visible mature
lumens at 10 d, CCM2-deficient HUVECs formed branched cords
similar to those of control cells in length but were frequently unable to
form visible lumens (Supplementary Fig. 7).
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b Figure 5 HEG1 is required to form normal
endothelial junctions in vivo. Dilated mesenteric
lymphatic vessels in Heg1–/– mice had severely
shortened endothelial junctions and gaps between
endothelial cells. (a) Endothelial cell junctions
were measured as the length of two overlapping
cell membranes. Junction lengths in Heg1+/+ and
Heg1–/– lymphatic vessels are shown divided into
terciles (1st, shortest third of junctions in each
group; 2nd, middle third of junctions in each
group; 3rd, longest third of junctions in each
group; mean ± s.d. for each tercile). n ¼ 66
Heg1+/+ junctions and 123 Heg1–/– junctions.
The data shown are from analysis of 6 vessel
cross-sections from one animal of each genotype.
(b) Percentage of endothelial junctions
o1,000 nm, 1,000–2,500 nm and 42,500 nm.
The same junctions were analyzed in panels a
and b. (c) Representative low-magnification (far
left) and high-magnification images of endothelial
cells. Asterisks indicate sites of endothelial gaps,
normally not present in collecting mesenteric
lymphatics; arrowheads indicate endothelial
junction limits. Endothelial gaps were present
in Heg1–/– but not Heg1+/+ vessels.
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Studies of lumen formation by endothelial cells in vitro and in the
intersegmental vessels (ISVs) of the zebrafish embryo in vivo have
shown that endothelial cells can assemble lumenized vessels through
the formation and fusion of intracellular vacuoles20–23. We assessed
the formation of vacuole-like structures in the ISVs of morphant
and control zebrafish embryos using transgenic zebrafish expressing
GFP-Cdc42 fusion proteins that outline the intracellular vacuoles that
form in endothelial cells22. Endothelial vacuole-like structures formed
normally in the ISVs of zebrafish embryos lacking heg or ccm2
(Supplementary Fig. 7 and Supplementary Movies 1–3 online).
Injection of fluorescent quantum dots into the dorsal aorta of
morphant zebrafish to bypass the block at the level of the branchial
arch arteries confirmed that these vessels formed a patent lumen
(Supplementary Fig. 7 and Supplementary Movies 4–6 online).
These findings suggest that defects in endothelial tube formation
observed in deficient endothelial cells do not arise because of loss of
intracellular endothelial vacuole-like structures.
HEG1-CCM signaling regulates endothelial junctions in vivo
An ultrastructural characteristic of human CCMs is the presence of
abnormal endothelial cell-cell junctions and gaps between endothelial
cells15–17, and a recent study showed a role for KRIT1 in the dynamic
regulation of endothelial cell-cell junctions in vitro18. Thus, one
mechanism by which HEG1-CCM protein signaling might regulate
cardiovascular development and integrity is through regulation of
endothelial cell association. To directly assess the role of HEG1 in
regulating endothelial junctions in vivo, we used transmission electron
microscopy to examine cell-cell junctions in the endothelium of
neonatal mouse lymphatic vessels. The dilated mesenteric lymphatic
vessels of Heg1–/– neonatal mice showed markedly shortened endo-
thelial junctions compared to vessels in control littermates (mean
length of junctions, 1,769 ± 506 nm for Heg1–/– versus 3,355 ±
1,009 nm for Heg1+/+; P ¼ 0.01; Fig. 5a,b) and were accompanied
by endothelial gaps not present in control collecting mesenteric
lymphatic vessels (Fig. 5c). Similarly shortened junctions were iden-
tified in the endocardium of ccm2-morphant zebrafish hearts (Sup-
plementary Fig. 8 online). Finally, analysis of the constricted,
bloodless aortas of E9 CCM2-deficient mouse embryos also revealed
shortened endothelial junctions despite the fact that the caliber of
these vessels was markedly reduced (Supplementary Fig. 8). These
findings indicate that defective endothelial junctions characterize both
the dilated and constricted cardiovascular phenotypes of animals
lacking HEG1-CCM protein signaling as well as human CCMs.
Notably, the levels of b-catenin, VE-cadherin and claudin-5, key
components of endothelial junctions, were preserved in the lymphatic
vessels of HEG-1 deficient mice, in the hearts and vessels of zebrafish
embryos lacking heg or ccm2 and in CCM2-deficient HUVECs
(Supplementary Fig. 9 online). These findings suggest that HEG1-
CCM protein signaling may regulate the function of these proteins
rather than their expression.
HEG1 receptors couple to CCM proteins through KRIT1
Our findings suggest that HEG1 receptors interact with CCM proteins
in an endothelial cell–autonomous signaling pathway: HEG1 is
expressed in endothelial cells in zebrafish and mice; Heg1–/–;
Ccm2lacZ/+ and Ccm2lacZ/lacZ mouse embryos and heg- and ccm2-
morphant zebrafish embryos show aberrant vessel formation at an
early developmental time point when vessels are composed exclusively
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Figure 6 HEG1 receptor intracellular tails
associate with CCM2 through KRIT1.
(a,b) Coimmunoprecipitation of mouse HEG1
and mouse CCM2 required the HEG1 receptor
intracellular tail. Hemagglutinin (HA)-tagged
CCM2 or Flag-CCM2 was coexpressed with
Flag-HEG1 or Flag-HEG1DC (a mutant lacking
the terminal 106 amino acids of the HEG1
C-terminal tail) in HEK293T cells. Immuno-
precipitation was done using antibodies to Flag
(a) or CCM2 (b). The results shown are
representative of 43 independent experiments.
(c) The HEG1 intracellular tail interacted with
KRIT1 and CCM2. HA-tagged mouse CCM2 and
Myc-tagged mouse KRIT1 were expressed in
HEK293T cells, and pull-down assays were done
with affinity matrices containing the intracellular
tail of either the human a2b integrin or human
HEG1. The HEG1 tail efficiently pulled down
KRIT1 in the absence of CCM2, but not vice
versa. The results shown are representative of
43 independent experiments. (d) HEG1
interacted with ccm2 through krit1. Flag-tagged
zebrafish krit1, HA-tagged zebrafish ccm2 and
HA-tagged zebrafish ccm2-L197R were
expressed in HEK293T cells, and pull-down
assays were done using human a2b or human HEG1 intracellular tail affinity matrices as in c. ccm2-L197R did not associate with the HEG1 tail (far right
lane). The results shown are representative of 43 independent experiments. (e) The HEG1 tail efficiently bound endogenous KRIT1. Pull-down assays
using a2b or HEG1 tail affinity matrices were done using lysates from CHO cells transfected with Flag-tagged human CCM2. Endogenous KRIT1 was
detected with monoclonal antibody to KRIT1 (top) and heterologous CCM2 with monoclonal antibody to Flag (bottom). The far right lane shows
immunoblotting of cell lysate equivalent to 5% of the input for the pull-down assays. The results shown are representative of 43 independent experiments.
(f) HEG1-CCM protein signaling at endothelial cell junctions. HEG1 receptors couple to KRIT1 and CCM2 through HEG1 tail–KRIT1 and KRIT1-CCM2
interactions, respectively. KRIT1 also interacts with the junctional proteins VE-cadherin and b-catenin (b-cat) and CCM2 also interacts with CCM3.
HEG1-CCM protein signaling is proposed to regulate junction formation and function. ECM, extracellular matrix; NPxY, NPXY amino acid sequences;
PTB, phosphotyrosine binding domain.
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of endothelial cells; and CCM2-knockdown HUVECs show defects in
tube formation. In addition, we detected heterologously expressed
mouse HEG1 at cell junctions in HUVECs (Supplementary Fig. 10
online). To determine whether HEG1 can interact with intracellular
CCM2, we coexpressed Flag-tagged, wild-type mouse HEG1 or mouse
HEG1 lacking most of its intracellular tail (HEG1DC) with hemag-
glutinin-tagged mouse CCM2 in HEK293T cells and conducted
coimmunoprecipitation experiments with antibodies to Flag and
CCM2. CCM2 coimmunoprecipitated with full-length HEG1 using
antibodies to Flag (to pull down HEG1) or CCM2 (Fig. 6a,b). In
contrast, although HEG1DC was expressed at the cell surface at levels
similar to those of full-length HEG1 (Supplementary Fig. 11 online),
CCM2 did not coprecipitate with HEG1DC (Fig. 6a,b).
To further define how the HEG1 intracellular tail associates with
CCM proteins, we used affinity matrices containing the intracellular
tail of human HEG1 or of human a2b integrin to pull down
hemagglutinin-tagged mouse CCM2 and Myc-tagged mouse KRIT1
heterologously expressed in HEK293T cells. The intracellular tail of
HEG1, but not that of a2b integrin, efficiently pulled down KRIT1 and
both KRIT1 and CCM2 when they were coexpressed (Fig. 6c). How-
ever, only small amounts of CCM2 were pulled down when it was
expressed alone (Fig. 6c), indicating that KRIT1 markedly facilitates
CCM2 interaction with the HEG1 intracellular tail.
To further assess the mechanism of CCM2 association with HEG1,
we compared the ability of human HEG1 to interact with zebrafish
krit1 coexpressed with wild-type zebrafish ccm2 or with ccm2-L197R,
a ccm2 protein with an amino acid substitution in the phospho-
tyrosine binding domain that blocks its binding to krit1 (ref. 8); the
corresponding mutant allele of CCM2 has been identified as a cause of
human CCM6. Expression of wild-type ccm2 efficiently rescued the
big-heart phenotype of ccm2-deficient zebrafish embryos, but expres-
sion of ccm2-L197R did not (Supplementary Fig. 12 online), indicat-
ing that this amino acid substitution leads to a loss of ccm2 function
in zebrafish and humans. As observed with the mouse proteins, the
HEG1 receptor tail efficiently pulled down both krit1 and wild-type
ccm2 when they were coexpressed in HEK293T cells, but only krit1
was efficiently pulled down when ccm2-L197R was coexpressed
(Fig. 6d). Finally, HEG1 receptor tails also efficiently pulled down
endogenous KRIT1 in CHO cells, despite the fact that the levels of
endogenous KRIT1 were so low that they could not be detected in 5%
of the input cell lysate by immunoblotting with the same antibody
(Fig. 6e). These findings support a model in which HEG1 receptors
couple to CCM proteins primarily through interaction with KRIT1 at
endothelial cell-cell junctions (Fig. 6f).
DISCUSSION
Human genetic studies have revealed that CCM is caused by haplo-
insufficiency of KRIT1, CCM2 or PDCD10, and genetic studies in
mice and zebrafish have implicated these proteins in cardiovascular
development. How the loss of this signaling pathway leads to these
diverse cardiovascular defects has not been clear. Our studies of the
expression and function of HEG1 and CCM2 support a mecha-
nism in which HEG1 receptor signaling through CCM proteins is
required to regulate endothelial cell-cell association during formation
of the cardiovascular system and for its integrity thereafter. We
identified endothelial junction defects identical to those in human
CCMs in the dilated hearts and vessels of zebrafish and mice deficient
in HEG1 or CCM2, suggesting that CCM proteins regulate vertebrate
cardiovascular development through control of endothelial cell
association and that defects in this regulation leads to human
CCM pathogenesis.
Several lines of evidence suggest that the vascular defects observed
in zebrafish, mice and humans lacking HEG1 and CCM proteins
reflect the loss of an endothelial cell signaling pathway. Although
Ccm2 gene expression was relatively low and not vascular specific,
Heg1 expression was detected specifically in vascular tissues and was
restricted to endothelial cells at the stages at which deficient mouse
and zebrafish embryos first develop cardiovascular defects. The
vascular defects observed in E9 Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ
mouse embryos and 48-h.p.f. morphant zebrafish embryos lacking
Heg or Ccm2 arose before the appearance of other vascular cell types,
such as pericytes or smooth muscle cells, in which HEG1 might
indirectly regulate endothelial cell function. Consistent with these
observations, mosaic analysis in zebrafish embryos has suggested that
krit1 functions cell autonomously during cardiovascular develop-
ment24. Finally, CCM2-knockdown endothelial cells were defective
in the formation of lumenized tubes, and biochemical studies showed
that HEG1 receptors coupled to CCM proteins such as CCM2
primarily through the KRIT1 protein. These findings strongly support
a conserved cell-autonomous mechanism in which HEG1 receptors
signal through CCM proteins to regulate endothelial cells during the
formation and function of the heart and vessels.
Common ultrastructural defects in endothelial junctions suggest
that the nonpatent branchial arch arteries that appear early in the
development of mouse and zebrafish embryos lacking HEG1-CCM
protein signaling, the diverse cardiovascular integrity defects in older
HEG1-deficient mice, and the vascular defects in human CCMs can all
be explained by varying degrees of loss of endothelial cell-cell
association. In our studies, the most severe cardiovascular defects
were observed in 48-h.p.f. morphant zebrafish embryos and E9
Heg1–/–; Ccm2lacZ/+ and Ccm2lacZ/lacZ mouse embryos. In these ani-
mals, the differentiation and proliferation of early endothelial cells and
their migration to sites of vessel formation (vessel patterning) were
undisturbed (consistent with our observation that CCM2 deficient
HUVECs migrated normally in vitro), but endothelial cell assembly
into a lumenized, patent circulatory system was blocked. Recent
studies in zebrafish suggest that patent vessels arise either through
the coalescence of vacuoles in single endothelial cells22 (that is, a
mechanism within endothelial cells) or through the circumferential
arrangement of endothelial cells that are connected by cell-cell junc-
tions21,23 (a mechanism between endothelial cells). Our finding that
endothelial cell vacuolization and lumenization were preserved in the
ISVs of zebrafish embryos lacking the HEG1-CCM protein pathway is
most consistent with a defect in endothelial cell-cell association.
The defects observed in the integrity of the heart, blood vessels and
lymphatic vessels of HEG1-deficient mice also support the idea that
impaired endothelial cell-cell association results from loss of HEG1-
CCM protein signaling. The dilated, leaky lymphatic vessels of HEG1-
deficient mice recapitulated many of the key structural and functional
defects observed in human CCMs and heg-deficient zebrafish hearts,
including shortened endothelial cell junctions, abnormal coverage of
endothelial cells by adjacent cell types such as pericytes or cardio-
myocytes, and vessel leakage and rupture. In addition, we observed
dilated lymphatic vessels in Heg1+/–; Ccm2lacZ/+ mice but not in
Heg1+/– or Ccm2lacZ/+ mice (data not shown), a result consistent
with a genetic link between HEG1 and CCM2 in the formation of
CCM-like dilated vessels and in early vessel formation in embryos.
Finally, KRIT1 was recently found to localize at and functionally
regulate endothelial cell junctions18, and we found that heterologously
expressed HEG1 receptors similarly colocalized with b-catenin at
endothelial junctions. Thus, a unifying mechanism to explain
these diverse vascular phenotypes is one in which HEG1 signaling
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through CCM proteins is required for endothelial cells to associate
with each other to create and maintain the vertebrate cardio-
vascular system.
A final question with important therapeutic implications is whether
and how these studies advance our understanding of human CCM
pathogenesis. Although molecular and genetic pathways are frequently
postulated to link embryonic cardiovascular development and adult
cardiovascular disease states, such links are often tenuous. It is there-
fore noteworthy that our studies of HEG1-CCM signaling in develop-
ing mice and zebrafish support conservation of the role of this
pathway in both development and disease. Our findings suggest that
the primary role of HEG1-CCM signaling is to control the association
of endothelial cells to create and maintain cardiovascular structures.
Thus, CCMs are predicted to be a disease of defective endothelial
association, and agents that positively regulate endothelial junction
formation might provide a means of stabilizing human CCMs or
preventing their de novo formation. Alternatively, activation of HEG1-
CCM signaling might provide a means of treating vascular diseases
characterized by vascular leakage or defective vessel integrity, such as
sepsis. Studies to define better the components and in vivo role of this
signaling pathway may therefore identify new strategies for treating
inherited and acquired vascular diseases.
METHODS
Mice. We generated SV/129 embryonic stem cells heterozygous for the Heg1
allele by deleting exon 1 using recombineering-based gene-targeting techniques,
and we microinjected the stem cells into C57Bl/6 blastocysts. We intercrossed
F1-generation Heg1
+/– mice (50% 129, 50% C57Bl/6) and conducted pheno-
typic analysis on Heg1–/– and wild-type littermates. We generated Heg1+/–mice
on a 495% C57Bl/6 background by backcrossing for 5 generations. We
generated Ccm2lacZ/+ mice from 129P2 embryonic stem cells in which an
IRES-bGeo cassette had been inserted into Ccm2 exon 6 using a retroviral gene
trap (Bay Genomics clone RRG051; ref. 14). We obtained Tg(Tek-cre)12Flv and
Gt(ROSA)26Sor transgenic mice from Jackson Research Laboratories. Unless
otherwise specified, we maintained all mice on a mixed genetic background.
The University of Pennsylvania Institutional Animal Care and Use Committee
approved all animal protocols. Genotyping primer sequences are available in
Supplementary Methods online.
In situ hybridization and immunostaining. Primer sequences used to generate
Heg1 and Ccm2 in situ probes are available in Supplementary Methods. We
carried out radioactive in situ hybridization, immunostaining and TUNEL
staining on paraformaldehyde-fixed, paraffin-embedded sections. Detailed
protocols are available at http://www.med.upenn.edu/mcrc/histology_core/.
We used the following antibodies for immunostaining of tissue sections: rabbit
monoclonal antibody to Ki67 (1:250; Vector Laboratories), mouse monoclonal
antibody to a-smooth muscle actin (1:100; 1A4, Sigma), rabbit polyclonal
antibody to LYVE1 (1:2,000; ref. 25), mouse monoclonal antibody to b-catenin
(1:100; BD Transduction), rat monoclonal antibody to Flk1 (1:50; Phar-
Mingen) and rabbit polyclonal antibody to claudin-5 (1:50; Zymed).
Zebrafish studies. We maintained and bred Tuebingen long-fin wild-type
zebrafish and Tg(fli1a:EGFP)y1 (ref. 26), Tg(kdr:EGFP) (ref. 27),
Tg(fli1a:EGFP-cdc42)y48 (ref. 22) and ccm2hi296aTg (ref. 28) mutant zebrafish.
We injected antisense morpholino oligonucleotides (Gene Tools) that interfere
with the splicing of ccm2 and heg11,12 into the yolks of one-cell-stage embryos at
a dose of 5 ng. To rescue the big-heart phenotype caused by the ccm2
morpholino, we first injected the one-cell-stage embryos with 5 ng of the
ccm2morpholino and then injected half of those embryos with 100 pg of cRNA
encoding ccm2 or ccm2-L197R. We carried out microangiography of zebrafish
embryos as described29. We injected red fluorescent (580 and 605 nm) 0.02-mm
carboxylate-modified FluoSphere beads (Invitrogen) or 10 mg ml–1 70-kDa
FITC-dextran (Sigma) into the sinus venosus of 48-h.p.f. zebrafish embryos.
We mounted the embryos laterally in 2% methylcellulose and acquired images
using an Olympus MVX10 microscope.
Immunoprecipitation and immunoblotting. We subcloned full-length mouse
HEG1 without endogenous signal peptide (amino acids 38–1,313) and
C-terminally truncated HEG1 (amino acids 38–1,207) into pcDNA3.1 with
a human interleukin-1 signal peptide, an N-terminal Flag epitope and a C-
terminal v5 epitope (see Supplementary Fig. 1b). We cloned His6-recombinant
human HEG1 intracellular tail containing an in vivo biotinylation peptide tag at
the N terminus into pET15b as previously described for integrin intracellular-tail
model proteins30. We expressed and purified tail proteins from Escherichia coli31.
For coimmunoprecipitation studies, we transfected plasmids driving expres-
sion of Flag-tagged full-length and truncated mouse HEG1 and hemagglutinin-
tagged mouse CCM2 into HEK293T cells. After 48 h, we incubated the cells for
10 min in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 25 mM EDTA, 1%
NP-40, 0.5% sodium deoxycholate, PhosStop (Roche) and complete protease
inhibitor (Roche), pH 8) drawn through a 25-gauge needle and cleared by
centrifugation. We conducted Flag immunoprecipitation with 2 mg ml–1 anti-
body to Flag (M2, Sigma) and CCM2 immunoprecipitation with polyclonal
antibody to CCM2 (2055, see Supplemental Methods) for 42 h and then
incubated with protein G–agarose (Invitrogen) for 1 h. We detected proteins
using the following antibodies: mouse monoclonal antibody to Flag (1:500; M2,
Sigma), mouse monoclonal antibody to hemagglutinin (1:2,000; Abcam) and
horseradish peroxidase–conjugated goat antibody to mouse IgG (1:5,000;
Jackson ImmunoResearch).
For affinity matrix pull-down assays, we transfected HEK293T and CHO
cells with plasmids driving expression of Myc-tagged mouse KRIT1, hemag-
glutinin-tagged mouse CCM2, Flag-tagged zebrafish krit1, hemagglutinin-
tagged zebrafish ccm2, hemagglutinin-tagged zebrafish ccm2-L197R and
Flag-tagged mouse CCM2. We incubated the cells for 10 min in lysis buffer
(25 mM HEPES (pH 7.4), 100 mM NaCl, 0.5% NP-40 and complete protease
inhibitor (Roche)). After clarification, we incubated 350 mg of lysate with
10 mg of immobilized human HEG1 tail overnight. We detected proteins using
the following antibodies: mouse monoclonal antibody to Flag (1:2,000; M2,
Sigma), mouse monoclonal antibody to Myc (1:2,000; Abcam), mouse mono-
clonal antibody to hemagglutinin (1:2,000; Abcam), polyclonal antibody to
KRIT1 (1:1,000; 6832, ref. 18), horseradish peroxidase–conjugated goat anti-
body to mouse IgG (1:5,000; Jackson ImmunoResearch) and horseradish
peroxidase–conjugated donkey antibody to rabbit IgG (1:5,000; Jackson
ImmunoResearch). We carried out all steps at 4 1C.
Electron microscopy and cell-cell junction quantitation. We fixed neonatal
mouse gut mesentery, 48-h.p.f. zebrafish embryos and E9.5 mouse embryos
overnight, embedded them in Polybed 812 (Polysciences), sectioned them,
stained them and examined them with a JEOL 1010 electron microscope fitted
with a Hamamatsu digital camera. We imaged all identifiable endocardial cell-
cell junctions from six Heg1+/+ and five Heg1–/– lymphatic vessel cross-sections
(66 and 123 junctions, respectively), and we quantitated junction lengths using
ImageJ. We similarly imaged and quantitated endothelial cell-cell junctions
from three control and four ccm2 morpholino–injected zebrafish atria cross-
sections (88 and 107 junctions, respectively) and four Ccm2+/+ and six
Ccm2lacz/lacz mouse dorsal aorta cross-sections (128 and 107 junctions,
respectively). We ordered the junctions by length and determined the mean
junction length for each tercile. We also calculated the percentage of junctions
o1,000 nm, 1,000–2,500 nm and 42,500 nm. Lastly, we calculated the
overall mean junction length from the mean junction lengths for each heart
or vessel cross-section.
Statistics.We calculated P values using an unpaired two-tailed Student t test or
w2 analysis as indicated.
Note: Supplementary information is available on the Nature Medicine website.
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the heart of glass– cerebral cavernous malformation protein pathway
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min Lu, Diane Zhou, Jan Kitajewski, Markus Affolter, Mark H Ginsberg & Mark L Kahn
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In the version of this article initially published, Shawn M. Sweeney was not included in the list of authors. The error has been corrected in the 
HTML and PDF versions of the article.
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Rabinovich & Petra C Arck
Nat. Med. 13, 1450–1457 (2007); published online 18 November 2007; corrected after print 7 May 2009
In the version of this article initially published, the plot labeled “Stress + Gal-1” duplicated the plot labeled “Control” for the IL-12p70 staining in 
Figure 2f. The corrected plots have now been provided in the HTML and PDF versions of the article. Two sentences were omitted from the sec-
tion on purification of uterine DCs in the Methods. The sentences should have read: “We obtained purified DCs from uterine tissue in very low 
numbers. Thus, we pooled isolated cells from each group and used this cell cocktail for the isotype control staining.” The error has been corrected 
in the HTML and PDF versions of the article. In Figure 4f, the lanes of the western blot were merged inappropriately. The properly presented 
blot, in which the gel lanes have been separated to indicate that the samples were not originally run side by side, has been provided in the PDF and 
HTML versions of the article. The standard curve of the cytometric bead array kit used to generate the cytokine data can be found in the revised 
Supplementary information available online.
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Supplemental Figure 7. 
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Supplemental Figure 7.  Endothelial cells lacking HEG1-CCM signaling exhibit 
defects in tube formation but not endothelial vacuolization.  (a–d) CCM2-deficient 
endothelial cells exhibit a cell autonomous defect in lumen formation.  (a) CCM2 mRNA 
levels were reduced by >85% in HUVEC expressing CCM2-specific but not scrambled 
(control) shRNA.  (b) CCM2-deficient HUVEC migrate normally in response to VEGF 
in a modified Boyden chamber assay.  No significant differences were observed (P values 
" 0.1).  (c) Control shRNA expressing endothelial cells formed tubes with visible lumens 
(black arrows), while CCM2-deficient endothelial cells formed cords that often lacked 
detectable lumens (red arrows).  GFP is co-expressed with lentiviral shRNAs.  (d) 
CCM2-deficient endothelial cells form more sprouts but fewer lumens.  The number of 
sprouts per 20 beads and number of visible lumens per sprout for HUVEC stably 
expressing CCM2 shRNA or control shRNA are shown.  N = 100 beads for each group; 
data shown are representative of four independent experiments.  (e) Endothelial vacuole 
formation is preserved in zebrafish embryos lacking heg or ccm2.  Shown are the 
intersegmental vessels of 24-26 hpf fli1a:EGFP-cdc42 transgenic zebrafish embryos 
treated with scrambled morpholino (control) or morpholinos to block expression of heg 
or ccm2.  The GFP-cdc42 fusion protein outlines the endothelial cell vacuoles that form 
and fuse during lumen formation (white arrows).  (f) The intersegmental vessels of 
zebrafish embryos lacking heg or ccm2 are patent.  Red fluorescent quantum dots injected 
into the dorsal aorta of 24-26 hpf fli1a:EGFP-cdc42 morphant embryos reveals patent 
intersegmental vessels lacking heg or ccm2.  Note the presence of red quantum dots 
within the green endothelial lumens (white arrows) of all embryos.  b, bead.  Scale bars in 
c, 5 µm; in e and f, 20 µm. 
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Supplemental Figure 9. 
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Supplemental Figure 9.  HEG1 or CCM2 deficiency does not reduce expression of 
endothelial junctional proteins.  (a) Immunostaining for VE-cadherin (green) in 48 hpf 
kdr:EGFP (red) transgenic zebrafish embryos treated with control morpholinos or 
morpholinos directed against heg or ccm2 is shown.  (b) Immunostaining for the 
lymphatic endothelial marker LYVE1 and junctional proteins beta-catenin and claudin-5 
in serial sections of dilated lymphatic vessels from a neonatal HEG1-deficient mouse is 
shown.  (c) Immunostaining for beta-catenin in CCM2-deficient and control HUVEC 
monolayers.  (d) Immunoblotting for VE-cadherin, beta-catenin and GAPDH was 
performed using cell lysate from control and CCM2-deficient HUVEC.  Scale bars in a, 
20 µm; in b and c, 100 µm. 
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Anoncoding antisense RNAin tie-1 locus regulates tie-1 function in vivo
Keguo Li,1 Yannick Blum,2 Anjali Verma,1 Zhong Liu,3 Kallal Pramanik,1 Noah R. Leigh,1 Chang Z. Chun,1
Ganesh V. Samant,1 Baofeng Zhao,3Maija K. Garnaas,1Mark A. Horswill,1 Stephen A. Stanhope,4 Paula E. North,5
Robert Q. Miao,3,5 George A. Wilkinson,1Markus Affolter,2 and Ramani Ramchandran1
1Department of Pediatrics, Medical College of Wisconsin, Developmental Vascular Biology Program, Children’s Research Institute, Milwaukee; 2Biozentrum der
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Recently, messenger RNAs in eukaryotes
have shown to associate with antisense
(AS) transcript partners that are often re-
ferred to as long noncoding RNAs (ln-
cRNAs) whose function is largely unknown.
Here, we have identified a natural AS tran-
script for tyrosine kinase containing immu-
noglobulin and epidermal growth factor ho-
mology domain-1 (tie-1), tie-1AS lncRNA in
zebrafish, mouse, and humans. In embry-
onic zebrafish, tie-1AS lncRNA transcript is
expressed temporally and spatially in vivo
with its native target, the tie-1 coding
transcript and in additional locations (ear
and brain). The tie-1AS lncRNA selec-
tively binds tie-1 mRNA in vivo and regu-
lates tie-1 transcript levels, resulting in
specific defects in endothelial cell con-
tact junctions in vivo and in vitro. The
ratio of tie-1 versus tie-1AS lncRNA is
altered in human vascular anomaly
samples. These results directly implicate
noncoding RNA-mediated transcriptional
regulation of gene expression as a funda-
mental control mechanism for physi-
ologic processes, such as vascular devel-
opment. (Blood. 2010;115:133-139)
Introduction
Over the past few years, intensive unbiased analysis of transcriptome
species has revealed that eukaryotic genomes contain a variety of RNA
species. RNA molecules are essentially classified into 2 types, protein
coding and nonprotein coding.The protein-coding transcripts ormessen-
ger RNA (mRNA) account for only approximately 2.3% of the human
genome.1 The majority of transcription appears to be nonprotein coding
or noncoding, and the function of these noncoding transcripts is largely
unknown.2 Of the noncoding RNAs, the regulatory short noncoding
RNAs, such as microRNAs, are well studied. The long noncoding
RNAs (lncRNAs),which compose the largest portion of themammalian
noncoding transcriptome, are the least understood, especially its func-
tion.3,4 lncRNAs are oriented in sense or antisense (AS) direction with
respect to a protein coding locus, and located in intronic or intergenic
regions.5 In humans and mice, 61% to 72% of all transcribed regions
possess lncRNAs in AS orientation,2,6 andAS lncRNA transcripts play
important roles in pathogenesis. For instance, the BACE1-AS transcript
was elevated in subjects with Alzheimer disease and in amyloid
precursor protein transgenic mice.7 A growing body of evidence
suggests that lncRNAs for most critical physiologic processes will be
identified. Angiogenesis, the development of new vasculature from
existing vasculature, is one of the fundamental developmental physi-
ologic processes regulated in a developing vertebrate embryo.8 Here, we
identify a natural AS transcript for tyrosine kinase containing immuno-
globulin and epidermal growth factor homology domain-1 (tie-1),
tie-1AS lncRNA in zebrafish, mouse, and humans. tie-1 is a cell-surface
tyrosine kinase receptor for angiopoietin ligands that is known to play a
role in vascular development in vertebrates.9-12 In embryonic zebrafish,
tie-1AS lncRNA transcript is expressed temporally and spatially in vivo
with its native target, the tie-1 coding transcript, and in additional
locations (ear and brain). Its expression is controlled by a 3-kb genomic
fragment in the 39 region of tie-1, and the bioinformatic predicted hybrid
structure between tie-1:tie-1AS was detected in vivo. Capped or
uncapped tie-1AS lncRNA selectively binds tie-1 mRNA in vivo and
regulates tie-1 transcript levels, resulting in specific defects in endothe-
lial cell contact junctions in vivo and in vitro. Further, the ratio of tie-1
versus tie-1AS lncRNA is altered in human vascular anomaly samples,
suggesting that the imbalance of tie-1 regulation by tie-1AS may be
important in disease. This is the first report, to our knowledge, that
identifies a long AS noncoding RNA in the tie-1 locus that regulates
proper vessel formation in vivo.
Methods
Zebrafish and human studies
All zebrafish studies were performed according to Medical College of
Wisconsin animal protocol guidelines under protocol no. 312-06-2. Re-
search on human patient samples for this work was performed under the
Medical College of Wisconsin–approved Institutional Review Board proto-
cols. RNA from tissue sample was isolated by Trizol method.
Reagents
The transgenic Tg(flk:EGFP) line13 was obtained from M.A.’s laboratory in
Basel, Switzerland. Probes used in this study, tie-1 and tie-1AS lncRNA, were
generated by T3/T7 transcription on polymerase chain reaction (PCR) products
of tie-1AS. T3 and T7 sequences were included into the PCR primers.
Quantitative PCR for tie-1 was performed as described previously14 using
gene-specific primer pairs for tie-1, cd-31, and zebrafish actin. All primer
sequences are provided in supplemental Table 1 (available on the Blood website;
see the SupplementalMaterials link at the top of the online article).
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Molecular biology: cloning of tie-1AS lncRNA
Rapid amplification of cDNA ends (RACEs) was performed by the
RLM-RACE Kit (Ambion) and SMART RACE cDNA Amplification Kit
(Clontech). An embryo pool spanning 1 hour postfertilization (hpf) to
3 days old was used to prepare total RNA. The RNA was treated with
DNase I for 30 minutes and recovered by RNeasy kit (QIAGEN). The
RACE products were cloned into pCR4-TOPO vector (Invitrogen) and
sequenced. RACE primers are listed in supplemental Table 1. The
sequences have been deposited in GenBank ID number GU166385.
MO and microinjections
Morpholino (MO) injections were performed as described previously.15
Gene Tools Inc designed the tie-1 splice MO: CATGTCTACTTACAGATC-
CAGATTG. For tie-1 MO efficacy experiments, reverse-transcribed (RT)–
PCR was performed using gene-specific primers in exons immediately
flanking the targeted region on 24 hpf RNA isolated from uninjected and
tie-1 MO-injected (5 and 10 ng) embryos. The mMESSAGE MACHINE
kit (Ambion) was used for generating sense RNA for tie-1AS lncRNA. For
quantitative PCR, RNA was extracted via the Trizol method and quantita-
tive PCR was carried out using DyNAmo HS SYBR Green qPCR Kit (New
England Biolabs). For RNA Pol inhibitor studies, 8 hpf zebrafish embryos
were injected with a-amanitin and allowed to develop until 24 hpf. For
tagetin, injections were performed at 1-cell stage. For tie-1AS lncRNA
promoter cloning, the region 152648 to 149799 corresponding to clone
CH211-286N19 in linkage group 7 (accession no. CR936976.15) was
amplified using forward primer, TAAGGTACCGCGGGGACATCTAAA-
GACAC; and reverse primer,ATTGGATCCCTTGGTGGCCCAGAAAAC.
The 3-kb PCR product was purified, digested with KpnI-BamHI, and cloned
into the KpnI-BglII site of pGL3-Basic (Promega) vector and is referred to
as pGL3-zfNcRNA-3kb construct. For microinjection, pGL3-hRobo4-3kb
promoter construct16 and pGL3 vector were linearized with SalI, and
pGL3-zfNcRNA-3kb promoter construct was linearized with BamHI;
100 pg of linearized DNA was injected into the cytoplasm of 1-cell stage
zebrafish embryo, embryos were lysed at 26 hpf, and firefly luciferase
activity was measured as per the instruction manual.
Endothelial cell culture and electroporation
Human umbilical vascular endothelial cells (HUVECs; passage 3-6) were
cultured in M199 medium with 20% fetal bovine serum (HyClone) and
endothelial cell growth supplement (BD Biosciences). Plasmid DNA
transfection was performed using the MicroPorator from NanoEnTek.
Briefly, 1 mg of plasmid DNA was mixed with 105 cells in 10 mL of
resuspension buffer, and electroporation was performed at 1000 V and
30 ms. After electroporation, cells were seeded in regular HUVEC growth
medium with transfection efficiency reaching 80%. The expression of
Tie-1, Hsp90, and actin was examined by Western blot analysis at 72 hours
after electroporation. The 3-dimensional tube formation assay was per-
formed at 48 hours, and tube formation was observed at 72 hours after
electroporation.
Results
Identification of tie-1AS in multiple species
Using the zebrafish information network database17,18 of in situ
expression profile across embryonic developmental stages, we
identified several novel expressed sequence tags (ESTs) that
showed a vascular-specific expression profile. We focused on
one EST (accession no. DU644726) that mapped to 73 bp down-
stream of the tie-1 coding locus. Because the 39-untranslated region
(UTR) of the zebrafish tie-1 gene was incomplete, we verified
whether this EST represented the 39-UTR of the tie-1 coding
transcript or represented a new transcript. A set of primers derived
from the EST was used to perform rapid amplification of cDNA
ends (RACE) reaction (supplemental Figure 1A arrows). Interest-
ingly, both the 59 and 39 RACE reactions in both directions
generated end-extended products. The 39 RACE reaction provided
a product that extends the 39UTR of the tie-1 gene to the polyA tail,
whereas the 59 RACE reaction generated a product in the opposite
direction of tie-1 coding transcript, thus providing evidence for a
novel transcript arising from the tie-1 genomic locus in the AS
direction. The noncoding and novel transcripts associated with
tie-1 have 456 bp of overlapped sequence with opposite transcrip-
tional orientation. The 59RACE transcript called “tie-1AS” was
detected in the presence of RT from RNA isolated from an embryo
pool of multiple stages (1-72 hpf; supplemental Figure 1B, 1RT
lane) and is 804 bp long. Sequencing of the tie-1AS revealed a
148-bp unique 59 sequence, followed by a 456-bp region that is
complementary to tie-1s’ last exon, and a 200-bp 39 region
complementary to tie-1s’ last intron-exon junction (supplemental
Figure 1C). The single largest open reading frame predicted within
this AS transcript, is 93 amino acids (data not shown). We
performed additional RACE reactions and cDNA walking in the
opposite orientation to multiple exons within the tie-1 locus and
found that indeed multiple AS transcripts or long noncoding RNA
are generated from the tie-1 locus (supplemental Figure 1D blue
boxes). These data indicate that the tie-1AS represented by EST
DU644726 is one of several noncoding RNAs transcribed from the
tie-1 locus. We only focused on the extreme 39-UTR tie-1AS for
further studies and from hereon will be referring to it as tie-1AS
lncRNA. Both mouse (supplemental Figure 1E) and human
(supplemental Figure 1F blue boxes) RNA indeed have similar
tie-1AS lncRNA as zebrafish and the nucleotide conservation
across the 3 species is 28.5%. These results suggest that the tie-1
locus has evolutionarily conserved noncoding RNAs that may
regulate tie-1 transcripts by similar mechanisms.
Expression profile of tie-1AS lncRNA and tie-1
To investigate developmental expression pattern of tie-1AS ln-
cRNA and tie-1, we performed quantitative real-time PCR for both
transcripts using sequence-specific primers (Figure 1A arrows) that
will amplify each transcript independently across multiple stages in
embryonic zebrafish development. Starting at 1 hpf and until
10 hpf, the levels of both transcripts are low. After gastrulation,
both transcripts show remarkable concordance at every stage until
72 hpf (compare Figure 1B tie-1 and Figure 1C tie-1AS lncRNA).
The levels of tie-1 transcript are a log higher at each stage (compare
ordinate axis in Figure 1B-C) compared with tie-1AS lncRNA,
suggesting that the low amount of tie-1AS lncRNA might be
sufficient to regulate endogenous tie-1 coding transcript levels.
Quantitative PCR analysis shows that the transcript levels of
tie-1AS lncRNA and tie-1 are remarkably congruent in develop-
ment but do not indicate the spatial location of the tie-1AS lncRNA
transcript in relation to the tie-1 gene. To determine the expression
pattern of tie-1AS lncRNA transcript, we performed in situ
hybridization (ISH) for tie-1AS lncRNA using a digoxigenin-
labeled tie-1AS lncRNA (or sense of tie-1) at 24 hpf and compared
with tie-1 expression pattern previously demonstrated at the same
stage.19 Tie-1 is expressed in the axial vessels as indicated by
arrows in Figure 1D and in intermediate cell mass (Figure 1D *).
Previous reports indicate tie-1 expression in intersomitic vessels
(ISVs),19 which we have noticed in longer dark-stained embryos.
Tie-1AS lncRNA is also expressed in the axial vessels, albeit
weakly (Figure 1E arrow), but shows strong expression in the
intermediate cell mass (Figure 1E *), otic vesicles (Figure 1E #),
and brain (Figure 1E brace). We have been unable to detect strong
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tie-1AS lncRNA expression in ISVs, but it is worth mentioning that
the axial vessel ISH results are in agreement with quantitative PCR
results that showed lower amounts of tie-1AS lncRNA expres-
sion compared with tie-1 expression at any given stage, especially
at 24 hpf. We have also performed ISH for tie-1AS lncRNAat other
stages but did not notice any dramatic differences in spatial
localization than at 24 hpf shown in Figure 1F. To fine-map the
expression regions of tie-1AS lncRNA, we sectioned 24 hpf (Fig-
ure 1E) whole-mount stained embryos and mounted them as
shown in Figure 1F. Tie-1AS lncRNA is expressed in both dorsal
aorta (DA) and posterior cardinal vein (PCV) and at the junction of
both structures (Figure 1F black arrows). The quantitative PCR and
the ISH results together show that tie-1AS lncRNA and tie-1
transcripts are found at the same location and time in embryonic
development, arguing for a regulatory role of the tie-1AS lncRNA
on the tie-1 gene.
To investigate control of tie-1AS lncRNA transcription, we
cloned a 3-kb genomic fragment downstream of AS to the tie-1
coding locus into a pGL-3 basic vector that contains luciferase
reporter gene. This vector is specifically designed to determine
promoter activity of DNA fragments. We also obtained a human
Roundabout4 (Robo4) promoter fragment cloned in the same
vector that was shown previously to be active in endothelial cells as
a positive control.16 We injected wild-type zebrafish embryos with
the empty pGL-3 vector, pRobo4promoter-luc, and ptie-1ASln-
cRNApromoter-luc at 1-cell stage. Injected embryos were assayed
at 26 hpf when expression of Robo415 and tie-1AS lncRNA (Figure
1C) is high in the vasculature. Lysates from 26 hpf embryos were
checked for luciferase activity. Compared with vector alone, the
ptie-1ASlncRNApromoter-luc construct showed a 5-fold increase
(Figure 1G black bar), whereas the pRobo4promoter-luc construct
showed a 14-fold increase in luciferase activity (Figure 1G gray bar).
This result suggests that a 3-kbDNAfragment downstreamof tie-1 gene
is sufficient to drive transcription of tie-1AS lncRNAin vivo.
Hybrid tie-1AS lncRNA:tie-1 RNA in vivo
We made use of the utilities RNAfold and RNAcofold from the
Vienna RNA package20,21 to determine whether hybridization
between tie-1AS lncRNA and tie-1 RNAwas likely to occur. In our
initial analysis, we set the temperature parameter to 28°C (represen-
tative of in vivo temperatures for zebrafish) and examined pre-
dicted RNA secondary structures and fold energies for tie-1AS
lncRNA and tie-1 RNA singularly as well as in a duplex. Predicted
secondary structures for the tie-1 RNA alone and in duplex with
tie-1AS lncRNA are depicted in supplemental Figure 2A (the
secondary structure for tie-1AS lncRNA is omitted). The hybridiza-
tion energies for tie-1, tie-1AS lncRNA, and their duplex are
21418.83, 2284.66, and 21885.96, respectively, implying that
the tie-1 and tie-1AS lncRNA are anticipated to duplex under
in vivo conditions.
To determine the specificity of this prediction, 2 additional
studies were performed. The first examined whether tie-1AS
lncRNA could be anticipated to have specific correspondence to
tie-1 RNA, as opposed to other potential targets. We computed the
ratio of the energy of the tie-1AS lncRNA/tie-1 mRNA structure
and the sum of the individual energies of the tie-1AS lncRNA and
tie-1 mRNA (1.107), and compared it with the analogous ratios for
the tie-1AS lncRNA and each mRNA identified in the NCBI
zebrafish reference sequence.22 The distribution of energy ratios is
depicted in supplemental Figure 2B with a marker representing that
of tie-1AS lncRNA and tie-1 mRNA. The ratio of tie-1AS lncRNA
and tie-1 mRNAduplex to singular energies is greater than 99.97%
of that of all other zebrafish mRNAs, implying that, compared with
other zebrafish mRNAs, tie-1 mRNA represents a strong target for
tie-1AS lncRNA.
Next, we studied whether the coding tie-1 mRNA could be
anticipated to have other targeting interfering RNA with similar
characteristics in terms of transcript length and base composition as
tie-1AS lncRNA by computing a distribution of duplex energies
between tie-1 mRNA and permuted tie-1AS lncRNA sequences,
and then comparing the actual energy of the tie-1AS lncRNA and
tie-1 mRNA with those observed (supplemental Figure 2C). The
energy of the tie-1AS lncRNA and tie-1 mRNA duplex is substan-
tially lower than that of any of the permuted tie-1AS lncRNAs, implying
that, compared with other similar RNAmolecules, tie-1AS lncRNAcan
be anticipated to particularly target tie-1 mRNA.
To confirm the bioinformatic prediction, we performed ribonucle-
ase protection assay and RT-PCR to determine whether the tie-1AS
lncRNA exists in vivo as a RNA-RNA duplex with tie-1 RNA
(Figure 2A). RNA was isolated from 24 hpf wild-type zebrafish
embryos, and the cytoplasmic (Figure 2A top panel) or nuclear
(Figure 2Abottom panel) RNA fractions were isolated as described
in supplemental Methods. Total RNA preparations were then
digested with RNaseA, which digests single-stranded RNAand not
duplex RNA, plus DNaseI (Figure 2A lanes 1-3) and DNaseI alone
(Figure 2A lanes 4-6). Using RT-PCR and primers specific to the
overlapping region of tie-1 RNA (Figure 2A P1-P2), we detected a
protected RNA fragment in both cytoplasmic and nuclear fractions
of RNA, indicating that tie-1:tie-1AS lncRNA RNA-RNA duplex
Figure 1. Expression patterns of tie-1AS lncRNA. (A) The primer pair locations for
quantitative PCR. Developmental expression profile of tie-1 (B) and tie-1AS (C) is
shown. The total RNAs were extracted using Trizol followed by DNase I treatment.
The RNAs were recovered by RNeasy kit (QIAGEN). (D) Tie-1 is expressed in the
axial vessels (f) and blood islands (*). (E) Tie-1AS lncRNA is expressed in the axial
vessels (f), intermediate cell mass (*), otic vesicles (#), and brain (brace).
(F) Transverse section of 24 hpf tie-1AS lncRNA embryo is shown. g indicates the
location of DA and PCV. (G) Luciferase activity in vivo (26 hpf) for a 3-kb fragment
upstream of zebrafish tie-1AS lncRNA. The hRobo4 promoter is used as a positive
control. **P , .01.
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exists in vivo (Figure 2A lane 1). We did not observe a detectable
signal (Figure 2A lane 2) using a second primer pair (Figure 2A
P3-P4), specific to the nonoverlapping single-stranded region of
tie-1AS lncRNA, although this sequence was amplified in nuclear
DNase-treated extracts (Figure 2A lane 5 bottom panel), suggesting
that indeed the lack of band in lane 2 and the presence of band in
lane 1 is arising from a duplex species of tie-1 RNA and tie-1AS
lncRNA. We have sequenced the amplicon in lane 1 and lane 4 and
confirmed its identity as tie-1. To confirm complete digestion by
RNase A, we checked b-actin mRNA, which was protected in
nuclear fraction (Figure 2A lane 3 bottom gel) but not in cytoplas-
mic (Figure 2A lane 3 top gel), fraction. Assuming partial cleavage
of RNA in nuclear fraction based on b-actin result and the complete
lack of protected band for tie-1:tie-1AS lncRNA in nuclear fraction,
an argument could be made that the protected tie-1:tie-1AS lncRNA
hybrid species exists exclusively in the cytoplasmic fraction of
embryo lysates. This result is consistent with regulation of endoge-
nous tie-1 sense transcript by tie-1AS lncRNA at the posttranscrip-
tional level.
Regulation of tie-1 by tie-1AS lncRNA
To investigate whether tie-1:tie-1AS lncRNA hybrid has a func-
tional role in regulating tie-1 transcript levels in vivo, we injected
the sense RNA of tie-1AS lncRNA in 1-cell zebrafish embryos and
allowed embryos to develop to 24 hpf, at which point we harvested
the RNA and performed quantitative PCR for tie-1 (Figure 2B) and
tie-2 transcript levels (Figure 2C). We injected capped or uncapped
sense RNA(100 pg) for tie-1AS lncRNA to determine whether tie-1
levels were modulated in these embryos. Interestingly, injection of
either capped and uncapped tie-1AS lncRNA sense RNA reduced
tie-1 expression at 24 hpf (Figure 2B, *P , .05) without affecting
tie-2 transcript levels (Figure 2C), indicating that the hybridization
of the tie-1AS lncRNA to tie-1 RNA in vivo results in down-
regulation of the endogenous tie-1 transcript. Further, this effect is
independent of the RNA capping process because both capped and
uncapped sense RNA showed the same effect arguing for RNA
based hybridization mediated mechanistic regulation of tie-1
transcript levels.
To investigate the RNApolymerase responsible for transcribing
tie-1AS lncRNA in zebrafish, we performed the classic Pol II
inhibitor (a-amanitin) treatment of zebrafish embryos and checked
for transcript levels of tie-1 (Figure 2E) and tie-1AS lncRNA
(Figure 2D) at 24 hpf. We observed a dose-dependent decrease in
both tie-1 and tie-1AS lncRNA transcripts in a-amanitin–treated
embryos starting at 50 pg, with robust inhibition observed at
450 pg. We also performed Pol III inhibitor (tagetin) treatment and
did not observe any change in tie-1 or tie-1AS lncRNA transcript
levels. These results indicate that RNApolymerase II is responsible
for transcribing tie-1AS lncRNA in zebrafish embryo, which is in
concordance with a recent report that suggests that the majority of
noncoding RNA are transcribed by Pol II.23
Endothelial junction defects in tie-1AS GOF
If tie-1 gene levels were reduced in embryos injected with tie-1AS
lncRNA-injected embryos, we would expect to observe phenotype
in injected embryos similar to conventional loss-of-function experi-
ments. As a positive control for tie-1 knockdown, we chose the
MO-mediated knockdown, which is routinely used in zebrafish
research to determine the function of a given gene in develop-
ment.24 We designed splice MO that targets the transmembrane
region of the Tie-1 receptor kinase (Figure 3A blue box). To
determine MO efficacy, we performed RT-PCR using specific
primers in the exons spanning across the targeted exons of Tie-1
TM region. Compared with the uninjected sample (Figure 3A
lane UI), embryos injected with 5 ng of the tie-1 MO (Figure 3A
lane 5) show a second smaller transcript in addition to the native
transcript. Indeed, increasing concentrations of tie-1 splice MOs
(10 ng) resulted in knockdown of endogenous tie-1 transcript and
replacement by an alternative transcript (Figure 3A, compare
Figure 2. Functional investigation of the tie-1AS lncRNA. (A) The RNA
duplex was examined by ribonuclease protection assay. The zebrafish
embryos at 24 hpf were digested with 0.25% trypsin into single cells, from
which cytoplasmic and nuclear RNA was extracted. The RNAs were
treated with DNase I and RNase A followed by RT-PCR. Primers used are
as follows: lanes 1 and 4, P1 and P2, amplicon size 114 bp; lanes 2 and 5,
P3 and P4, amplicon size 133 bp; and lanes 3 and 6, b-actin, amplicon
size 147 bp. (B) Overexpression of tie-1AS lncRNA down-regulates the
expression of tie-1. *P , .05. (C) No effect on the expression of tie-2. The
zebrafish embryos were injected at the 1-cell stage with 150 pg of tie-1AS
mRNA, and quantitative PCR was performed at 24 hpf. (D) Chemical
treatment of zebrafish embryos with a-amanitin shows dose-dependent
sensitivity to tie-1AS lncRNAand tie-1 (E) transcription.
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lanes 5 and 10), indicating that the MO affects endogenous tie-1
transcripts in a dose-dependent manner.
To investigate the possible phenotype of tie-1 LOF, we followed
the well-established function of Tie-1 in maintaining the integrity
of the mammalian vasculature.12 Tie-1–deficient mouse embryos
show no perturbation of embryonic angiogenesis but loss of vessel
integrity.9,10 We injected tie-1 MO or tie-1AS lncRNA into trans-
genic embryos where the vascular endothelial growth factor
receptor-2 or flk promoter drives the expression of enhanced green
fluorescent protein Tg(flk: EGFP)13 in the vasculature and investi-
gated vessel integrity at 24 hpf. Injected embryos were immuno-
stained for tight junction and adherens junction proteins using
antibodies to zona occludens (ZO-1; Figure 3B ZO-1 panels) and
Ve-cadherin (CDH-5; Figure 3B CDH-5 panels), respectively. The
ZO-1 protein25 is present in all cell junctions, whereas the CDH-5
protein26 is localized exclusively in endothelial cell junctions. Both
proteins have been shown previously in zebrafish to be in similar
location13 as in mouse and humans.
We immunostained tie-1AS lncRNA injected, tie-1 MO in-
jected, and uninjected embryos for ZO-1 and CDH-5 proteins at
24 hpf. Uninjected embryos (Figure 3B UI) show ISVs that were
properly patterned with well-organized contact with endothelial
cell of the DAand cardinal vein (CV) for both ZO-1 (Figure 3B UI,
ZO-1) and CDH-5 (Figure 3B UI, CDH-5). In contrast, both the
tie-1AS lncRNA-injected and the tie-1 MO-injected embryos
showed aberrant ZO-1 staining (compare respective panels for tie-1
MO and tie-1AS lncRNA in Figure 3B). The ZO-1 staining in both
tie-1 MO and tie-1AS lncRNA showed asymmetric distribution
through the cell surface, whereas in uninjected embryos the ZO-1
staining was restricted to cell contact junctions. In terms of
vascular-specific junctions, CDH-5 staining clearly shows asymmet-
ric or uniform distribution of CDH-5 protein on all sides of the cell
in tie-1AS lncRNA sample (Figure 3B), compared with the
uninjected panel. The ISV structure in both tie-1AS lncRNAand the
tie-1 MO-injected embryos appears thinner, and the ISV length
from DA to dorsal surface is shorter. Quantification of the
percentage CDH-5 mislocalization along the length of a single ISV
in each sample group is shown in Figure 3C. In general, more ISV
cells show CDH-5 mislocalization along the ISV length in tie-1
MO and tie-1AS lncRNA samples.
To investigate the effects of human tie-1AS lncRNAon endothe-
lial tube formation in vitro, we electroporated HUVECs with AS
transcripts encoding 3 different regions in the 39-UTR of the
human tie-1 gene locus as indicated in Figure 4A. The 3 humanAS
(hAS) transcripts are called hAS-1, hAS-2, and hAS-3. The hAS-1
Figure 3. The phenotype of zebrafish tie-1AS lncRNA overexpression. (A) The
MO targeting splice-site is complementary to the 13th exon-intron boundary. RT-PCR
was performed to confirm MO-targeting effects. (B) Immunostaining of Tg(flk: EGFP)
embryos injected with tie-1AS (150 pg) or tie-1 MO (5-10 ng) at the 1-cell stage and
fixed at 24 hpf. Staining was performed using CDH5, ZO-1, and anti-GFP antibodies.
Most tie-1AS lncRNA-injected embryos showed an asymmetric distribution of Cdh-5
staining on endothelial cell membrane in vivo as shown in the enlarged inset. ISVs
(white asterisk) also show a truncated phenotype. Details of image capture are
available in supplemental Methods. (C) Quantitation of the phenotype was performed
as described in supplemental Methods, and the ratio of length of ISVs showing
phenotype to an ISV with normal CDH-5 distribution is plotted. In general, the trend in
tie-1AS lncRNA and tie-1 MO-injected embryos shows higher ratios indicating more
ISVs with asymmetric CDH-5 distribution per embryo.
Figure 4. Human lncRNA regulates Tie-1 expression in endothelial cells and is
necessary for VEGF-induced tube formation and the disease connection.
(A) A schematic of the 3 human lncRNA AS (h-AS) tie-1 transcripts is shown.
(B) hAS-2 transfection in endothelial cells down-regulates Tie-1 protein levels
compared with no-treatment control (NC), vector control (Vector), or hAS-1 or hAS-3
transfected lysates. (C) After transfection with empty vector and tie-1 noncoding
RNAs h-AS1 or h-AS2, HUVECs were suspended in type I collagen gels and treated
with vehicle or 100 ng/mL VEGF. After 24 hours of incubation, cells were photo-
graphed using QCapture Program (QImaging Inc). Representative images are shown
for 2 independent experiments. Details of image capture are available in supplemen-
tal Methods. (D) Quantification of mean lengths of tubes formed with VEGF-treated
transfected HUVECs. *P , .05. (E) Tissues from patients diagnosed with vascular
anomalies have aberrant levels of tie-1AS lncRNA transcript compared with tie-1.
Interestingly, RNA from normal placenta tissue shows an exact reverse pattern with
high levels of tie-1 and low to nondetectable levels of tie-1AS lncRNA.
NONCODING RNAREGULATIONAT tie-1 LOCUS 137BLOOD, 7 JANUARY 2010 z VOLUME 115, NUMBER 1
For personal use only. at MEDIZINBIBLIOTEK on March 26, 2012. bloodjournal.hematologylibrary.orgFrom
and hAS-3 encodes identical regions with the hAS-3–encompass-
ing region further upstream of hAS-1 (Figure 4A). The hAS-2
spans the last exon of the tie-1 gene and covers the last intron-exon
junction. This AS contains both intron and exon sequences of tie-1
in the reverse orientation, which is similar to the zebrafish AS used
in all the experiments here. First, we electroporated HUVECs with
the 3 hASs and generated lysates to detect Tie-1 protein levels via
Western blot. Among the different sample groups, only hAS-2–
transfected lysate (Figure 4B lane hAS-2) showed appreciable
difference in Tie-1 protein levels compared with hAS-1 (Figure 4B
lane hAS-1), hAS-3 (Figure 4B lane hAS-3), untransfected (Figure
4B lane NC), or empty vector transfected (Figure 4B lane vector)
cells. No appreciable differences were noticed for housekeeping
proteins Hsp90 or actin (Figure 4B Hsp90/actin). This result
indicates that hAS-2 like zebrafish tie-1AS lncRNA selectively
targets tie-1 transcript, resulting in down-regulation of the Tie-1
protein.
We next performed an in vitro tubulogenesis assay in collagen
gel in the presence and absence of vascular endothelial growth
factor (VEGF). In both empty vector (Figure 4C vector) and hAS-1
(Figure 4C hAS-1) transfected endothelial cell panels, we notice
tube formation in the presence of VEGF. However, in hAS-2–
transfected endothelial cell (Figure 4C hAS-2), tube formation is
absent in the presence of VEGF, indicating that down-regulation of
Tie-1 protein results in disruption of endothelial tube formation in
vitro. This result is in concordance with previous reports of Tie-1
function in modulating endothelial cell junctions and in turn
stability of endothelial network.27,28 Quantitation of the VEGF-
induced tube formation (Figure 4D) shows a statistically significant
difference (*P , .05) between hAS-2 and vector or hAS-1–
transfected cells.
Tie-1AS lncRNA disease connection
Mutations in Tie’s have been previously implicated in patients with
vascular malformations.29-33 To investigate whether the human
tie-1AS lncRNA levels are altered in vascular malformation, we
performed quantitative PCR for tie-1 and tie-1AS lncRNA on RNA
isolated from vascular anomaly34 tissue from 12 patients previ-
ously diagnosed for various anomalies and compared them with
RNA from normal placenta. In general, placenta share several
markers with hemangioma tissue35 and therefore were used for
comparisons. The quantitative PCR comparison was performed to
the CD31 endothelial marker. We noticed that the tie-1AS lncRNA
levels show a 5- to 10-fold increase (Figure 4E black bar, tie-1AS
lncRNA) in vascular anomaly patient samples compared with
normal placenta. Interestingly, normalized tie-1 levels (Figure 4E
white bar, tie-1 panel) have not dramatically changed among the
sample groups. Importantly, the ratio of tie-1 versus tie-1AS
lncRNA is opposite in normal placenta tissue compared with
vascular anomaly tissue. These results suggest that the balance
between tie-1AS lncRNA and tie-1 is probably critical for regula-
tion of tie-1 levels, and diseases where vasculature is implicated
may observe a shift in this regulation, arguing for a specific
function for tie-1AS lncRNA in vascular conditions.
Discussion
A growing body of evidence suggests that mammalian genomes
encode many thousands of large intergenic transcripts. To date, the
functional significance of these transcripts is poorly understood. In
this study, we have identified a noncoding AS RNA in the 39-UTR
of the tie-1 gene locus that is expressed in the AS direction to the
tie-1 gene. The salient features of this study include (1) a vascular-
specific noncoding RNA that is expressed in both previously
known and unknown regions of native tie-1 transcript expression in
vivo, (2) selective targeting of tie-1 transcript by direct interaction
of the noncoding RNAwith its cognate RNA in vivo that results in
down-regulation of the tie-1 transcript, (3) phenotypic conse-
quences in vivo and in vitro of the noncoding RNA mediated
down-regulation of tie-1 transcripts, and (4) potential imbalance in
tie-1/noncoding tie-1AS ratios in vascular-related disease states.
The noncoding tie-1AS lncRNA is expressed in the temporal
and, for the most part, spatial location that matches the endogenous
tie-1 gene expression pattern. Interestingly, regions in the brain,
such as the forebrain and hindbrain, and otic vesicles show strong
expression of the noncoding species exclusively. This argues for a
tie-1 gene role previously unrecognized in the brain and ear
function, perhaps in the vasculature of these organs. Indeed,
2 recent studies implicate angiopoietins, ligands for Tie’s, in
lymphatic vessel development in ear.36,37 Whether the ear expres-
sion observed in the fish translates into a role for tie-1 in inner ear
development or vasculature associated with ear development in
mouse remains to be seen. Because the noncoding RNA for tie-1 is
conserved in humans and mice, this paradigm of using noncoding
RNA expression pattern to speculate putative novel gene function
(simply based on expression alone) of well-studied genes is
intriguing.
The presence of noncoding AS transcript at the same time and
space as its native endogenous transcript suggests a regulatory
paradigm; and based on our comprehensive zebrafish genome
searches, it is clear that the energy of the tie-1AS lncRNA:tie-1
RNA complex is substantially lower than what is typically ob-
served, which argues for selective duplex formation with one
another. Indeed, experimental data confirm this prediction in vivo.
Hybridization of the AS long noncoding RNA to its target is
predicted to destabilize it and in turn result in loss of protein.4 This
is probably the functional significance with the noncoding tie-1AS
lncRNA both in vivo and in vitro. Both uncapped and capped
noncoding tie-1AS lncRNA targets tie-1, suggesting that (1) the
hybridization mediated down-regulation mechanism of target gene
is independent of RNA capping and (2) this down-regulation is
probably an RNA-mediated mechanism. However, definitive evi-
dence is needed before reaching this conclusion.
Down-regulation of gene expression often leads to loss of
function phenotypes, especially for haploinsufficient genes. Tie-1
loss of function is established in the late angiogenesis phase38 and
is required cell autonomously for endothelial cell survival and
vascular network extension during late embryogenesis.9 In tie-1AS
lncRNA-injected embryos, we have similarly noticed that endothe-
lial cell junctions typified by Ve-cadherin are mislocalized, there-
fore arguing for loss or aberrant cell contacts. This phenotype also
corresponds well to the expression of tie-1AS at the junction
between PCV and DA as shown by ISH. Importantly, the human
tie-1AS lncRNAalso prevents tube formation of endothelial cells in
response to VEGF stimulus, arguing that the aberrant cell contact
observed in vivo results in loss of cell-cell adhesion necessary for
tube formation in vitro. Both humans and zebrafish share the same
39-UTR tie-1AS lncRNA region that targets the tie-1 gene, which
spans the exon-intron junction of the last tie-1 exon in the AS
direction and in essence behaves mechanistically as a splice MO.
Therefore, this argues that noncoding AS RNA-mediated down-
regulation of target gene may mimic other AS technology.
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At present, the function of noncoding RNA in disease is still
unclear4; and to date, mutations in noncoding RNA have not been
reported in disease. Mutations in Tie, especially Tie-2, have been
implicated in vascular malformation, in particular congenital
venous malformations.29 The imbalance in the ratio of tie-1 and
noncoding lncRNA in patients diagnosed with vascular malforma-
tions suggests aberrant gene regulation in disease, but whether this
regulation is critical for the pathogenesis of disease is unknown.
In conclusion, we have identified a novel long noncoding AS
transcript that regulates tie-1 gene levels in vivo and in vitro, resulting in
phenotypic consequences similar tomammals.To our knowledge, this is
the first report on the identification of a long noncodingRNAthat plays a
functional regulatory role in vascular development.
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During embryonic development, the vertebrate vasculature is undergoing vast growth and remodeling.
Blood vessels can be formed by a wide spectrum of different morphogenetic mechanisms, such as budding,
cord hollowing, cell hollowing, cell wrapping and intussusception. Here, we describe the vascular
morphogenesis that occurs in the early zebrafish embryo. We discuss the diversity of morphogenetic
mechanisms that contribute to vessel assembly, angiogenic sprouting and tube formation in different blood
vessels and how some of these complex cell behaviors are regulated by molecular pathways.
© 2009 Elsevier Inc. All rights reserved.
Introduction
Branched tubular organs, such as the insect tracheal system or the
vertebrate cardiovascular system, kidney or lung, are found throughout
the animal kingdom. Formation of such tubular networks from
precursor cells or tissues involves a variety of morphogenetic processes,
such as tube formation, elongation, branching and fusion. These
processes are brought about by complex cellular behaviors, which
include cell polarization, cell migration, cell rearrangements, cell shape
changes and cell division. Although tubular organs are extremely
diverse in anatomy and function, the cellular activities that govern tube
formation and branching morphogenesis appear to be quite similar
(Baer et al., 2009; Andrew and Ewald, 2010). In this review, we describe
the current understanding of blood vessel formation in the early
zebrafish embryo. We are placing special emphasis on the morphoge-
netic processes that contribute to vascular development and discuss
the regulatory components that accompany these events.
In vertebrates, the cardiovascular system constitutes a highly
ramified network of tubes that transports gas, nutrients, hormones
and metabolites throughout the body. It also has important roles in
the regulation of homeostasis and wound healing and is involved in
the pathology of numerous diseases including cancer and inflamma-
tion (Carmeliet, 2003). The cardiovascular system emerges as one of
the first organs during embryonic development and retains morpho-
genetic plasticity in adult life. Blood vessels are an integral component
of all organs and are vital not only for their function but also for their
formation during embryonic development (Nikolova and Lammert,
2003; Red-Horse et al., 2007; Sakaguchi et al., 2008). Blood vessels are
highly diverse: they differ in size and are specialized depending on
their function and the tissue or organ they are embedded in (Aird,
2007; Rocha and Adams, 2009). In general, they consist of an inner
epithelium (endothelium) lining the lumen; depending on the type of
vessel, this endothelium is surrounded by a basal lamina and by mural
cells, such as pericytes and smooth muscle cells, which both support
and regulate the function of the endothelium (Armulik et al., 2005).
Over the last decade, the molecular pathways controlling vascular
development have attracted much attention, and a large number of
key molecules has been identified that regulate different aspects of
blood vessel morphogenesis. The basic frameworks of the vascular
anatomy are conserved among vertebrates, which makes it possible to
assign homologies between distinct blood vessels and to directly
compare the formation of these vessels in different vertebrate species
(Isogai et al., 2001; see Fig. 1). The zebrafish embryo has proven to be
a useful model to study vascular morphogenesis in vivo. The vascu-
lature can be easily visualized using a variety of labeling techniques,
such as endothelial specific expression of fluorescent protein or by
microangiography (Fig. 1). Its small size, experimental accessibility,
optical clarity and rapid development allow to observe cellular
activities, such as cell migration, cellular rearrangements and cell
divisions, as they occur during blood vessel formation in the embryo.
It is also possible to follow cardiovascular mutant phenotypes for
several days because oxygenation of the early zebrafish embryo does
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not rely on blood circulation. Furthermore, functional studies by for-
ward and reverse genetics have shown that the molecular compo-
nents that regulate vascular development are conserved between
mammals and fish (Beis and Stainier, 2006; Lawson and Weinstein,
2002b; Thisse, 2002). Thus, the zebrafish embryo presents a unique
system in which live imaging can be combined with functional studies
to gain a more complete insight into how the molecular and
morphogenetic mechanisms are integrated at the (sub)cellular level
to shape the vascular tree.
Vasculogenesis
The formation of vertebrate blood vessels is commonly subdivided
into two distinct morphogenetic processes, called vasculogenesis and
angiogenesis. Vasculogenesis is defined by in situ aggregation of
angioblasts into a blood vessel (Coffin and Poole, 1988; Poole and
Coffin, 1989; Risau, 1995; Risau et al., 1988), while further sprouting
of vessels from existing vessels occurs via a process called angiogen-
esis (Risau, 1995).
Origin and specification of endothelial cells
Angioblasts are precursors of endothelial cells not yet incorporated
into blood vessels. They originate from the ventrolateral mesoderm
(Kimmel et al., 1995; Stainier et al., 1995). Analyses of genes ex-
pressed in the hematopoietic and endothelial cell lineages have
revealed a remarkable conservation between vertebrate species. In
particular, transcription factors belonging to the ETS, GATA and LMO
families have been shown to control specification of these lineages in
mammals as well as fish (De Val et al., 2008; Detrich et al., 1995; Liu
and Patient, 2008; Thompson et al., 1998; Zon et al., 1991). At the
beginning of somitogenesis, transcription factors, such as scl/tal1 and
lmo2, which specify angioblasts and hematopoietic cells, are
expressed in two domains along the body axis, the anterior and the
posterior lateral mesoderm (Dooley et al., 2005; Liao et al., 1998;
Patterson et al., 2007). During somitogenesis these cell populations
acquire unique gene expression profiles. For example, flk1-positive/
scl-positive precursor cells differentiate into flk1-positive/scl-nega-
tive and flk1-negative/scl-positive cells, which will give rise to
endothelial and hematopoietic cells, respectively (Gering et al.,
1998). There seems to be no transcriptional factor regulating
exclusively the endothelial specification but a combination of multiple
factors with overlapping expression patterns (reviewed by De Val and
Black, 2009).
Formation of the dorsal aorta and the cardinal vein
The basic anatomy of the initial embryonic circulatory system is
quite similar among vertebrates. In addition, the first embryonic
vessels to appear, the dorsal aorta (DA) and the posterior cardinal vein
(PCV), are formed by a distinct morphogenetic mechanism called
vasculogenesis in all vertebrates (Isogai et al., 2001). In zebrafish,
angioblasts are specified well before the first blood vessels are formed.
Expression of molecular markers such as fli1a shows that angioblasts
are located in two lateral stripes at 12–14 hpf. By 28–30 hpf, the DA
and the PVC can be discerned and are fully lumenized (Roman et al.,
2002). In vivo imaging, using a Tg(fli1a:EGFP) reporter fish line, has
shown that angioblasts migrate as individual cells towards the
embryonic midline where they coalesce (Lawson and Weinstein,
2002b). During recent years, a considerable amount of research has
focused on how this migration process is regulated, how these cells
form the axial vessels and how DA and PCV are specified. As indicated
in Fig. 2, the PCV forms subsequently to the DA (Eriksson and Löfberg,
2000; Herbert et al., 2009; Jin et al., 2005), and this relationship
appears to be conserved among vertebrates (Coffin and Poole, 1988;
Hirakow and Hiruma, 1981; Meier, 1980).
Formation of the DA in zebrafish has been studied by transmission
electron microscopy (TEM) (Eriksson and Löfberg, 2000; Meier, 1980)
and more recently by analysis of transgenic zebrafish embryos
(Herbert et al., 2009; Jin et al., 2005; Lawson and Weinstein,
2002b). During vasculogenesis, angioblasts are attracted towards
the midline by guidance cues thought to emanate from the endoderm
Fig. 1. The vascular system in mouse and fish embryos. (A) Visualization of the vascular system by immunohistochemical localization of PECAM-1 in a day 10 mouse embryo (photo
courtesy of Ralf Adams, MPI, Münster, Germany). Owing to the opacity of the mouse embryo, only superficial blood vessels can be seen. BA: branchial arches (1st and 2nd); ISV:
intersegmental vessel; DLAV: dorsal longitudinal anastomotic vessel. (B–D) The vascular system in a 3-day-old zebrafish embryo visualized by reporter gene analysis (TG:flk1:EGFP
in green) and by microangiography using quantum dots (red in panels C and D). Some blood vessels are indicated according to Isogai et al. (2001). AA: aortic arches (1–6); CV: caudal
vein; CCV: common cardinal vein; DA: dorsal aorta; PCV: posterior cardinal vein; PHS: primary head sinus; SA: segmental artery; SV segmental vein. At these stages, anatomical
similarities between the two species are best observed in the branchial arches and in the ISV of the trunk. ISV and DLAV form quite similarly in both species (Isogai et al., 2003; Walls
et al., 2008).
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(Jin et al., 2005; Fig. 2A). Once the angioblasts have reached the
embryonic midline, they form aggregates and tube formation
commences (Fig. 2B). TEM studies have shown that angioblasts
initially form “aggregates of tightly packed cells” between hypochord
and the underlying mesoderm (Eriksson and Löfberg, 2000). These
aggregates are discontinuous along the anterior–posterior axis and
the cells are spherical at the beginning of the process. At around the
17-somite stage (17.5 hpf), more flattened tube forming cells are
found posterior to the 7th–9th somite in the fish embryo. From
analysis of transgenic zebrafish, it has been suggested that endothelial
cells migrate in two waves to the midline and it has been suggested
that the first wave contributes to the DA while the cells of the second
wave will form the primary vein (Jin et al., 2005). Alternatively,
endothelial cells from both migratory waves may join in a single
medial cord and segregate independently from this structure. The
latter possibility has recently gained strong support from in vivo time-
lapse analyses, which showed that the precursor cells of the caudal
vein dissociate from the primordium of the DA by a process termed
ventral sprouting (Herbert et al., 2009). Ventral sprouting is initiated
around 20 h post-fertilization shortly before the emergence of dorsal
sprouts, which will give rise to segmental arteries (SA) (see below) at
a time when the DA is not yet lumenized. This finding together with
the observation that the expression of the arterial marker ephrinb2a
(efnb2a) is restricted to a subpopulation within the vascular cord
suggested that the primary arteries and veins are derived from a
common primordium that contains a mixed population of arterial as
well as venous angioblasts (Herbert et al., 2009; Jin et al., 2005).
Specification of arterial versus venous fates has been shown to
depend on the interaction of the VEGF and Notch signaling pathways
(reviewed by Lawson and Weinstein, 2002a; Siekmann et al., 2008).
Sonic hedgehog (SHH) signals from the notochord lead to an
activation of vegf-a expression in ventral somites (Lawson et al.,
2002). VEGF-A is sensed by the angioblasts via VEGF-receptor-2/
KDR/FLK1 (KDR-Like/KDRL in zebrafish), which leads to the activa-
tion of Notch signaling and the transcriptional activation of other
factors which results in arterial differentiation in a subset of
angioblasts (Cermenati et al., 2008; Lawson et al., 2003; Pendeville
et al., 2008; Zhong et al., 2001). In contrast to arterial development,
specification of venous fates is independent of VEGF-A signaling
(Covassin et al., 2006; Lawson et al., 2003). In agreement with these
concepts, modification of VEGF or Notch signaling levels influences
the segregation and ventral sprouting behavior. Angioblasts showed
excessive ventral migration, when VEGF-A and Notch signals were
blocked, whereas downregulation of FLT4 led to a reduction in ventral
sprouting (Herbert et al., 2009).
Arterial and venous specification of angioblasts is reflected by
particular gene expressions (Lawson and Weinstein, 2002a). Notably,
two members of the Eph-ephrin subclass of the receptor tyrosine
kinase family are differentially expressed in arteries (EphrinB2/Efnb2)
and veins (EphB4) (Adams et al., 1999; Lawson et al., 2001). Genetic
analyses in mouse have demonstrated an important role for
bidirectional Ephb4-Efnb2 signaling for vascular morphogenesis
(reviewed by Adams and Alitalo, 2007). In mouse and fish, EPHB4-
Efnb2 signaling has been shown to be involved in sorting of neuronal
cells, which leads to their segregation into adjacent hindbrain
segments (Kemp et al., 2009; Mellitzer et al., 1999). To test whether
these factors also play a role in the segregation of arterial and venous
angioblasts in the primary vascular cord, Herbert and colleagues
(2009) modified EPHB4a and EfnB2a levels and interfered with
forward and reverse properties of EPHB4a-EfnB2a signaling. Either
overexpression or knockdown of EPHB4a/Efnb2a function caused
aberrant migration of transplanted angioblasts consistent with
defects in arterio-venous segregation. Taken together, these findings
show that repulsive EPH4a-EfnB2 signaling regulates arterio-venous
segregation, thereby controlling the directionality of angioblast
sprouting.
Anterior–posterior differences in artery formation
While the process of vasculogenesis has been best described in the
dorsal aorta of the trunk, there is increasing evidence of regional
differences in the way the primary vessels form and it has been
proposed that distinct cues guide endothelial cells in different
domains of the body (Coffin and Poole, 1991; Eriksson and Löfberg,
2000). In agreement with this view, several zebrafish mutants have
been isolated that exhibit vascular defects in particular regions of the
body (Jin et al., 2007).
Some experiments have shed light on the differences that regulate
the formation of the DA of the trunk and the paired lateral dorsal
aortae (LDA), which is located in anterior body regions. In an earlier
study, the role of the endoderm for formation of the DA was examined
in casanova (sox32) mutants that lack endoderm (Jin et al., 2005). In
these embryos, medial migration of angioblasts was slowed but the
DA formed normally, suggesting that endoderm is dispensable for DA
formation. However, it has more recently been shown that the
endoderm plays an essential role for LDA formation in the anterior
region of the embryo (Siekmann et al., 2009). Strikingly, mutants for
the chemokine receptor cxcr4a, which is expressed in the LDA, lack
the LDA. CXCR4 is known to bind to CXCL12, which is specifically
expressed in the anterior endoderm underlying the developing LDA.
Furthermore, loss of CXCL12 function phenocopies the cxcr4a
deficiency. These findings illustrate the molecular diversity in
endothelial cells and the importance of local extrinsic cues for the
formation and patterning of the primary aorta.
Fig. 2. Phases of vasculogenesis in the zebrafish embryo. Schematic cross sections of the trunk region at representative stages of development (according to Herbert et al., 2009 and
Jin et al., 2005). (A) Medial migration. From 14 hpf onward, angioblasts (purple) that originate in the lateral plate mesoderm migrate over the endoderm towards the midline just
below the hypochord, where they aggregate to form a vascular cord (B). (B) Arterio-venous segregation and ventral sprouting. At around 17 hpf, angioblasts start to express markers
of arterio-venous differentiation, such as ephrin-b2a in arterial cells (marked in red). These cells are located in the dorsal portion of the vascular rod and will give rise to the DA,
whereas ephb4a expressing cells are located more ventrally and will contribute to the PCV and CV. At 21 hpf, angioblasts located in the ventral part of the vascular cord start
migrating ventrally and accumulate below the forming DA (B, C). (C) Lumen formation. The DA forms and lumenizes prior to the PCV and CV in the absence of blood cells (brown) by
cord hollowing. Venous angioblasts aggregate and coalesce around the blood cells to ultimately form a tube. (D) Functional Vasculature. At 30 hpf, both vessels are fully formed and
carry blood flow. Endothelial cell junctions are indicated in green.
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Transforming a cord into a tube: lumen formation in the primary blood
vessels
The morphogenesis of biological tubes has been a longstanding
interest in developmental biology and it has been shown that tubes
can form in very different ways (Baer et al., 2009; Lubarsky and
Krasnow, 2003). After angioblasts have aggregated into a cord-like
structure, they ultimately have to assemble a tube. This could in
principal occur by different morphogenetic processes, including (i)
cell hollowing, where cells form vacuoles that fuse between cells to
form a continuous intracellular lumen; (ii) wrapping, where cells
migrate in a polarized state and surround the future lumen; (iii) cord
hollowing, where cells within the cord attain apical–basal polarity and
the lumen is formed by membrane separation and fluid influx; or by
(iv) cavitation, where cells in the middle of the rod undergo apoptosis
leaving a luminal space behind (Hogan and Kolodziej, 2002; Kucera et
al., 2007; Lubarsky and Krasnow, 2003).
Tube formation of the DA has been studied at the cellular level by
transgenic and immunofluorescent analyses in zebrafish embryos (Jin
et al., 2005). Shortly after angioblasts have formed a cord, the DA
begins to lumenize (21 hpf; Figs. 2B, C). Analysis of proteins involved
in apical–basal polarization, such as fibronectin or β-catenin, has
shown that this process is preceded by endothelial polarization and
the formation of junctions between ECs, suggesting that a cord
hollowing process forms the lumen of the DA. At the 20-somite stage
(19 hpf), cell junctions, as visualized by ZO-1 and Claudin5, are
discernable between the cells forming the dorsal aorta (Jin et al.,
2005). The mechanisms of lumen formation in the zebrafish dorsal
aorta and caudal vein have recently been examined by in vivo time-
lapse analyses (Herbert et al., 2009). These studies confirmed a cord
hollowing mechanism in the DA, whereas the lumen of the CV is
formed by ventrally sprouting venous angioblasts that coalesce
around resident blood cells. This mode of lumen formation has not
been described before and it is likely to be different from cell
wrapping as described above because the sprouting angioblast do not
seem to migrate as an epithelial sheet of cells.
In a recent, comprehensive study, lumen formation of the paired
dorsal aortae has been examined in the mouse embryo (Strilić et al.,
2009). By anatomical and immunofluorescent analyses, Strilić and
colleagues show that the lumen of the dorsal aortae forms in discrete
steps similar to those observed in the zebrafish and, for the first time,
they were able to decipher the molecular mechanisms involved in this
process. Consistent with observations in zebrafish, the first steps of
lumen formation are initiated upon formation of intercellular
adherens junctions between angioblasts. Junctional remodeling then
leads to an apical interface between adjacent ECs, followed by an
accumulation of anti-adhesive CD34-sialomucins, such as CD34 and
Podocalyxin (PODXL). Proper localization of these proteins to the
apical surface depends on the presence of VE-cadherin. The
subsequent formation of the aortic lumen is driven by a VEGF-A-
dependent constriction of the apical surfaces as well as EC elongation
induced by the F-actin cytoskeleton. These cell shape changes
apparently rely on interactions between Moesin with CD34-sialomu-
cins, which lead to an apical localization of F-actin. This view is
supported by the analysis of Moesin and of Podxl mutants which both
exhibit reduced levels of apical F-actin and a delay in aortic lumen
formation. Furthermore, loss of Podxl leads to a reduction of Moesin at
the sites of endothelial contacts, suggesting that PODXL connects with
Moesin in order to recruit F-actin.
In summary, these studies indicate that the morphogenetic
mechanisms that drive lumen formation in the dorsal aorta/aortae
have been conserved between teleosts and mammals. In either case,
coalescence of ECs and subsequent apical–basal polarization of a
vascular cord appear to be the primary steps. The lumen is then
formed between apical surfaces of apposing ECs by a cord hollowing
process. Whether the molecular mechanisms that underlie lumen
formation are conserved between fish and mouse remains to be
determined. Furthermore, it will be interesting to learn about the
morphogenetic processes that may be required to further inflate the
lumen.
Angiogenesis
While the primary axial vessels are formed by vasculogenesis,
elaboration of the vasculature, i.e. the formation of secondary blood
vessels, occurs via angiogenesis, a process by which new blood vessels
are generated from a pre-existing one. However, with respect to
morphogenetic cell behaviors, angiogenesis can occur in quite
different ways. Originally, it has been described as a sprouting
process, by which a new vessel is branching off a primary vessel
(reviewed by Patan, 2000). In addition to sprouting, a considerably
different mode of angiogenesis called intussusception has been
described in mammals (reviewed by Makanya et al., 2009). During
intussusceptive angiogenesis, a vessel splits along its longitudinal axis
into two new branches, thus effectively enlarging the vascular surface
area. This process plays an important role in vascular remodeling
during plexus formation. In zebrafish, angiogenesis by intussuscep-
tion has not yet been described and therefore we focus our discussion
on sprouting angiogenesis.
Sprouting angiogenesis
Sprouting angiogenesis was described as a general mechanism of
microvascular growth during the 1970s, and its relevance for tumor
growth and metastasis was soon recognized (Folkman, 1982). Early
on angiogenesis was studied in a variety of in vivo and tissue culture
systems such as the chorion allantoic membrane of the chick or the
corneal pocket (reviewed by Patan, 2000). As an outcome of these
studies, sprouting angiogenesis was described as a sequence of events
that include (i) migration of ECs toward the angiogenic stimulus, (ii)
alignment of ECs in a bipolar mode, (iii) lumen formation and cell
divisions distant to the tip of the sprout and (iv) connection of
individual sprouts to initiate circulation (Ausprunk and Folkman,
1977; Patan, 2000).
In recent years, much progress has been made in establishing
systems in which angiogenic processes can be followed in detail.
These include the retinal vasculature of the mouse, which develops
postnatally, and the zebrafish embryo, in which all aspects of
angiogenesis can be followed in vivo. Embryonic vasculogenesis and
angiogenesis in zebrafish occur in ways very similar to those in
mammals. In contrast to the latter, zebrafish embryos do not require
extra-embryonic vasculogenesis due to their extrauterine develop-
ment. This greatly facilitates the analysis of embryonic blood vessel
formation, as it is not influenced by prior extra-embryonic events.
Although all major blood vessels are easily accessible in the zebrafish
embryo, the intersegmental blood vessels (ISV) have been most
thoroughly studied because of their metameric organization and
relatively simple anatomy.
ISV formation in the zebrafish embryo
Formation of ISVs in the zebrafish embryos involves two waves of
angiogenic sprouting (Isogai et al., 2003). ECs of the primary wave
form the segmental arteries (SA). During the primary wave, ECs
sprout from the DA at ∼22 hpf. These sprouts grow dorsally and –
once they have reached the level of the dorsal neural tube – connect
with their neighbors from anterior and posterior segments to form the
future dorsal longitudinal anastomotic vessel (DLAV). The second
wave, which starts at 32 hpf, involves ECs from the PCV (Yaniv et al.,
2006). These sprouts will either connect to an existing SA, thereby
transforming it into a vein (SV), or, alternatively, they will grow up to
the level of the horizontal myoseptum and form a population of cells
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named parachordal lymphangioblasts (PLs) (Hogan et al., 2009;
Isogai, 2003). The majority of these cells eventually migrates away
from the horizontal myoseptum and contributes to the lymphatic
vasculature (Hogan et al., 2009).
Formation of the SA has been described in detail by in vivo time-
lapse and immunofluorescent analyses (Blum et al., 2008; Childs et al.,
2002; Isogai et al., 2003; Lawson and Weinstein, 2002b). These studies
have led to several models of SA morphogenesis. While earlier studies
suggested that the SA is made up by 3 cells that are arranged serially in
a head to tail fashion (Childs et al., 2002), mosaic analyses and the
analysis of endothelial cell junctions showed that SAs are composed of
4–6 cells that extensively overlap along the proximodistal axis of the
vessel (Blum et al., 2008). Taken together, these findings suggest a
model of SA formation, as shown in Fig. 3. Initially, one or two cells
migrate out of the epithelium of the DA forming the sprout (Fig. 3A).
During dorsal outgrowth, this sprout consists usually of 3–4 cells, one
tip cell and two or three stalk cells (Fig. 3B). When the tip cell has made
contacts with its anterior and posterior neighbors, the basic scaffold of
the SA is formed (Fig. 3C). Because of cell divisions that occur at
varying time points, the stalk can consist of a variable number of cells
generating a large degree of morphological heterogeneity, which is
illustrated by the variation of junctional patterns (Blum et al., 2008).
However, further cell divisions and cellular rearrangements during
vessel assembly lead to a paired configuration of cells along the
proximodistal extent of the SA, which then forms a lumen. In the
following section, we discuss some of the morphogenetic and mole-
cular mechanisms that govern the different aspects of SA formation.
Since much progress has also been made in other angiogenesis models,
we will discuss them in comparison with SA formation.
Sprouting of SA and SV appears to be triggered by different signals.
For example, VEGF-A is critical for SA formation, while it appears
dispensable for SV formation, since SV sprout normally in embryos
that are mutant for phospholipase C-γ (plc-γ , which is a downstream
mediator of VEGF-A/VEGFR-2 signaling; Bahary et al., 2007; Habeck et
al., 2002; Lawson et al., 2003; Nasevicius et al., 2000; Covassin et al.,
2009; Covassin et al., 2006). Here, we will focus on the morphogenesis
of the SA. The regulation of angiogenesis by VEGFs and their receptors
has been studied in many previous publications in great detail
(reviewed by Cébe-Suarez et al., 2006; Matsumoto and Mugishima,
2006; Olsson et al., 2006; Shibuya and Claesson-Welsh, 2006;
Yamazaki and Morita, 2006). While early studies focused on general
pro-angiogenic functions of VEGF signaling, more specific roles for
VEGF signaling in patterning of angiogenic sprouts have recently been
revealed (Covassin et al., 2006; Gerhardt et al., 2003; Ruhrberg et al.,
2002). Upon VEGF-A/VEGFR-2 signals, ECs initiate the angiogenic
program, which entails the loosening of junctional connections with
neighboring cells, migratory behavior towards the angiogenic
stimulus and cell division (reviewed by Lampugnani and Dejana,
2007). Cells within the nascent sprout respond in different ways to
the VEGF-A. Whereas cells located at the base (termed stalk cells)
show increased rates of proliferation, the leading cell (termed tip cell)
sends long and dynamic filopodia into the surrounding environment
to guide the growing sprout towards the stimulus (Gerhardt et al.,
2003). Endothelial tip and stalk cells do not only have different
functions and behaviors (discussed below), they also show differ-
ences in gene expression. For example, Platelet derived growth factor
B (Pdgfb) and Flt4 are expressed at higher levels in the tip cell than in
the stalk cell (Gerhardt et al., 2003; Siekmann and Lawson, 2007).
Patterning and angiogenic behavior of sprouts are regulated by the
cooperation of the Notch and VEGFR-2 signaling pathways (Hellström
et al., 2007; Siekmann et al., 2008; Siekmann and Lawson, 2007;
Suchting et al., 2007; reviewed by Phng and Gerhardt, 2009;
Siekmann et al., 2008). The tip cell, receiving the highest level of
VEGFR-2 signal, responds with an upregulation of the Notch ligand
Delta-like-4 (DLL4), which leads to increased intracellular Notch
signaling in the neighboring stalk cells (Hellström et al., 2007). In
zebrafish, loss of DLL4 function leads to prolonged angiogenic activity
in the ISVs, whereas over-activation of Notch signaling leads to a
quiescent phenotype (Leslie et al., 2007; Siekmann and Lawson,
2007). DLL4 also regulates angiogenesis by suppressing VEGF-C
dependent FLT4 (VEGFR-3) signaling in endothelial cells in mouse
and fish (Hogan et al., 2009; Tammela et al., 2008). In zebrafish, VEGF-
C/FLT4 signaling is required for venous and lymphatic development
(Covassin et al., 2006; Küchler et al., 2006). However, a “kinase-dead”
allele of FLT4 is able to rescue the hyperbranching phenotype caused
by the loss of DLL4 function (Hogan et al., 2009). Furthermore, in the
absence of DLL4, arterial cells become more sensitive to varying levels
of VEGF-C in the embryo (Hogan et al., 2009). These experiments
point out a mechanism for how different endothelial lineages can
respond specifically to sources of VEGF-C in the trunk. Venous and
lymphatic cells, which do not express dll4, are able to respond to
VEGF-C/FLT4, whereas in arterial cells this pathway is inhibited by
DLL4 (Hogan et al., 2009).
Although the molecular mechanisms that control angiogenic
behavior in the sprout may not be identical in fish and mouse, there
is a common theme in that differences in intracellular Notch signaling
confer different cell behaviors along the proximodistal axis of the
sprout. Tip cells (low Notch) extend numerous filopodia, are highly
migratory and thus display the strongest angiogenic behavior while
the proximal stalk cells (high Notch) appear less migratory. It has
Fig. 3. A model for the morphogenetic events that lead to the formation of ISV and DLAV in the Trunk. Two neighboring sprouts are depicted as representative examples. The leading
cells are indicated in green and purple, respectively. At 22 hpf ECs of the DA form sprouts (A) that grow along the somite boundaries up to the dorsal roof of the neural tube (B).
During these stages, the sprout consists of 2 to 4 cells that are stabilized by interendothelial junctions (not indicated). At the dorsal side of the embryo, the tip cells send extensions
toward their anterior and posterior neighbors to establish connections. During this phase, the ECs establish a scaffold consisting of a vascular cord that is not yet lumenized (B, C).
Further cell rearrangements and cell divisions lead to formation of a continuous apical surface that may surround initial luminal spaces (yellow) (D). At around 32 hpf, a secondary
wave of angiogenic sprouts emerges from the PCV. These sprouts either generate a group of lymphatic cells, called parachordal lymphangioblasts (not shown), or connect with the
adjacent primary vessel (D, on the right), which will become a segmental vein. Blood flow in ISVs commences after SA, SV and DLAV have been established (E).
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been proposed that the reduced migratory behavior of stalk cells is
important to maintain sprout integrity and connection to the DA
(Siekmann et al., 2008).
While the general aspects of angiogenesis in the ISVs of the fish
and the postnatal vasculature of the mouse retina are very similar,
there appear to be differences in gene expression and pattern of cell
proliferation. While in the mouse retina cell proliferation is largely
restricted to the stalk (Gerhardt et al., 2003), in fish similar rates can
be observed in stalk and tip cells (Blum et al., 2008). Furthermore,
based on gene expression—intersegmental sprouts in the fish appear
not as polarized as those in the mouse retina. In contrast to the mouse
retina, the tip cell markers dll4 and flt4 are quite uniformly expressed
in tip and stalk cells of the sprouting SA (Hogan et al., 2009; Leslie et
al., 2007; Siekmann and Lawson, 2007). Similar to zebrafish, ISV
sprouts in the mouse embryo show a relatively even distribution of
DLL4 protein (Tammela et al., 2008). These differences between
distinct types of blood vessels raise the possibility that, compared to
the mouse retina, the state of the tip cell in ISV is less defined. It will be
interesting to see whether these differences are due to different
interpretations of VEGF/Notch signals or whether they are connected
to different morphogenetic processes occurring in the two systems
(see below).
How the angiogenic sprout lumenizes is still controversial.
Different morphogenetic behaviors and cellular configurations in
the sprout can have significant impact on how a vessel is formed. In
principle, there are at least 3 different morphogenetic processes of
tubulogenesis that may occur in an angiogenic sprout: budding, cord
hollowing or cell hollowing (see Fig. 4A). When a novel tube is formed
by budding, the ECs that follow the tip cells maintain their epithelial
character with a defined apical–basal polarity. During budding, the
luminal space of the sprout remains continuous with that of the
parent vessel, extending up to the tip cell. Tube branching by budding
has been described in many experimental systems including the
tracheal system in Drosophila and several branched organs in
mammals (Baer et al., 2009). Vessel branching by budding appears
to occur in larger caliber capillaries that are constantly perfused. In the
mouse retina, the lumen is located immediately adjacent to the tip cell
(see Fig. 4B). In addition, in vivo time-lapse recording of blood vessels
in the zebrafish brain appears consistent with such morphogenetic
mode of tubular branching (Huisken and Stainier, 2009).
Formation of ISV does not occur by budding since the initial
sprouts do not contain a lumen continuous with the DA (Fig. 4C).
Rather, the lumen becomes patent at the time when SA, DLAV and SV
have formed proper connections. After labeling circulating blood with
fluorescent tracer dyes, it was observed that (from the perspective of
the DA) the lumen opens up in a stepwise manner from proximal to
Fig. 4. Different morphogenetic mechanisms that underlie sprouting angiogenesis. (A)
Three examples for the cellular organization of an angiogenic sprout. Depending on
how the cells are arranged in the sprout, different types of vessels may form. Left:
Branching morphogenesis by budding. ECs remain epithelial, while the sprout grows
via cell division within the stalk. The lumen remains open and continuous at all times.
Middle: Formation of a multicellular tube by cord hollowing. This shows an example,
where cells grow in a paired configuration maintaining an apical surface in between.
The lumen remains open at the base but is closed in distal region. Close to the tip, cells
may be of a more mesenchymal character and undergo cell divisions. Cellular
rearrangements will then lead to a continuous apical surface and open up the luminal
space. Right: Formation of a unicellular tube with an intracellular lumen. At the tip of a
capillary, the lumen may also form within a string of cells. The cells hollow out by
vacuole formation followed by exocytosis. This mode of lumen formation will generate
a so-called intracellular lumen. (B) Lumen formation behind the leading tip cell in the
mouse retina. The lumen of the nascent sprout extends to the tip of the growing sprout.
This situation is in agreement with the configuration shown in panel A. Isolectin B4
labeling (green) of an endothelial tip cell projecting long filopodia. Nuclei, Dapi, blue
(B). Semithin (B′) and close up of ultrathin (B″) en face section of the sprouting front in
the retina illustrating continuous lumen formation (l) just behind the tip cell (t). The
endothelial tip cell in panel C is pseudocolored brown. Figure courtesy of Denise Stenzel
and Holger Gerhardt, London Research Institute—Cancer Research UK. © Gerhardt et al.,
2003. Originally published in J. Cell Biol. doi:10.1083/jcb.200302047. (C) Lumen
formation in the ISV and DLAV of a zebrafish embryo. During scaffold formation, neither
ISV nor DLAV are perfused, suggesting that the lumen is formed subsequently. Blood
flow is initiated after subsequent remodeling and establishment of the intersegmental
veins (compare to Fig. 3). Confocal still pictures from an in vivo time-lapse movie of a
transgenic zebrafish embryo (TG:fli1a:EGFPy1;gata1:DsRedsd2). ECs are labeled in green;
erythrocytes are labeled in red. (D) Alternate models of lumen formation in the
zebrafish ISV. Depending on the cellular arrangement of cells in an angiogenic sprout,
de novo lumen formation can occur in at least two different ways. If cells are arranged in
a serial fashion, the lumen may be generated by cell hollowing (left, see also A). In this
process, ECs pinocytose solutes from extracellular space and form vacuoles that
coalesce and fuse to give rise to an intracellular lumen. Eventually intracellular vacuoles
of neighboring cells will fuse by exocytosis and form a patent lumen (see Kamei et al.,
2006). Alternatively, if cells are arranged in a paired fashion, they may form a lumen by
cord hollowing (right, see also A). This process requires establishment of a continuous
apical surface that is bounded by at least two ECs. Vacuoles can then be exocytosed into
this intercellular space, which will eventually become the vascular lumen.
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distal (Kamei et al., 2006). Because vacuole formation and fusion has
long been considered an important component of lumen formation,
the stepwise expansion of luminal space was interpreted as a
succession of vacuolar fusion events that generate a unicellular tube
containing an intracellular lumen (Kamei et al., 2006; Fig. 4D).
Capillaries that contain intracellular lumens have indeed been
described (Bar et al., 1984) and have been called “seamless tubes”
because they are characterized by the absence of cell junctions along
the longitudinal axis of the vessel. More recently, analyses of cell
junctions within nascent sprouts and patent ISVs showed that the
cells in the stalk overlap extensively along the proximodistal axis and
that ISVs are multicellular tubes containing an extracellular lumen
(Blum et al., 2008). This cellular configuration is more consistent with
a lumen formation process by cord hollowing (Fig. 4D). In this model,
cells in the stalk rearrange to form a continuous apical surface. The
lumen is then formed by a process, in which small pre-luminal spaces
(rather than vacuoles) are formed by exocytosis and/or paracellular
influx of liquids. The stepwise opening of the lumen from the direction
of the aorta would then be consistent with the completion of cell
rearrangements in the stalk. The events described here would be quite
comparable to those described above for the lumen formation in the
dorsal aorta.
The three mechanisms discussed here are not necessarily mutually
exclusive. For example, it is possible that sprouting angiogenesis
contains aspects of both, budding and chord hollowing, depending on
the extent to which apical–basal polarity is maintained in the stalk
cells. Likewise, it is possible that a single blood vessel contains regions
of intracellular as well as regions of extracellular lumen. Taken
together, it is clear that different vessels can form by various morpho-
genetic mechanisms. It remains to be explored what the decisive
factors are that determine which mechanism is used. It is likely that
parameters such as vessel caliber, blood pressure of the parental
vessel as well as cell number within the sprout play important roles.
Guidance cues along the way—endothelial pathfinding
To effectively oxygenate a given organ, blood vessels have to be
evenly distributed within this tissue. This can be achieved in different
ways, for example by controlling the number of angiogenic sprouts
that are generated (e.g. ISV) or by the formation of a plexus (e.g.
retinal vasculature in the mouse), which is then remodeled by a
pruning process. In recent years, a number of ligands (and their
respective receptors) that provide endothelial guidance cues have
been described, including the Semaphorin, Netrin, Ephrin and Slit
systems (reviewed by Larrivée et al., 2009). Interestingly, these
signals were originally described as cues for axonal growth cones
(reviewed by Eichmann et al., 2005). It has become clear since that
many of the signaling pathways that act during axonal pathfinding are
also employed for guidance of angiogenic sprouts.
In the zebrafish, the guidance of angiogenic sprouts is best studied
during SA formation. Segmental arteries sprout from the DA at the
intersomitic boundary; as they grow out, they follow the intersomitic
fissure up to the horizontal myoseptum, from where they change their
path to grow more or less straight to the dorsal roof of the neural tube.
The exit point of intersegmental sprouts is regulated by molecular
guidance cues. In out of bounds (obd) mutants, angiogenic sprouts
form ectopically along the ventral somite border (Childs et al., 2002).
Furthermore, these sprouts no longer avoid the ventral somite and the
ISVs take on a plexus-like organization. Molecular analyses showed
that obd encodes the receptor PlexinD1 that is expressed in ECs and
interacts with the ligands SEMA3A1/2, which is expressed in ventral
somites. Upon ligand binding, a repulsive signal is activated in the ECs
prohibiting them from moving into the somite region (Torres-
Vazquez, 2004). Recently, it has been shown that the interaction of
different Plexins and Semaphorins is also important for the timing of
SA sprout formation (Lamont et al., 2009).
Analyses in mouse have uncovered an additional and quite
different molecular mechanism that limits the number of sprouts.
Bautch and coworkers have shown that a soluble form of FLT-1
(VEGFR-1), sFLT-1, is secreted from ECs adjacent to the forming sprout
(Chappell et al., 2009). This isoform is able to bind VEGF, thereby
removing it from the environment surrounding the sprout. It is
thought that sFLT-1 serves two purposes: it ensures the ordered
formation of sprouts from an activated endothelium and it prevents
the early sprout to connect back to its original vessel.
The sharing of attracting and repulsive signaling pathways by
neurons and ECs appears to be a common theme. In fact, it has been
shown that growing neurons and nascent capillaries can walk the
same tracks (Mukouyama et al., 2002). It will be interesting to see
whether in these instances neurons and ECs simply use the same
cues provided by the stromal cells or whether they also navigate by
direct cell–cell interactions. It is noteworthy that not only the tip cell
but also stalk cells appear to express guidance receptors albeit at
lower levels (Larrivée et al., 2009). In zebrafish, for example, the
guidance receptor PlexinD1 is expressed at comparable levels in the
tip and the stalk of nascent SA (Torres-Vázquez et al., 2004). This
raises the possibility that also stalk cells are involved in angiogenic
pathfinding. Indeed, it appears that the tip cell fate is not fixed and
that cells at the stalk can become tip cells and vice versa. In murine
allantoic explant cultures, migratory ECs are passing each other at
the tip (Perryn et al., 2008). In a similar fashion, ECs are changing
lead during the outgrowth of vascular cords that sprout from
differentiating murine embryonic stem cells (Holger Gerhardt,
personal communication). It has been suggested that these tip cell
turnovers are regulated by oscillations in Notch signaling along the
vascular sprout (Phng and Gerhardt, 2009). It should be noted that
these vascular cords are not perfused during early outgrowth and
are, in that respect, similar to developing SAs rather than vessels in
the postnatal mouse retina.
Cell–cell adhesion during sprouting angiogenesis
The above observations indicate that the angiogenic sprout is
highly plastic with regard to signaling events and cell–cell interac-
tions and that cellular rearrangements play an important role in blood
vessel morphogenesis. It is generally believed that cellular rearrange-
ments involve remodeling of intercellular junctions (Baer et al., 2009).
In Drosophila, adherens junctions play an important role for cellular
rearrangement during various processes, such as border cell migra-
tion or tracheal morphogenesis (Pacquelet and Rørth, 2005; Ribeiro et
al., 2004). In the case of border cell migration very different cell
behaviors, invasive cell migration and cell adhesion require DE-
cadherin. These distinct cellular activities are mediated by homophilic
interactions of DE-cadherin between different cell types: interactions
among border cells maintain cohesion of the migratory cells while
interactions between border cells and nurse cells allow invasive
migration into the substratum (Niewiadomska et al., 1999). The role
of VE-cadherin during vertebrate angiogenesis is less clear. Mice that
are mutant for VE-cadherin die at mid-gestation exhibiting vascular
defects that are consistent with a role for VE-cadherin in maintaining
vascular integrity (Carmeliet et al., 1999; Crosby, 2005). Further in
vitro analyses have also emphasized a role of VE-cadherin in
endothelial cell survival and stabilizing the endothelium, in part by
antagonizing VEGFR-2 signaling (reviewed by Lampugnani and
Dejana, 2007; Vestweber et al., 2009). Recent organotypic cell culture
and knockdown experiments in zebrafish point at a role of VE-
cadherin in angiogenic sprouting (Abraham et al., 2009). In these
studies, quiescent endothelial tubes did not respond to VEGF
stimulation unless VE-cadherin function was reduced. They further
showed that VE-cadherin suppresses sprouting by inhibiting VEGF-
R2/RAC1 signaling. In the zebrafish ISV, knockdown of VE-cadherin
led to the formation of ectopic “branch points” along the proximo-
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distal axis of the ISV, which were interpreted as prolonged angiogenic
behavior of the ECs within the ISV.
While the above results suggest an anti-angiogenic function, other
studies indicate a more pro-angiogenic role for VE-cadherin. As
discussed above, blood vessel formation is a very dynamic process
involving cell rearrangements and cell migration. These dynamics
have been studied using murine allantoic explant cultures, which
allow to measure the migration of individual and groups of ECs in a
process called vasculogenic sprouting, which involves the outgrowth
of multicellular sprouts from a primary plexus (Perryn et al., 2008;
Rupp et al., 2004). ECs actively migrate over the substrate, frequently
passing each other during outgrowth of the vascular rod. These
rearrangements are effectively inhibited by addition of a VE-cadherin
blocking antibody (Perryn et al., 2008), indicating that VE-cadherin is
required for cellular rearrangements as they occur during vasculo-
genic sprouting. In zebrafish, we have observed that VE-cadherin is
also essential for cellular rearrangements during SA formation (H.-G.
Belting and M. Affolter, unpublished observation). Therefore, it
appears that in addition to functions in vascular integrity and cell
survival, VE-cadherin is also involved in sprouting angiogenesis. One
can easily imagine that, analogous to the role of DE-cadherin in border
cell migration, VE-cadherin may fulfill dual functions at the same
time: maintenance of cell–cell contacts and cellular rearrangements.
Conclusions and perspectives
Blood vessel formation includes a spectrum of different morpho-
genetic processes such as budding, cord hollowing, cell hollowing, cell
wrapping and intussusception. The genetic and molecular bases,
which initiate and control these different processes is not known. It is
clear, however, that ECs of different vascular beds are different in their
gene expression profile and that blood vessels are anatomically highly
diverse (Rocha and Adams, 2009). Morphogenesis may also be
influenced by extraneous factors such as diverse extracellular
matrices and signals, shear stress due to blood pressure or differences
in cell number (Aird, 2007; Nguyen et al., 2006; Sottile, 2004).
The morphogenetic events that underlie blood vessel formation
are likely to determine the way a vessel ultimately lumenizes. During
sprouting angiogenesis, larger vessels appear to extend their lumens
in conjunction with the outgrowing sprout, while small capillaries
may form their lumens de novo by cell hollowing or cord hollowing.
The respective contribution to lumen formation in different vessels
remains to be determined.
Elaboration of the vascular tree requires additional processes, such
as vessel fusion and pruning. How these processes occur at the
morphogenetic level has not yet been described in much detail. With
regard to vessel fusion, one can envisage that cellular remodeling
plays a major role. Furthermore, it is likely that the fusion process
occurs differently depending on vessel type. In the zebrafish, the
DLAVs form in a non-perfused state and blood circulation commences
subsequently. Recently, VE-cadherin localization during DLAV forma-
tion revealed that cells from adjacent sprouts undergo extensive
rearrangements (Blum et al., 2008). Initial contacts between neigh-
boring sprouts require VE-cadherin, as knockdown of VE-cadherin
function leads to slowed-down formation of cell–cell contacts
(Montero-Balaguer et al., 2009). It will be interesting to examine
the exact cellular mechanisms that drive vessel fusion during DLAV
formation and compare them with those occurring in perfused
vessels.
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